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Reesha	  R.	  Patel	  	   NAV1.1	  AND	  NAV1.6:	  ELECTROPHYSIOLOGICAL	  PROPERTIES,	  EPILEPSY-­‐ASSOCIATED	  MUTATIONS	  AND	  THERAPEUTIC	  TARGETS	  	  Voltage-­‐gated	   sodium	   channels	   (VGSCs)	   are	   critical	   for	   the	   initiation	   and	  propagation	   of	   electrical	   signals	   in	   neurons;	   consequently	   they	   are	   significant	  regulators	   of	   neuronal	   excitability.	   They	   are	   exquisitely	   tuned	   and	   aberrations	   in	  their	  activity	  can	  lead	  to	  pathophysiological	  conditions.	  This	  dissertation	  highlights	  the	   roles	   of	   two	   prominent	   brain	   isoforms	   of	   VGSCs,	   Nav1.1	   and	   Nav1.6.	   These	  isoforms	  have	  distinct	  localization	  in	  the	  brain.	  Specifically,	  Nav1.1	  is	  predominantly	  expressed	   in	   the	   soma	   and	   proximal	   axon	   initial	   segment	   (AIS)	   of	   GABAergic	  neurons,	   while	   Nav1.6	   is	   found	   at	   the	   distal	   AIS	   and	   nodes	   of	   Ranvier	   of	   both	  GABAergic	  and	  excitatory	  neurons.	  Several	  mutations	  have	  been	  identified	  in	  Nav1.1	  and	   recently	   mutations	   in	   Nav1.6	   have	   been	   discovered	   in	   patients	   with	   distinct	  epileptic	  phenotypes	  that	  respond	  poorly	  to	  current	  anti-­‐epileptics.	  There	  is	  a	  need	  to	  better	  understand	  mechanistically	  how	  mutations	  in	  these	  channel	  isoforms	  lead	  to	  epilepsy	  in	  order	  to	  identify	  more	  efficacious	  treatment	  strategies.	  Therefore,	  the	  aims	  of	  this	  dissertation	  were	  to	  1)	  examine	  the	  differential	  biophysical	  properties	  of	   Nav1.1	   and	   Nav1.6,	   2)	   determine	   the	   biophysical	   consequences	   of	   epilepsy-­‐associated	  mutations	  in	  Nav1.1	  and	  Nav1.6	  and	  examine	  the	  effects	  of	  cannabinoids	  on	   wildtype	   and	   mutant	   channel	   activity	   and	   3)	   test	   the	   effects	   of	   selective	  inhibition	  of	  Nav1.1	  versus	  Nav1.6	  on	  epileptiform	  activity.	  To	  address	  these	  aims,	  whole-­‐cell	   electrophysiology	   and	  mutlielectrode	   array	   recordings	  were	  used.	   	   The	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results	  demonstrate	  that	  1)	  Nav1.1	  and	  Nav1.6	  have	  important	  differences	  in	  their	  biophysical	   properties	   that	   may	   be	   important	   in	   the	   fine-­‐tuning	   of	   neuronal	  excitability,	   2)	   epilepsy-­‐associated	   mutations	   in	   Nav1.1	   and	   Nav1.6	   alter	   several	  biophysical	   properties	   of	   the	   channels	   but	   have	   differential	   effects	   on	   resurgent	  current	  generation	  suggesting	  a	  divergence	  in	  the	  mechanism	  by	  which	  they	  induce	  epileptogenesis	   and	   cannabidiol	   can	   inhibit	   aberrant	   channel	   activity	   and	   reduce	  neuronal	   excitability	   and	  3)	   pharmacological	   inhibition	  of	  Nav1.6,	   but	   not	  Nav1.1,	  abolishes	   epileptiform	   activity.	   Overall,	   this	   dissertation	   provides	   insight	   into	   the	  distinct	  contributions	  of	  Nav1.1	  and	  Nav1.6	  to	  physiological	  and	  pathophysiological	  firing	   activity	   and	   their	   ability	   to	   be	   targeted	   for	   therapeutic	   purposes.	   This	  knowledge	   is	   critical	   for	   understanding	   the	   potential	   role	   of	   VGSCs	   in	   epilepsy	  syndromes	   and	   identifying	   possible	   drug	   targets	   for	   more	   efficacious	   treatment	  strategies.	  	  	  	   	  Theodore	  R.	  Cummins,	  Ph.D.,	  Chair	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  encephalopathy	  	  FHF	   Fibroblast	  homologous	  factors	  	  GEFS+	   Generalized	  epilepsy	  with	  febrile	  seizures	  plus	  	  HEK293T	   Human	  Embryonic	  Kidney	  Cells	  with	  SV40	  Large	  T-­‐Antigen	  	  LFP	   Local	  field	  potential	  	  MPL	   1-­‐methyl-­‐2-­‐pyrrolidinone	  	  SMEI	   Severe	  myoclonic	  epilepsy	  in	  infancy	  	  TTX	  	   Tetrodotoxin	  	  VGSC	   	   	   	   Voltage-­‐Gated	  Sodium	  Channel	  	  WT	   	   	   	   	   Wildtype	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I. INTRODUCTION	  
	  A. Overview	  	  Epilepsy	   is	  one	  of	   the	  earliest	  brain	  disorders	  to	  be	  described	   in	  an	  ancient	  Babylon	  text	  on	  medicine,	  Sakikku	  –	  meaning	  ‘all	  diseases,’	  over	  3,000	  years	  ago,	  yet	  it	   still	   remains	   one	   of	   the	  most	   prevalent	   neurological	   disorders	   affecting	   over	   3	  million	   people	   in	   the	   US	   alone	   and	   65	   million	   people	   worldwide	   according	   to	  Citizens	   United	   for	   Research	   in	   Epilepsy	   (CURE).	   Epilepsy	   is	   the	   development	   of	  repeated,	   unprovoked	   episodes	   of	   abnormal	   electrical	   activity	   manifesting	   as	  episodes	   of	   convulsions	   or	   loss	   of	   consciousness	   called	   seizures.	   It	   is	   a	   frequently	  debilitating	  condition	  that	  results	  from	  an	  imbalance	  in	  the	  excitatory	  and	  inhibitory	  activity	   in	   the	  brain.	  The	  etiology	  of	  epilepsy	  has	  been	   linked	   to	   infection,	   trauma,	  genetic	   mutations,	   and	   other	   disorders	   of	   the	   brain.	   This	   dissertation	   focuses	   on	  genetic	   mutations	   identified	   in	   brain	   isoforms	   of	   voltage-­‐gated	   sodium	   channels,	  Nav1.1	   and	   Nav1.6,	   resulting	   in	   distinct	   phenotypes	   classified	   as	   early	   infantile	  epileptic	  encephalopathy	  6	  (EIEE6)	  and	  early	  infantile	  epileptic	  encephalopathy	  13	  (EIEE13),	  respectively.	  	  	  Voltage-­‐gated	   sodium	   channels	   (VGSCs)	   are	   critical	   for	   the	   initiation	   and	  propagation	   of	   electrical	   signals	   in	   neurons;	   consequently	   they	   are	   significant	  regulators	   of	   neuronal	   excitability.	   Their	   activity	   is	   exquisitely	   tuned	   and	  aberrations	  in	  their	  activity	  lead	  to	  pathophysiological	  conditions.	  Several	  hundreds	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of	   mutations	   have	   been	   identified	   in	   the	   Scn1a	   gene	   coding	   Nav1.1	   and	  with	   the	  advancement	   of	   whole-­‐exome	   sequencing,	   mutations	   in	   Scn8a	   coding	   for	   Nav1.6	  recently	  have	  been	  identified.	  Our	  current	  understanding	  of	  the	  expression	  of	  these	  channels	  in	  the	  brain	  along	  with	  the	  biophysical	  consequences	  of	  the	  many	  Nav1.1	  mutations	  and	  few	  Nav1.6	  mutations	  that	  have	  been	  characterized	  in	  heterologous	  expression	  systems	  provides	  insight	  into	  possible	  mechanisms	  by	  which	  they	  lead	  to	  changes	  in	  neuronal	  excitability,	  setting	  up	  a	  circuit	  susceptible	  to	  abnormal,	  hyper-­‐synchronous	  activity.	  One	  potential	  mechanism	   that	  has	  not	   yet	  been	  examined	   is	  alterations	   in	   resurgent	   sodium	   current	   generation	  by	   epilepsy-­‐associated	  mutant	  channels.	   Resurgent	   sodium	   current	   is	   an	   atypical,	   near	   threshold	   current	   that	  occurs	   immediately	   following	   an	   action	   potential	   and	   is	   predicted	   to	   enhance	  neuronal	   excitability.	   This	   dissertation	   examines	   the	   biophysical	   consequences	   of	  epilepsy-­‐associated	   mutations	   in	   Nav1.1	   and	   Nav1.6	   with	   a	   specific	   focus	   on	  resurgent	  sodium	  current.	  	  	  Despite	  the	  development	  of	  new	  anti-­‐epileptic	  drugs	  (AEDs),	  approximately	  20	  to	  40%	  of	  patients	  with	  a	  seizure	  disorder	  are	  refractory	  to	  treatment	  [1].	  EIEE6	  and	  EIEE13	  are	  intractable	  epilepsy	  syndromes	  that	  respond	  poorly	  to	  classic	  AEDs.	  In	   the	   case	   of	   EIEE6,	   classic	  AEDs	   that	   target	  VGSCs	   are	   contraindicated	   and	  may	  exacerbate	  seizures.	  Alternative	  therapeutic	  strategies	  are	  being	  pursued	  including:	  Nav1.1	  activators,	  ketogenic	  diets,	  and	  exogenous	  cannabinoids.	  Cannabidiol	  (CBD)	  has	  received	  much	  attention	  for	  its	  potential	  to	  treat	  intractable	  pediatric	  epilepsies,	  but	   still	   lacks	   scientific	   validation	   of	   its	   efficacy.	   The	   molecular	   mechanisms	   by	  
	   3	  
which	   CBD	   exerts	   anti-­‐epileptic	   effects	   are	   largely	   not	   known.	   This	   dissertation	  examines	  how	  both	  endogenous	  and	  exogenous	  cannabidnoids	  modulate	  wildtype	  and	   mutant	   VGSC	   activity	   and	   how	   selective	   targeting	   of	   specific	   VGSC	   isoforms	  alters	  epileptiform	  activity.	  	  	  	  	  Overall,	   this	  dissertation	  provides	   insight	   into	   the	  biophysical	  properties	  of	  brain	   isoforms	   of	   voltage-­‐gated	   sodium	   channels,	   their	   potential	   contribution	   to	  physiological	  and	  pathophysiological	   firing	  activity,	  and	  their	  ability	  to	  be	  targeted	  for	  therapeutic	  purposes.	  This	  knowledge	  is	  critical	  for	  understanding	  the	  potential	  role	  of	  VGSCs	  in	  genetic	  and	  acquired	  epilepsy	  syndromes	  and	  identifying	  possible	  drug	  targets	  for	  more	  efficacious	  treatment	  strategies.	  	  	  
	  B. Brief	  history	  of	  the	  discovery	  of	  voltage-­‐gated	  sodium	  channels	  	   Neurons,	   and	   other	   excitable	   cells,	   can	   communicate	   through	   electrical	  signals	   termed	   action	   potentials.	   Seminal	   work	   by	   Hodgkin	   and	   Huxley	   set	   the	  foundation	  of	  our	  understanding	  of	  the	  underpinnings	  of	  action	  potentials.	  In	  1939,	  Hodgkin	   and	   Huxley	   inserted	   a	   glass	   microelectrode	   into	   the	   giant	   squid	   axon,	  directly	   measuring	   the	   potential	   across	   the	   membrane,	   and	   recorded	   the	   first	  intracellular	  action	  potential	  [2].	  	  They	  found	  that	  the	  during	  the	  action	  potential	  the	  interior	  of	  the	  nerve	  becomes	  substantially	  more	  positive	  then	  the	  exterior	  and	  later	  attributed	  this	   to	  an	   increase	   in	   the	  permeability	  of	   the	  membrane	  to	  sodium	  ions	  [3].	   To	   further	   study	   current	   voltage	   relationships	   of	   the	   ionic	   currents,	   they	   and	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others	   created	   a	   new	   technique	   called	   voltage-­‐clamp,	   which	   allowed	   them	   to	  maintain	   the	   membrane	   at	   a	   specific	   potential.	   In	   a	   series	   of	   landmark	   papers,	  Hodgkin	   and	   Huxley	   described	   and	   quantitatively	   detailed	   the	   voltage-­‐dependent	  ionic	  currents	  underlying	  the	  action	  potential	  –	  the	  Hodgkin	  and	  Huxley	  model	  [4-­‐7].	  This	   foundational	  work	   later	   led	   to	   the	   idea	  proposed	  by	  Hille,	  Armstrong	  and	  others	   in	   the	   1960s	   that	   sodium	   and	   potassium	   are	   conducted	   by	   specific	   ion	  channels	  [8-­‐11].	  	  Selective	   block	   of	   channels	   by	   a	   puffer	   fish	   toxin,	   tetrodotoxin	   (TTX),	   and	  tetraethylammonium	  suggested	  that	  sodium	  and	  potassium	  ions	  must	  pass	  through	  separate	  aqueous	  pores	   [10,	  12,	  13].	  This	  was	  confirmed	  with	  development	  of	   the	  patch	  clamp	  technique	  by	  Erwin	  Neher	  and	  Bert	  Sakmann	  in	  1976	  -­‐	  in	  which	  a	  glass	  pipette	  is	  pushed	  against	  the	  cell	  membrane	  forming	  a	  tight	  seal	  with	  a	  resistance	  in	  the	  Gigaohm	  range,	  pulled	  away	  from	  the	  cell	  creating	  a	  membrane	  vesicle	  at	  the	  tip	  of	  the	  pipette,	  after	  which	  the	  membrane	  patch	  is	  ruptured	  to	  allow	  recording	  from	  single	   channels	   [14,	   15].	   The	   functional	   properties	   of	   the	   channel	   and	   molecular	  models	   of	   the	   function	   of	   VGSCs	   were	   further	   established	   in	   the	   1970s	   by	   Hille,	  Armstrong,	  Bezanilla	  and	  others	  [16].	  	  	  	   In	  1980,	  the	  voltage-­‐gated	  sodium	  channel	  α	  subunit	  was	  first	  purified	  from	  the	   electric	   eel	   (Electrophorus	   electricus)	   [17].	   The	   channels	   were	   then	   identified	  with	   scorpion	   toxins	   by	   photoaffinity	   labeling	   revealing	   a	   large	   α	   subunits	   of	   260	  kDa	  [18].	  Cloning	  and	  sequencing	  cDNA	  encoding	  the	  α	  subunits	  of	  sodium	  channels	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established	  their	  primary	  structure	  and	  showed	  that	  mRNA	  encoding	  the	  α	  subunit	  is	  sufficient	   for	  expression	  of	   functional	  channels	  [19-­‐21].	   In	  recent	  years,	   the	  first	  glimpse	  into	  the	  three	  dimensional	  structure	  of	  these	  channels	  was	  uncovered	  with	  the	   crystal	   structure	   of	   a	   related	   homo-­‐tetrameric	   bacterial	   sodium	   channel	   [22].	  Since	  their	  discovery,	  these	  channels	  have	  been	  extensively	  studied,	  and	  while	  our	  understanding	  of	  them	  has	  come	  a	  long	  way	  there	  is	  still	  much	  we	  do	  not	  know.	  	  
	   C. Voltage-­‐gated	  sodium	  channels	  	  1.	  Brief	  Description	  	   Voltage-­‐gated	  sodium	  channels	  consist	  of	  a	  large	  α	  subunit	  (~260	  kDa)	  that	  can	   associate	   covalently	   and	   non-­‐covalently	   with	   auxiliary	   proteins	   including	   β	  subunits	  (~30-­‐40	  kDa)	  of	  which	  there	  are	  four:	  Navβ1	  –	  Navβ4.	  The	  alpha	  subunit	  is	  made	  up	  of	  approximately	   two	  thousand	  amino	  acid	  residues	  that	   form	  a	  complex	  tertiary	   structure	   consisting	   of	   four	   homologous	   domains	   (DI-­‐DIV)	   linked	   by	  intracellular	  loops	  wherein	  each	  domain	  contains	  six	  transmembrane	  segments	  (S1-­‐S6)	  (Figure	  1A)	  [19].	  The	  S1	  to	  S4	  segments	  within	  each	  domain	  come	  together	  to	  form	   the	   voltage	   sensing	   module.	   Specifically,	   the	   S4	   segment	   contains	   multiple	  (four	  to	  eight)	  positively	  charged,	  basic	  residues	  (mostly	  arginines	  but	  also	  lysines)	  that	  allow	  it	  to	  ‘sense’	  changes	  in	  potential	  across	  the	  membrane,	  and	  therefore	  it	  is	  often	  referred	  to	  as	  the	  voltage	  sensor	  [19].	  	  The	  S5-­‐S6	  segments	  and	  the	  outer	  loop	  between	   them	  known	  as	   the	  P	   loop	   form	   the	  pore-­‐forming	  module	  and	  selectivity	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filter.	   	   The	   three-­‐dimensional	   structure	   of	   the	   channel,	   modeled	   in	   part	   from	   the	  crystal	   structure	   of	   the	   bacterial	   sodium	   channel,	   suggests	   that	   the	   four	   domains	  arrange	   symmetrically	   with	   the	   voltage	   sensing	   module	   lying	   outside	   the	   pore-­‐forming	   modules	   (Figure	   1B)	   [23].	   In	   a	   simplistic	   scheme,	   VGSCs	   primarily	  transition	  between	  three	  states	  as	  a	  result	  of	  movement	  of	  the	  voltage	  sensors	  and	  consequent	   conformational	   changes	   in	   the	   channel.	   At	   resting,	   hyperpolarized	  potentials	   channels	   are	   predominately	   in	   a	   closed	   state	   and	   upon	   depolarization	  channels	   transition	   to	   an	   open	   state	   to	   conduct	   sodium	   ions	   after	   which	   the	  channels	  enter	  an	  inactivate	  state	  (Figure	  1C).	  	   2. Activation	  and	  ion	  conduction	  	   Rapid,	   voltage-­‐dependent	   activation	   of	   VGSCs,	   resulting	   in	   opening	   of	   the	  channel	   upon	   depolarization,	   is	   due	   to	   outward	  movement	   of	   the	   DI-­‐DIII	   voltage	  sensors.	  The	  first	  description	  of	  this	  by	  Hodgkin	  and	  Huxley	  was	  insightful	  and	  still	  remains	  accurate.	  They	  demonstrated	  the	  steep	  voltage-­‐dependence	  of	  activation	  of	  sodium	   channels	   and	   attributed	   it	   to	   the	  movement	   of	   three	   ‘electrically	   charged	  particles’	  across	   the	  membrane	   [24].	  Cloning	  and	  sequence	  analysis	  of	   the	  sodium	  channel	  gave	  insight	  into	  the	  structure	  of	  these	  channels	  and	  the	  hypothesis	  that	  the	  S4	   segments,	   due	   to	   the	   many	   basic	   residues	   it	   contains,	   might	   act	   as	   a	   voltage	  sensor	   [19].	   Later,	   mutagenesis	   studies	   demonstrated	   that	   indeed	   mutating	   the	  positive	   residues	   in	   the	   S4	   segments	   leads	   to	   a	   decrease	   in	   the	   steepness	   of	   the	  voltage-­‐dependence	   of	   activation	   curve	   [25,	   26].	   The	   movement	   of	   the	   voltage	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sensors	  has	  been	  described	  by	  a	  ‘sliding	  helix’	  or	  	  ‘helical	  screw’	  model	  in	  which	  the	  S4	  segment	  rotates	  around	  its	  axis	  as	  it	  moves	  outward	  which	  is	  coupled	  to	  a	  rolling	  motion	  of	  the	  S1-­‐S3	  segments	  around	  the	  S4	  sensor	  [27-­‐29].	  Other	  models	  have	  also	  been	  proposed	  which	  differ	  in	  the	  distance	  and	  nature	  of	  how	  the	  S4	  segment	  moves	  [30].	  Ultimately,	  outward	  movement	  of	  the	  voltage	  sensor	  results	  in	  opening	  of	  the	  activation	  gate	   formed	  by	   the	  portion	  of	   the	  S6	   segment	   from	  each	  domain	  at	   the	  intracellular	  surface	  of	   the	  channel	  [22].	  The	  rapid	  activation	  property	  of	  VGCSs	   is	  unique	   and	   allows	   for	   the	   steep	   upstroke	   of	   the	   action	   potential	  with	   the	   specific	  movement	  of	  sodium	  ions	  through	  the	  pore	  at	  nearly	  the	  rate	  of	  free	  diffusion	  [31].	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Figure	  1.	  Voltage-­‐gated	  sodium	  channels	  A,	  Linear	  schematic	  of	  the	  structure	  of	  voltage-­‐gated	  sodium	  channels.	  B,	  Three-­‐dimensional	  side	  view	  of	  the	  channel	  from	  the	  crystal	  structure	  of	  a	  bacterial	  voltage-­‐gated	  sodium	  channel.	  C,	  Simplistic	  state	  transition	  model.	   This	   figure	  was	   created	   using	   Adobe	   Illustrator	   CS5.	   The	   three-­‐dimensional	  structure	  pictured	  in	  panel	  B	  was	  taken	  with	  permission	  (see	  Appendix	  A)	  from	  Payandeh	  et	  al.,	  Nature,	  2011.	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The	   crystal	   structure	   of	   the	   bacterial	   sodium	   channel	   revealed	   four	   major	  parts	   to	   the	   pore	   including:	   a	   large	   extracellular	   funnel,	   a	   narrow	   ion	   selectivity	  filter,	   a	   large	   central	   cavity	   followed	   by	   the	   activation	   gate	   [22].	   	   Several	   studies	  utilizing	   different	  methodological	   approaches	   demonstrated	   that	   the	   extracellular	  linker	  between	  S5-­‐S6	  segments,	  referred	  to	  as	  the	  P-­‐loop,	  form	  the	  outer	  funnel	  and	  selectivity	   filter	  while	   the	   S6	   segments	   come	   together	   to	   form	   the	   pore	   [31].	   The	  selectivity	   of	   VGSCs	   for	   sodium	   ions	   arises	   from	   the	   selectivity	   filter	   creating	   a	  seamlessly	  hydrated	  path	  for	  the	  specific	  size	  and	  charge	  of	  sodium.	  	  	   3. Inactivation	  	  Within	  1-­‐2	  milliseconds	  after	  opening,	  sodium	  channels	   typically	  undergo	  a	  process	   termed	   inactivation	   [4,	  6]	  wherein	   the	   intrinsic	   inactivation	  particle	  binds	  the	   channel	   pore	   prohibiting	   sodium	   ions	   from	   passing	   which	   is	   commonly	  described	   by	   a	   hinged	   lid	   mechanism	   (Figure	   2A).	   The	   first	   clues	   regarding	   the	  nature	  of	  the	  inactivation	  particle	  came	  from	  experimental	  application	  of	  proteolytic	  enzymes	  to	  the	  intracellular	  surface	  of	  the	  channels	  resulting	  in	  loss	  of	  inactivation	  which	  suggested	  that	  the	   inactivation	  particle	   is	  proteinaceous	   in	  composition	  and	  part	  of	  an	  intracellular	  region	  of	  the	  α	  subunit	  [11,	  25,	  32].	  Antibodies	  targeting	  the	  DIII-­‐DIV	  linker	  prevented	  inactivation	  and	  helped	  to	  further	  narrow	  the	  location	  of	  the	   inactivation	  particle	   [33,	  34].	  The	   inactivation	  particle	  was	   identified	  as	   three,	  highly	   conserved	   hydrophobic	   residues	   (isoleucine-­‐phenylalanine-­‐methionine)	  within	   the	  DIII-­‐DIV	   linker;	   the	  phenylalanine	   residue	  being	  essential	   [35,	  36].	  The	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binding	   site	   of	   the	   inactivation	   particle	   has	   been	   suggested	   to	   be	   coordinated	   by	  specific	   residues	   within	   the	   S3-­‐S4	   linker	   of	   both	   DIII	   and	   DIV	   [37,	   38].	   Another	  region	   of	   the	   channel	   important	   for	   inactivation,	   specifically	   in	   stabilizing	  inactivation	   and	   preventing	   channel	   reopening,	   is	   the	   C-­‐terminal	   tail	   region	  proximal	   to	   the	   membrane	   [39,	   40].	   The	   process	   of	   inactivation	   is	   initiated	   and	  limited	   by	   movement	   of	   the	   DIV-­‐S4	   voltage	   sensor	   due	   to	   the	   subsequent	  conformational	  change	  in	  the	  channel	  exposing	  the	  binding	  site	  for	  the	  inactivation	  particle	  [41-­‐43].	  This	  property	  of	  voltage-­‐gated	  sodium	  channels	  is	  critical	  for	  action	  potential	  repolarization	  in	  the	  absence	  of	  potassium	  channels	  and	  is	  responsible	  for	  the	   refractory	   period	   following	   an	   action	   potential	   spike	   -­‐	   regulating	   firing	  frequency.	  	  	  An	  alternative	  type	  of	  inactivation,	  referred	  to	  as	  slow	  inactivation,	  occurs	  on	  a	   longer	   timescale	   and	   is	   mediated	   by	   a	   structurally	   distinct	   process	   than	   fast	  inactivation	   [44].	   Slow	   inactivation	   is	   considerably	   less	  well	   understood	   than	   fast	  inactivation.	   	   Structurally,	   it	   has	   been	   proposed	   to	   be	   the	   result	   of	   ‘collapse’	   or	  rearrangement	   of	   the	   pore	   [45],	   although	  whether	   this	   is	   collapse	   of	   the	   inner	   or	  outer	   pore	   is	   controversial.	   Long	   depolarizations	   are	   needed	   to	   induce	   slow	  inactivation	  and	  recovery	  from	  slow	  inactivation	  can	  be	  on	  the	  orders	  of	  seconds	  or	  minutes.	  The	  functional	  role	  of	  slow	  inactivation	  on	  firing	  activity	  is	  not	  completely	  understood,	  but	  it	  has	  been	  suggested	  to	  be	  important	  in	  regulating	  excitability	  [46].	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4. Diversity	  of	  isoforms	  	   There	   are	   nine	   voltage-­‐gated	   sodium	   channel	   α	   subunits:	   Nav1.1	   –	   Nav1.9	  [47].	   These	   channels	   have	   distinct	   functional	   as	   well	   as	   pharmacological	  characteristics.	   One	   such	   pharmacological	   characteristic	   is	   their	   sensitivity	   to	  tetrodotoxin	  (TTX),	  which	  has	  been	  used	  to	  classify	  these	  channels	   into	  two	  major	  groups:	   those	   that	   are	  TTX-­‐sensitive	   (Nav1.1,	  Nav1.2,	  Nav1.3,	  Nav1.6	   and	  Nav1.7)	  with	   IC50	   values	   in	   the	   low	   nM	   range	   and	   those	   that	   are	   TTX-­‐resistant	   (Nav1.5,	  Nav1.8	   and	   Nav1.9)	   with	   IC50	   values	   in	   the	   μM	   range.	   These	   channels	   also	   have	  distinct	  expression	  patterns.	  Nav1.1,	  Nav1.2,	  Nav1.3	  and	  Nav1.6	  are	  predominantly	  expressed	   in	   the	   central	   nervous	   system	   (CNS).	   Nav1.4	   is	   primarily	   expressed	   in	  skeletal	  muscle	  while	  Nav1.5	   is	  primarily	   found	   in	   cardiac	  muscle.	  Nav1.7,	  Nav1.8	  and	   Nav1.9	   are	   primarily	   expressed	   in	   the	   peripheral	   nervous	   system.	   These	  channels	   are	   also	   expressed	   in	   tissues	   outside	   of	   their	   predominant	   locations	   to	  varying	  degrees.	   	  5. Post-­‐translational	  regulation	  	   VGSCs	   are	   highly	   regulated	   proteins	   that	   can	   undergo	   extensive	   post-­‐translational	   modifications	   throughout	   the	   intra-­‐	   and	   extracellular	   regions	   of	   the	  channel.	  There	  is	  a	  large	  body	  of	  data	  indicating	  that	  Nav1.2	  and	  Nav1.5	  activity	  can	  be	   regulated	   by	   a	   multitude	   of	   post-­‐translational	   modifications	   and	   second	  messenger	   proteins	   including:	   phosphorylation,	   palmitoylation,	   methylation	   and	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calmodulin.	  Phosphorylation,	  the	  covalent	  addition	  of	  a	  phosphoryl	  group	  to	  serine,	  threonine	   or	   tyrosine	   residues	   mediated	   by	   various	   kinases,	   can	   modulate	   VGSC	  activity.	   	   Protein	   kinase	   A	   has	   been	   found	   to	   both	   increase	   and	   decrease	   peak	  sodium	  current	  [48-­‐50].	   	  Protein	  kinase	  C	  decreases	  sodium	  current	  and	  slows	  the	  rate	   of	   inactivation	   [51,	   52]	   while	   Fyn	   kinase	   decreases	   peak	   sodium	   current,	  increases	  the	  rate	  of	   inactivation	  and	  shifts	  the	  voltage-­‐dependence	  of	   inactivation	  to	   more	   hyperpolarizing	   potentials	   [53].	   	   Other	   kinases	   have	   also	   been	   found	   to	  modulate	  VGSC	  activity	  [54,	  55].	  Less	  studied	  post-­‐translational	  modifications	  such	  as	   palmitoylation,	   the	   covalent	   attachment	   of	   a	   lipid	   palmitate	   group	   to	   cysteine,	  serine	   or	   threonine	   residues	   catalyzed	   by	   thioesteraes,	   and	   methylation,	   the	  attachment	  of	  a	  methyl	  group	  to	  arginine	  or	  lysine	  residues,	  have	  also	  been	  found	  to	  modulate	   VGSC	   activity.	   Pharmacologically	   inhibiting	   palmitoylation	   of	   Nav1.2	  slows	   the	   rate	   of	   inactivation	   as	   well	   as	   the	   recovery	   from	   inactivation	   [56].	  Methylation	   of	   Nav1.5	   increases	   peak	   sodium	   current	   by	   increasing	   surface	  expression	   of	   the	   channel	   [57].	   Numerous	   other	   post-­‐translational	   modifications	  have	  also	  been	  proposed	   to	  modulate	  VGSC	  activity	  and	  still	  others	  have	  not	  been	  explored.	  	  Beyond	   post-­‐translational	   regulation,	   many	   other	   interacting	   proteins	   or	  second	  messenger	  proteins,	  activated	  downstream	  of	  primary	  signaling	  molecules,	  can	   directly	   bind	   to	   the	   channel	   and	   modulate	   their	   activity.	   	   A	   major	   second	  messenger	   is	   calcium,	  which	   can	   lead	   to	   the	   activation	   of	   calmodulin.	   Calmodulin	  has	  been	  found	  to	  bind	  to	  different	  regions	  of	  VGSCs	  in	  the	  presence	  and	  absence	  of	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calcium	   [58,	  59].	   	  Depending	  on	   the	   state	  of	   the	   calmodulin,	   region	  of	   interaction,	  and	  VGCS	  isoform,	  calmodulin	  can	  alter	  various	  properties	  of	  VGSCs	  [60].	  	  Much	   less	   is	  known	  about	  modulation	  of	  Nav1.1	  and	  Nav1.6.	  While	  Nav1.1,	  Nav1.2	   and	   Nav1.6	   are	   highly	   conserved;	   they	   exhibit	   clear	   differences	   in	   their	  functional	   properties.	   It	   is	   likely	   that	   these	   two	   isoforms	   are	   differentially	  modulated	  but	   this	  needs	   to	  be	   further	  explored.	  These	  modifications	  by	  signaling	  pathways	  and	  second	  messenger	  modifications	  can	  be	  altered	  in	  disease	  states	  and	  may	  be	  involved	  in	  episodic	  disorders	  such	  as	  epilepsy	  [61].	  	  	  D. Resurgent	  sodium	  current	  	  1. Mechanism	  
	   Resurgent	   sodium	   current	   is	   the	   result	   of	   unbinding	   of	   an	   open-­‐channel	  blocker	   at	   intermediate	   repolarizing	   potentials	   following	   depolarization.	   After	  depolarization	  and	  channel	  opening,	  and	  under	  specific	  conditions,	  some	  fraction	  of	  the	  channels	  can	  undergo	  a	  blocked	  state	  that	  is	  faster	  than	  and	  distinct	  from	  classic	  fast	   inactivation.	   Upon	   repolarization	   to	   negative,	   intermediate	   potentials	   the	  blocker	   unbinds	   allowing	   the	   flow	   of	   resurgent	   current	   after	   which	   the	   channels	  inactivate	  or	  deactivate	  (Figure	  2A)	  [62]	  .	  This	  can	  allow	  channels	  to	  cycle	  between	  open,	  blocked	  and	  unblocked	  states	  bypassing	  fast	  inactivation,	  which	  is	  responsible	  for	  the	  refractory	  period	  following	  an	  action	  potential,	  permitting	  rapid	  firing.	  As	  the	  open-­‐channel	  blocker	  is	  thought	  to	  compete	  with	  the	  intrinsic	   inactivation	  particle	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to	   bind	   the	   channel	   pore,	   the	   rate	   of	   fast	   inactivation	   is	   a	   major	   determinant	   of	  resurgent	  sodium	  current	  generation.	  This	  has	  been	  demonstrated	  with	  both	  toxins	  as	  well	  as	  by	  disease	  mutations	  that	  result	  in	  a	  slower	  rate	  of	  fast	  inactivation	  and	  consequently	  enhance	  resurgent	  sodium	  currents	  [63-­‐65].	  These	  currents	  were	  first	  described	  in	  cerebellar	  Purkinje	  neurons	  [66].	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Figure	  2.	  Mechanism	  of	  resurgent	  sodium	  current	  generation	  A,	  Illustration	  of	  channel	   conformations	   at	   each	   potential	   step	   in	   the	   voltage	   protocol.	   Current	  produced	  when	  channels	  undergo	  classic	  fast	  inactivation	  (blue	  dotted	  trace)	  versus	  current	  produced	  when	  some	  fraction	  of	  the	  channels	  undergo	  open	  channel	  block	  (red	   trace)	   can	  be	   seen	  below	   the	   corresponding	  voltage	  protocol.	  B,	  Depiction	  of	  where	   inward	   resurgent	   sodium	   current	   would	   occur	   during	   a	   typical	   action	  potential.	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To	  date,	   the	  only	   identified	  endogenous	  open	  channel	  blocker	   implicated	   in	  resurgent	   current	   generation	   is	   Navβ4.	   Navβ4	   –	   null	   mice	   have	   complete	   loss	   of	  resurgent	   sodium	   current	   in	   medium	   spiny	   neurons	   of	   the	   striatum	   [67].	  Knockdown	   of	   Navβ4	   via	   small	   interfering	   RNA	   in	   cerebellar	   granule	   neurons	  abolishes	  resurgent	  sodium	  current	  which	  can	  be	  restored	  with	  Navβ4	  peptide	  [68].	  Additionally,	  knockdown	  of	  Navβ4	  in	  dorsal	  root	  ganglion	  (DRG)	  neurons	  decreased	  resurgent	   sodium	   current	   while	   overexpression	   of	   Navβ4	   increased	   Nav1.6	  mediated	   resurgent	   sodium	   current	   [69].	   Specifically,	   the	   membrane	   proximal	   C-­‐terminal	   portion	   of	   the	   Navβ4	   subunit,	   containing	   several	   positively	   charged	   and	  hydrophobic/aromatic	   residues,	   acts	   as	   an	   open	   channel	   blocker.	   Indeed,	  intracellular	   addition	   of	   a	   peptide	   mimicking	   this	   sequence,	   Navβ4154-­‐167	  (KKLITFILKKTREK),	   can	   recapitulate	   resurgent	   sodium	   currents	   in	   heterologous	  expression	   systems	   lacking	   an	   endogenous	   open	   channel	   blocker	   [70,	   71].	  	  Intriguingly,	   co-­‐expression	   of	   the	   VGSC	   α	   subunit	   and	   Navβ4	   is	   not	   sufficient	   to	  produce	   resurgent	   sodium	  currents	   in	   some	  heterologous	  expression	   systems	   (i.e.	  HEK293	   and	   ND7/23	   cells)	   suggesting	   that	   other	   modulatory	   proteins	   and/or	  cellular	  background	  factors	  are	  critical.	  A	  requirement	  for	  resurgent	  sodium	  current	  generation,	   at	   least	   in	   Purkinje	   neurons,	   is	   phosphorylation	   of	   part	   of	   the	   sodium	  channel	  complex	   [72].	   Intracellular	  application	  of	  alkaline	  phosphatase	   to	  outside-­‐out	  patches	  from	  Purkinje	  neurons	  abolishes	  resurgent	  sodium	  current	  and	  this	  can	  be	  partially	  rescued	  with	  the	  phosphatase	  inhibitor	  vanadate	  [63,	  73].	  Interestingly,	  β	   toxins,	   an	   exogenous	   open	   channel	   blocker,	   can	   produce	   a	   similar	   resurgent	  sodium	  current	  [74].	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Several	   studies	   have	   identified	   modulatory	   proteins	   and	   chemical	  compounds	   that	   alter	   the	   activity	   of	   resurgent	   sodium	   current.	   Fibroblast	  homologous	  factors	  (FHFs),	  auxiliary	  proteins	  of	  sodium	  channels,	  inhibit	  resurgent	  current	   generation	   by	   biasing	   channels	   to	   an	   inactive	   state	   [75].	   Inflammatory	  mediators	  can	  enhance	  fast	  resurgent	  sodium	  current	  as	  well	  as	  resurgent	  current	  with	   slow	   kinetics	   generated	   by	   TTX	   resistant	   Nav1.8	   expressed	   in	   DRG	   neurons	  [76].	  It	  is	  not	  entirely	  clear	  how	  inflammatory	  mediators	  increase	  resurgent	  sodium	  current	  generation,	  but	  one	  possibility	  is	  that	  these	  molecules	  are	  acting	  indirectly	  via	   signaling	   pathways	   leading	   to	   post-­‐translational	   modification	   of	   the	   channel	  complex.	   Indeed,	   protein	   kinase	   C	   phosphorylation	   of	   a	   serine	   residue	   (1479)	   in	  Nav1.7	   has	   been	   shown	   to	   increase	   resurgent	   sodium	   current	   generation	   [77].	  Blood-­‐depressing	   substance	   I	   modestly	   slows	   the	   rate	   of	   inactivation	   of	   sodium	  currents	   isolated	   from	   Purkinje	   neurons,	   and	   dramatically	   increases	   resurgent	  sodium	  current	  [78].	  Navβ4	  has	  been	  identified	  to	  be	  a	  target	  of	  β-­‐site	  APP-­‐cleaving	  enzyme	  1	  (BACE1).	  BACE1	  knockout	  in	  Purkinje	  neurons	  demonstrates	  an	  increased	  rate	  of	  resurgent	  sodium	  current	  decay	  compared	  to	  wildtype	  resulting	  in	  a	  slower	  spontaneous	  firing	  rate	  [79].	  Chemical	  compounds	  have	  also	  been	  shown	  to	  enhance	  or	   inhibit	   resurgent	   sodium	   currents.	   Oxaliplatin,	   a	   chemotherapeutic	   drug,	  increases	   Nav1.6	   mediated	   resurgent	   and	   persistent	   sodium	   current	   from	   DRG	  neurons	  at	  cooler	  (22°C)	  temperatures,	  which	  is	  thought	  to	  mechanistically	  underlie	  the	   cooling-­‐aggravated	   neuropathy	   seen	   with	   oxaliplatin	   treatment.	   [80].	  Conversely,	  anandamide	  (AEA),	  an	  endogenous	  cannabinoid,	  can	  selectively	  inhibit	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resurgent	   sodium	   current	   over	   peak	   transient	   current	   generated	   by	   Nav1.7	   in	  HEK293	  cells	  [81].	  	  	   2. Functional	  implications	  	  	   The	   brief	   reopening	   of	   channels,	   due	   to	   unbinding	   of	   the	   open-­‐channel	  blocker,	   during	   the	   repolarization	   phase	   of	   the	   action	   potential	   provides	   a	  depolarizing	   drive	   to	   approach	   threshold	   for	   firing	   additional	   action	   potentials.	  Channels	   that	   undergo	   open-­‐channel	   block	   recover	   faster	   from	   apparent	  inactivation	  and	  are	  available	  after	  an	  action	  potential	  spike	  effectively	  decreasing	  the	   refractory	   period	   following	   an	   action	   potential	   spike	   [62,	   82].	   Indeed,	   sodium	  currents	  have	  been	  observed	  to	  flow	  during	  the	  interval	  between	  action	  potentials	  [82,	   83].	   Therefore,	   these	   currents	   are	  predicted	   to	   enhance	  neuronal	   excitability.	  Accordingly,	   knockdown	   of	   Navβ4,	   preventing	   resurgent	   current	   generation,	  decreases	   both	   spontaneous	   firing	   as	   well	   as	   repetitive	   firing	   with	   long	  depolarization	   stimuli	   [67-­‐69].	  Modeling	   studies	  have	   corroborated	   these	   findings	  [84-­‐86].	  Importantly,	  while	  resurgent	  current	  facilitates	  rapid	  firing	  and	  burst	  firing,	  it	   is	   not	   sufficient	   for	   this	   spiking	   pattern.	   The	   density	   and	   localization	   of	   the	   full	  complement	  of	  ion	  channels	  determines	  the	  spiking	  pattern	  of	  a	  neuron.	  	  
	   3. Expression	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The	   major	   channel	   that	   generates	   resurgent	   sodium	   current	   is	   Nav1.6.	   In	  Purkinje	  neurons	  from	  Nav1.6	  –	  null	  mice,	  resurgent	  sodium	  current	  is	  abolished.	  	  However,	  a	  major	  determinant	  of	  resurgent	  sodium	  current	  generation	  is	  the	  rate	  of	  inactivation,	  and	  slowing	  the	  rate	  of	   inactivation	  can	  allow	  other	  channel	   isoforms	  to	   generate	   resurgent	   currents	   [63].	   Indeed,	   in	   some	   neuronal	   populations	   other	  isoforms	  predominantly	  contribute	  to	  the	  generation	  of	  resurgent	  current	  [87,	  88].	  These	  currents	  have	  been	  shown	  to	  increase	  with	  developmental	  age.	  This	  may	  be	  because	  of	  the	  concomitant	  increase	  in	  Nav1.6	  expression	  in	  many	  of	  these	  neuronal	  populations.	  While	   resurgent	   sodium	  currents	  have	   so	   far	  been	  observed	   in	  many	  neuronal	   populations	   in	   different	   brain	   regions	   as	  well	   as	   the	   peripheral	   nervous	  system,	  TTX-­‐sensitive	   resurgent	   currents	   are	  normally	   completely	   absent	   in	  other	  neuronal	   populations	   including:	   mouse	   spinal	   neurons,	   CA3	   neurons	   of	   the	  hippocampus	   and	   small	   diameter	   spinal	   sensory	   neurons	   [89-­‐92].	   For	   this	  dissertation	   research	   it	   is	   important	   to	   note	   that	  many	   populations	   of	   neurons	   in	  critical	   circuits	   involved	   in	  epilepsy	  have	  been	   found	   to	  express	  resurgent	  current	  including:	   striatal	   medium	   spiny	   neurons,	   perirhinal	   layer	   II	   pyramidal	   neurons,	  hippocampal	   dentate	   gyrus,	   ventral	   CA1	   pyramidal	   neurons,	   globus	   pallidus,	  subthalamic	  nuclei,	  and	  medial	  entorhinal	  cortex	  [92].	  	  
	   E. Expression	  of	  brain	  isoforms	  of	  voltage-­‐gated	  sodium	  channels	  
	   	  As	   mentioned	   above,	   there	   are	   four	   predominant	   isoforms	   of	   VGSCs	  expressed	  in	  the	  brain:	  Nav1.1,	  Nav1.2,	  Nav1.3	  and	  Nav1.6.	  There	  have	  been	  many	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studies	   examining	   the	   expression	   of	   these	   brain	   isoforms	   of	   VGSCs	   that	   have	  identified	  very	  distinct	  cellular	  (i.e.	  neuronal	  populations)	  as	  well	  as	  subcellular	  (i.e.	  neuronal	   compartments)	   localization	   of	   each	   isoform.	   	   Each	   isoform’s	   function	  within	   these	   different	   regions	   is	   highly	   specialized	   as	   evidenced	   by	   disruption	   of	  their	  activity	  or	  expression	  leading	  to	  pathological	  conditions	  and/or	  lethality.	  	  Nav1.1	   expression	   has	   been	   observed	   in	   different	   neuronal	   compartments	  including:	  soma,	  dendrites,	  nodes	  of	  Ranvier	  as	  well	  as	  the	  axon	  initial	  segments	  in	  various	  neuronal	  populations.	  Early	   studies	  described	  Nav1.1	  as	  having	  a	   somato-­‐dendritic	   expression	   pattern	   [93-­‐96].	   Later	   studies	   found	   dense	   expression	   of	  Nav1.1	  at	   the	  proximal	   (closer	   to	   the	   soma)	  axon	   initial	   segment,	   characterizing	  a	  distinct	   microdomain,	   of	   retinal	   ganglion	   cells,	   spinal	   cord	   motor	   neurons	   and	  parvalbumin	  positive	  GABAergic	  neurons	   [97-­‐100].	  Nav1.1	  has	  also	  been	   found	  at	  the	  nodes	  of	  Ranvier	  of	  some	  neuronal	  populations	  [99,	  100].	  	  	  Nav1.2	  is	  highly	  expressed	  in	  unmyelinated	  axons	  and	  nerve	  terminals	  [101,	  102].	   Early	   in	   development	   Nav1.2	   is	   expressed	   in	   the	   axon	   initial	   segment	   of	  hippocampal	  and	  cortical,	  principal	  neurons	  and	  cerebellar	  granule	  neurons.	  During	  development	   and	   myelination	   of	   axons,	   Nav1.2	   channels	   are	   mostly	   replaced	   by	  Nav1.6	   [88,	   102,	   103].	   However,	   expression	   of	   Nav1.2	   is	   still	   retained	   to	   varying	  degrees	   in	   the	   axon	   initial	   segment,	   axons	   and	   nerve	   terminals	   of	  mature	   retinal	  ganglion	   cells	   and	   cerebellar	   granule	  neurons	   [88,	  96,	  101,	  104].	  Recently,	  Nav1.2	  
	   21	  
expression	   was	   observed	   in	   the	   proximal	   axon	   initial	   segment	   of	   somatostatin	  positive	  but	  not	  parvalbumin	  positive	  GABAergic	  neurons	  [105].	  	  	  While	   Nav1.3	   mRNA	   was	   detected	   during	   prenatal	   development,	   its	  expression	   diminishes	   during	   early	   postnatal	   days	   and	   is	   lost	   in	   the	   adult	   rodent	  brain	   [96,	   106].	   However,	   Nav1.3	   expression	   is	   retained	   in	   adult	   human	   brain,	  where	   it	   is	   found	   subcellularly	   in	   a	   somato-­‐dendritic	   distribution	   [107].	  	  Interestingly,	  many	  studies	  have	  reported	  an	  upregulation	  of	  Nav1.3	  expression	   in	  many	   different	   CNS	   regions	   under	   pathological	   conditions	   including:	   epilepsy,	  traumatic	  brain	  injury	  and	  spinal	  cord	  injury	  [108-­‐113].	  	  	   Nav1.6	   is	   ubiquitously	   expressed	   in	   the	   brain.	   In	   particular,	   Nav1.6	  expression	   is	   dense	   in	   the	   axon	   initial	   segment	   and	   nodes	   of	   Ranvier	   of	   many	  neuronal	   populations	   [97,	   101,	   102,	   114,	   115].	   It	   has	   also	   been	   observed	   in	  dendrites	  and	  at	  synapses	  [114,	  116].	  	  
	   F. Epilepsy-­‐associated	  mutations	  in	  Nav1.1	  and	  Nav1.6	  
	   Many	   de	   novo	   and	   inherited	  mutations	   have	   been	   identified	   in	   VGSCs	   that	  underlie	  disorders	  of	  excitability	  including	  paralysis,	  pain,	  cardiac	  arrhythmias	  and	  epilepsy.	  While	  epilepsy	  associated	  mutations	  have	  been	  identified	  in	  several	  VGSC	  isoforms	   (Nav1.1,	   Nav1.2,	   Nav1.3,	   Nav1.6	   and	   Nav1.7),	   in	   this	   dissertation	   the	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biophysical	   consequences	   of	   epilepsy-­‐associated	   mutations	   in	   Nav1.1	   and	   Nav1.6	  are	  highlighted	  and	  further	  explored.	  	  
	   1. Nav1.1	  	   Numerous	  mutations	  have	  been	  identified	  in	  Nav1.1;	  while	  the	  majority	  are	  protein	   truncation	   mutations,	   many	   result	   in	   missense	   mutations	   that	   occur	  throughout	   the	   channel	   protein	   [117].	   The	   protein	   truncation	   mutations	   clearly	  result	   in	   loss-­‐of-­‐function	   in	   channel	   activity.	   Many	   studies	   have	   examined	   the	  biophysical	   defects	   of	   Nav1.1	   missense	   mutations	   in	   heterologous	   expression	  systems.	  Mutations	  associated	  with	  Dravet	  Syndrome	  mostly	  result	  in	  apparent	  loss-­‐of-­‐function	  in	  channel	  activity,	  while	  mutations	  associated	  with	  generalized	  epilepsy	  with	  febrile	  seizures	  plus	  (GEFS+)	  have	  mixed	  gain-­‐	  and	  loss-­‐of-­‐function	  effects	  on	  channel	   properties	   [118].	   Because	   Nav1.1	   expression	   is	   predominantly	   in	  GABAergic	   neurons,	   loss	   of	   Nav1.1	   activity	   leads	   to	   decreased	   excitability	   of	  GABAergic	   neurons	   and	   consequently	   reduced	   inhibitory	   tone.	   Indeed,	  heterozygous	  Scn1a	  mice,	  a	  model	  of	  Dravet	  Syndrome,	  show	  decreased	  excitability	  of	   GABAergic	   neurons	   [119,	   120].	   	   This	   is	   the	   current	   major	   hypothesis	   for	   the	  mechanism	   underlying	   Dravet	   Syndrome,	   however	   alternative	   hypotheses	   have	  been	  proposed	  [121,	  122].	  	  	  Phenotypically,	  mutations	  in	  Nav1.1	  mostly	  result	  in	  GEFS+	  or	  a	  more	  severe	  phenotype	   known	   as	   Dravet	   Syndrome	   or	   severe	   myoclonic	   epilepsy	   in	   infancy	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(SMEI).	  These	  patients	  start	  to	  exhibit	  seizures	  within	  the	  first	  year	  of	  birth	  that	  are	  typically	   initiated	   by	   fever	   but	   later	   progress	   into	  many	   seizure	   types.	   Often	   they	  develop	  mild	  to	  severe	  cognitive	  and	  behavioral	  deficits	  that	  persist	  into	  adulthood	  [120].	  Most	  are	  refractory	  to	  treatment	  with	  classic	  AEDs	  and	  some	  AEDs,	  in	  which	  the	  main	  mechanism	  of	  action	  is	  to	  target	  VGSC	  activity,	  can	  exacerbate	  seizures	  in	  some	  cases.	  	   2. Nav1.6	  
	   Recently,	   the	   first	   epilepsy-­‐associated	   mutation	   in	   Nav1.6	   was	   identified	  [123].	   Since	   then,	   several	   mutations	   in	   Nav1.6	   have	   been	   revealed	   [124].	   Of	   the	  mutations	   that	   have	   been	   characterized	   in	   heterologous	   expression	   systems,	   the	  majority	   lead	   to	   gain-­‐of-­‐function	   effects	   on	   channel	   properties.	   Specifically,	  biophysical	   defects	   including	   enhanced	   activation,	   incomplete	   inactivation	   and	  increased	  persistent	  current	  have	  been	  observed	  [123,	  125,	  126].	  Mechanistically,	  it	  can	   be	   hypothesized	   that	   an	   increase	   in	   Nav1.6	   activity	   would	   lead	   to	   increased	  neuronal	  activity	  and	  consequently	  hyper-­‐excitability	  due	  the	  ubiquitous	  expression	  of	  Nav1.6.	  	  	  Mutations	   in	   Nav1.6	   lead	   to	   a	   phenotypically	   distinct	   epileptic	  encephalopathy	   from	   Dravet	   Syndrome,	   currently	   classified	   as	   EIEE13.	   Seizure	  onset	   is	   typically	   later	   in	   patients	   with	   EIEE13	   compared	   to	   those	   with	   Dravet	  Syndrome	  but	  still	  within	  early	   life,	  and	  seizure	  type	   is	  much	  more	  variable	  [127].	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Febrile	   seizures,	   a	  hallmark	  of	  Dravet	   Syndrome,	   are	   rare	   in	  patients	  with	  Nav1.6	  mutations.	   These	   patients	   also	   typically	   display	  movement	   disorders	   and	   develop	  mild	  to	  severe	  cognitive	  deficits	  [126].	  While	  the	  majority	  of	  these	  patients	  to	  do	  not	  respond	   well	   to	   current	   treatment	   strategies,	   VGSC	   blockers	   have	   shown	   some	  efficacy	   in	   the	  management	  of	  seizures	   in	  some	  patients	  with	  mutations	   in	  Nav1.6	  [128,	  129].	  	   	  	  G. Current	  anti-­‐epileptic	  drug	  action	  	   Voltage-­‐gated	  sodium	  channels	  are	  the	  target	  for	  many	  drugs	  used	  clinically	  including:	   local	   anesthetics,	   anti-­‐arrhythmias	   and	   anti-­‐epileptics.	   The	   primary	  mechanism	   of	   action	   for	   the	   most	   commonly	   used	   AEDs	   such	   as	   phenytoin,	  carbamazepine,	  lamotrigine	  and	  many	  others	  is	  to	  inhibit	  VGSC	  activity	  [130].	  These	  drugs	  bind	  to	  a	  common	  receptor	  site	  in	  the	  pore	  of	  the	  channel	  from	  either	  entering	  through	   the	   intracellular	   end	   of	   the	   pore	   or,	   in	   the	   case	   of	   small	   hydrophobic	  inhibitors,	  through	  a	  hydrophobic	  pathway	  in	  the	  membrane	  [31,	  131].	  The	  receptor	  site	   is	   formed	  by	  pore-­‐lining	  amino	  acid	  residues	   in	  the	  S6	  segments	  of	  domains	  I,	  III,	  and	  IV,	  thus	  binding	  of	  drug	  occludes	  the	  pore	  [132-­‐134].	  Specifically,	  two	  amino	  acid	   resides,	   phenylalanine	   1764	   and	   tyrosine	   1771	   (numbers	   corresponding	   to	  Nav1.2),	  in	  the	  middle	  of	  the	  S6	  segment	  of	  domain	  IV	  has	  been	  shown	  to	  be	  critical	  for	  drug	  binding	  [132].	  This	  region	  of	  the	  channel	  is	  highly	  conserved	  among	  VGSC	  isoforms,	  therefore	  making	  classic	  AEDs	  relatively	  nonselective.	  Indeed,	  these	  drugs	  are	  also	  used	  to	  treat	  many	  other	  disorders	  such	  as	  migraine	  and	  neuropathic	  pain	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due	  to	  their	  actions	  on	  other	   isoforms	  of	  VGSCs	  as	  well	  as	  other	  molecular	  targets	  [135].	  	  	  An	   important	   property	   of	   classic	   AEDs	   targeting	   VGSCs	   that	   makes	   them	  clinically	   efficacious	   is	   their	   voltage-­‐	   and	   frequency	   dependent	   properties.	   These	  properties	  arise	  due	  to	  higher	  affinity	  of	  the	  drug	  for	  the	  open	  or	  inactivated	  state	  of	  the	   channel	   rather	   than	   the	   resting,	   closed	   state	   [131].	   Thus,	   with	   successive	  depolarizations	  a	   greater	  number	  of	   channels	  become	  blocked,	   a	  property	   termed	  frequency-­‐dependent	   inhibition.	   This	   allows	   for	   targeting	   of	   hyperexcitable	  neurons.	   Clinically,	   it	   is	   important	   to	   find	   drugs	   that	   will	   selectively	   inhibit	  excessive,	   abnormal	   activity	   while	   maintaining	   physiological	   activity	   to	   prevent	  unwanted	  drug	  side	  effects.	  	  	   H. Hypothesis	  and	  specific	  aims	  	  	  Nav1.1	  and	  Nav1.6	  are	  highly	  expressed	  VGSC	  isoforms	  in	  the	  brain	  that	  are	  localized	   to	   distinct	   cellular	   and	   subcellular	   regions.	   	   Nav1.1	   is	   prominently	  expressed	   in	  parvalbumin	  positive	  GABAergic	  neurons	  specifically	  at	   the	  proximal	  axon	   initial	   segment	   of	   these	   neurons.	   Nav1.6	   is	   more	   ubiquitously	   found	   in	   the	  brain	  in	  both	  excitatory	  and	  inhibitory	  neurons	  and	  is	  highly	  localized	  in	  the	  distal	  axon	  initial	  segment	  and	  nodes	  of	  Ranvier.	  Parvalbumin	  positive	  GABAergic	  neurons	  characteristically	   fire	   very	   rapid	   APs	   (6.5	   –	   122	  Hz)	   [136].	  We	   hypothesized	   that	  Nav1.1	  and	  Nav1.6	  channels	  have	  distinct	  biophysical	  properties	  that	  differentially	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contribute	   to	   the	   critical	   properties	   of	   sodium	   channels	   necessary	   for	   fast	   firing	  including:	   slow	   development	   of	   inactivation	   during	   depolarizing	   potentials	   in	   the	  inter-­‐spike	   interval,	   rapid	   recovery	   of	   channels	   after	   an	  AP	   spike,	   and	   incomplete	  inactivation	  during	  APs;	  making	  both	  isoforms	  necessary	  for	  a	  fast	  firing	  phenotype.	  Therefore	   the	   first	   aim	   of	   this	   dissertation	   was	   to	   investigate	   the	   differential	  biophysical	   properties	   of	   Nav1.1	   and	   Nav1.6	   using	   whole-­‐cell	   patch	   clamp	  recordings	  (Aim	  1.1).	  To	  date,	  there	  has	  been	  no	  extensive	  biophysical	  comparison	  of	   Nav1.1	   and	   Nav1.6,	   which	   is	   critical	   to	   understanding	   how	   these	   two	   channel	  isoforms	   could	   potentially	   contribute	   to	   the	   fast	   firing	   phenotype	   of	   parvalbumin	  positive	  GABAergic	  neurons.	  	  Interestingly,	  resurgent	  sodium	  current	  and	  Navβ4,	  a	  VGSC	  auxiliary	  subunit	  capable	   of	   acting	   as	   an	   open	   channel	   blocker,	   expression	   are	   correlated	   with	  neurons	   that	   fire	   rapidly	   [137,	   138].	   This	   suggests	   that	   these	   currents	   may	   be	  contributing	  to	  the	  fast	  firing	  phenotype.	  Indeed,	  Navβ4	  mediated	  resurgent	  sodium	  current	  is	  predicted	  to	  increase	  neuronal	  firing	  by	  (1)	  providing	  a	  depolarizing	  drive	  to	  approach	   threshold	   for	   firing	   subsequent	  APs	  and	   (2)	  effectively	   increasing	   the	  number	   of	   channels	   available	   to	   open	   immediately	   following	   an	   AP.	   The	   latter	   is	  attributed	  to	  the	  ability	  of	  Navβ4	  to	  allow	  channels	  to	  bypass	  fast	   inactivation	  and	  enhance	   channel	   recovery	   [62].	   We	   therefore	   hypothesized	   that	   Navβ4	   could	  protect	   channels	   from	   accumulating	   into	   inactivated	   states,	   decreasing	   use-­‐dependent	  reduction	  of	  current	  and	  allowing	  channels	  to	  better	  follow	  trains	  of	  APs.	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This	   led	   to	   the	  second	  part	  of	   the	   first	  aim,	  which	  was	   to	   investigate	   the	  effects	  of	  Navβ4	  peptide	  on	  Nav1.1	  and	  Nav1.6	  channel	  properties	  (Aim	  1.2).	  	  Nav1.1	   and	   Nav1.6	   channels	   are	   crucial	   for	   normal	   physiological	   function.	  Disruption	   of	   channel	   activity	   by	  mutations	   in	   the	   genes	   encoding	   these	   channels	  can	  lead	  to	  pathophysiological	  conditions.	  There	  have	  been	  hundreds	  of	  mutations	  identified	  in	  Scn1a,	  coding	  Nav1.1,	  which	  predominantly	  result	  in	  loss	  of	  function	  in	  channel	   activity	   and	   lead	   to	   an	   epileptic	   phenotype.	   Recently,	   the	   first	   human	  epilepsy-­‐associated	   mutation	   was	   identified	   in	   Scn8a,	   coding	   Nav1.6,	   after	   which	  several	   others	   were	   identified.	   Of	   the	   Nav1.6	   epilepsy-­‐associated	   mutations	  characterized	  in	  heterologous	  expression	  systems,	  most	  mutations	  result	  in	  gain	  of	  function	   in	   channel	   activity.	   Resurgent	   sodium	   current	   generation	   by	   epilepsy-­‐associated	  mutant	  channels	  has	  not	  been	  examined.	  As	  resurgent	  sodium	  current	  is	  predicted	  to	  increase	  neuronal	  excitability	  and	  may	  be	  important	  for	  the	  fast	  firing	  ability	  of	  parvalbumin	  positive	  GABAergic	  neurons,	  alterations	  in	  this	  current	  could	  be	   a	   potential	   mechanism	   by	   which	   epilepsy-­‐associated	   mutant	   VGSCs	   cause	   the	  hyper-­‐excitability	  underlying	  the	  associated	  epileptic	  phenotypes.	  We	  hypothesized	  that	   epilepsy-­‐associated	   mutations	   in	   Nav1.1	   and	   Nav1.6	   would	   alter	   resurgent	  sodium	  current	  generation.	  The	  second	  aim	  of	  this	  dissertation	  was	  to	  examine	  the	  biophysical	  consequences	  of	  epilepsy-­‐associated	  mutations	  in	  Nav1.1	  (N1788K	  and	  R1648H)	  and	  Nav1.6	  (N1768D	  and	  L1331V)	  specifically	  investigating	  the	  effects	  on	  resurgent	  current	  generation	  (Aim	  2).	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Our	   findings	   in	   Aim	   2	   demonstrated	   that	   epilepsy-­‐associated	  mutations	   in	  Nav1.6	   dramatically	   enhance	   resurgent	   current	   generation	   while	   epilepsy-­‐associated	   mutations	   in	   Nav1.1	   do	   not,	   leading	   us	   to	   ask	   if	   this	   current	   can	   be	  selectively	   targeted.	   Although	   there	   are	   currently	   no	   known	   selective	   blockers	   of	  resurgent	   current	   generated	  by	  Nav1.1	   or	  Nav1.6,	   there	   is	   evidence	   that	  AEA	  and	  ajulemic	   acid,	   a	   synthetic	   derivative	   of	   Δ9-­‐tetrahydrocannabinol,	   can	   selectively	  inhibit	   resurgent	   current	   over	   peak	   transient	   current	   generated	   by	   Nav1.7	   and	  Nav1.5,	   respectively	   [81,	   139].	   It	   is	   not	   entirely	   clear	   how	   these	   compounds	   are	  working.	   We	   hypothesized	   that	   AEA	   would	   similarly	   inhibit	   Nav1.1	   and	   Nav1.6	  generated	   resurgent	   sodium	  current	  over	  peak	   transient	   current.	  Additionally,	  we	  hypothesized	  that	  CBD	  may	  also	  target	  VGSC	  activity	  due	  to	  its	  proposed	  efficacy	  in	  the	   treatment	   of	   pediatric	   epilepsies	   and	   similarity	   in	   structure	   to	   Δ9-­‐tetrahydrocannabinol.	  The	  third	  aim	  of	  this	  dissertation	  was	  to	  determine	  whether	  Nav1.1	  and	  Nav1.6	  generated	  resurgent	  current	  and	  aberrant	  activity	  generated	  by	  Nav1.1	  and	  Nav1.6	  mutant	  channels	  can	  be	  targeted	  with	  AEA	  or	  CBD	  (Aim	  3.1).	  	  	  	   Moreover,	  our	   findings	   in	  Aim	  2	  suggest	   that	  epilepsy-­‐associated	  mutations	  in	  Nav1.1	  and	  Nav1.6	  work	  through	  distinct	  mechanisms	  to	  induce	  epileptogenesis	  and	  will	   likely	   require	   different	   treatment	   strategies.	   Indeed,	  most	   VGSC	   blockers	  are	   contraindicated	   for	   the	   treatment	   of	   Dravet	   Syndrome	  while	   they	   show	   some	  efficacy	   in	   the	   treatment	   of	   severe	   epileptic	   encephalopathy	   due	   to	   Nav1.6	  mutations.	   We	   hypothesized	   that	   selective	   inhibition	   of	   Nav1.1	   would	   increase	  hyper-­‐excitability	   due	   to	   its’	   prominent	   expression	   in	   parvalbumin	   positive	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GABAergic	   neurons,	   while	   selective	   inhibition	   of	   Nav1.6	   may	   dampen	   overall	  excitability	  due	  to	  its	  ubiquitous	  expression.	  Recently,	  two	  selective	  small	  molecule	  inhibitors,	   ICA	   and	   LY	   compounds,	   of	   Nav1.3	   and	   Nav1.7,	   respectively	   were	  discovered	   [140].	   The	   selectivity	   of	   these	   compounds	   was	   attributed	   to	   three	  residues	   in	   domain	   IV	   of	   the	   channel,	   which	   are	   correspondingly	   conserved	   in	  Nav1.1	  and	  Nav1.6.	  Therefore,	  we	  hypothesized	  that	  these	  compounds	  would	  show	  similar	  differential	  selectivity	  for	  Nav1.1	  and	  Nav1.6.	  We	  determined	  the	  selectivity	  of	  the	  ICA	  and	  LY	  compounds	  with	  respect	  to	  Nav1.1	  and	  Nav1.6,	  and	  examined	  how	  selectively	   inhibiting	   each	   isoform	   alters	   epileptiform	   activity	   induced	   by	   4-­‐aminopyridine	  in	  mouse	  cortical	  brain	  slices	  using	  multielectrode	  array	  recordings	  (Aim	  3.2).	  	   	   	   	   	   	  	   The	  findings	  presented	  in	  this	  dissertation	  further	  our	  understanding	  of	  the	  role	  of	  VGSCs	   in	   the	  brain.	  Specifically,	   it	  highlights	   the	  distinct	   functional	   roles	  of	  two	   major	   VGSC	   isoforms	   expressed	   in	   the	   brain,	   Nav1.1	   and	   Nav1.6	   and	   their	  contribution	   to	   physiological	   and	   pathophysiological	   activity.	   The	   implications	   of	  these	  findings	  on	  disease	  and	  therapy	  as	  well	  as	  the	  future	  directions	  of	   this	  work	  are	  further	  discussed	  in	  Chapter	  V.	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II. HUMAN	  NAV1.6	  CHANNELS	  GENERATE	  LARGER	  RESURGENT	  CURRENTS	  THAN	  HUMAN	  NAV1.1	  CHANNELS,	  BUT	  THE	  NAVβ4	  PEPTIDE	  DOES	  NOT	  PROTECT	  EITHER	  ISOFORM	  FROM	  USE-­‐DEPENDENT	  REDUCTION	  
	  This	  chapter	  was	  adapted	  from	  a	  manuscript	  published	  in	  Plos	  One.	  doi:	  10.1371/journal.pone.0133485	  	   Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Yucheng	  Xiao	  and	  Theodore	  R.	  Cummins	  	  R.	  R.	  Patel	  designed	  experiments,	  conducted	  all	  electrophysiological	  experiments	  except	  those	  presented	  in	  Figure	  16,	  analyzed	  and	  interpreted	  the	  data	  and	  drafted	  the	  manuscript.	  	  A. Introduction	  	  VGSCs	  mediate	  the	  inward	  current	  underlying	  the	  rising	  phase	  of	  the	  action	  potential	   and	   are	   consequently	   key	   regulators	   of	   excitability.	   These	   channels	   are	  comprised	  of	  a	  principal	  α	  subunit	  encoded	  by	  nine	  genes	  that	  associate	  covalently	  and	   non-­‐covalently	  with	   one	   or	  more	   auxiliary	   β	   subunits	   encoded	   by	   four	   genes	  [141].	   Three	   isoforms	   of	   VGSCs	   are	   highly	   expressed	   in	   the	   adult	   rodent	   central	  nervous	   system	   including:	   Nav1.1,	   Nav1.2	   and	   Nav1.6	   [142].	   In	   this	   study,	   we	  focused	   on	   Nav1.1	   and	   Nav1.6	   because	   of	   their	   distinct	   cellular	   and	   subcellular	  localization.	   Specifically,	   Nav1.1	   is	   predominantly	   found	   in	   parvalbumin	   positive	  
	   31	  
GABAergic	   neurons	   at	   detectable	   levels	   in	   the	   soma	   and	   proximal	   axon	   initial	  segment	   [143-­‐145].	   In	   contrast,	  Nav1.6	   is	   found	   in	  both	  GABAergic	  and	  excitatory	  neurons	   within	   the	   soma,	   dendrites,	   nodes	   of	   Ranvier	   and	   distal	   axon	   initial	  segment	  [116,	  144].	  The	  axon	  initial	  segment	  is	  a	  key	  feature	  of	  neurons	  containing	  a	  high	  density	  of	  VGSCs	  and	  is	  the	  site	  of	  AP	  initiation	  [146-­‐148].	  These	  two	  channel	  isoforms	   are	   thought	   to	   have	   minimal	   overlap	   within	   the	   axon	   initial	   segment	  suggesting	   that	   they	   have	   distinct	   functions	   [144,	   149].	   It	   has	   previously	   been	  shown	   that	   different	   VGSC	   isoforms	   can	   play	   specific	   roles	  within	   the	   axon	   initial	  segment	   [150].	   Hu	   et	   al.	   found	   that	   the	   high-­‐threshold	   Nav1.2,	   expressed	   in	   the	  proximal	  axon	  initial	  segment	  of	  excitatory	  neurons,	  regulates	  the	  backpropagation	  of	   APs	   into	   somato-­‐dendritic	   compartments	   while	   the	   low-­‐threshold	   Nav1.6	  determines	   the	   threshold	   for	   firing	   an	   AP	   that	   will	   propagate	   down	   the	   axon.	   In	  parvalbumin	   positive	   GABAergic	   neurons,	   Ogiwara	   et	   al.	   found	   that	   Nav1.1	   is	  important	   for	   the	   maintenance	   but	   not	   initiation	   of	   fast	   firing.	   However,	   the	   full	  extent	  to	  which	  Nav1.1	  and	  Nav1.6	  contribute	  to	  sustaining	  high	  frequency	  firing	  is	  unclear.	  	  	  Interestingly,	   one	   of	   the	   four	   auxiliary	   β	   subunits	   of	   VGSCs,	   Navβ4,	   is	   also	  enriched	   at	   the	   axon	   initial	   segment	   and	   nodes	   of	   Ranvier	   in	   many	   neuronal	  populations	  that	  have	  high	  frequency	  firing	  characteristics	  [138].	  The	  C-­‐terminal	  tail	  of	   Navβ4	   has	   been	   proposed	   to	   act	   as	   an	   open-­‐channel	   blocker	   that	   blocks	   the	  channel	  in	  the	  open	  state	  and	  upon	  repolarization	  unbinds	  to	  elicit	  a	  resurgence	  of	  sodium	   current,	   termed	   resurgent	   sodium	   current,	   after	   which	   the	   channels	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inactivate	   or	   deactivate	   [68,	   70].	   	   Resurgent	   sodium	   current	   is	   thus	   an	   atypical	  sodium	   current	   that	   occurs	   near	   threshold	   potentials	   immediately	   following	   an	  action	   potential	   spike.	   These	   currents	   were	   first	   identified	   in	   cerebellar	   Purkinje	  neurons,	   a	   type	   of	   parvalbumin	   positive	   GABAergic	   neuron,	   and	   since	   have	   been	  observed	   in	  many	  neuronal	   populations	   [66,	   82,	   90,	   91,	   151].	   Castelli	   et	  al.	   found	  that	   resurgent	   sodium	   current	   generation	   by	   pyramidal	   neurons	   in	   the	   perirhinal	  cortex	  could	  be	  abolished	  by	  focal	  application	  of	  TTX	  to	  the	  proximal	  axon,	  likely	  the	  axon	  initial	  segment.	  It	  is	  predicted	  that	  resurgent	  sodium	  current	  generation	  would	  enhance	  cellular	  excitability	  by	  providing	  a	  depolarizing	  drive	  after	  an	  AP	  spike	  to	  approach	  threshold	  for	  firing	  another	  AP	  [84,	  86,	  152].	  	  	  To	   date,	   there	   has	   been	   no	   extensive	   comparison	   of	   the	   biophysical	  properties	  of	  Nav1.1	  and	  Nav1.6,	  which	  is	  critical	  to	  understanding	  how	  these	  two	  channel	   isoforms	   could	   potentially	   contribute	   to	   the	   high	   frequency	   firing	  characteristics	  of	  parvalbumin	  positive	  GABAergic	  neurons.	  The	  aims	  of	   this	  study	  were	  to	  1)	  directly	  compare	  the	  biophysical	  properties	  of	  human	  Nav1.1	  and	  Nav1.6,	  2)	  determine	  whether	  resurgent	  sodium	  currents	  alter	  sodium	  influx	  in	  response	  to	  different	   AP	   waveforms	   that	   are	   characteristic	   of	   different	   cell	   types	   and	   3)	  determine	   if	   Navβ4	   peptide	   protects	   channels	   from	   undergoing	   use-­‐dependent	  reduction.	   	   We	   found	   that	   these	   channel	   isoforms	   have	   distinct	   biophysical	  properties	  that	  could	  contribute	  to	  different	  characteristics	  of	  VGSCs	  important	  for	  fast	  firing.	  Moreover,	  resurgent	  sodium	  current	  generation	  increases	  sodium	  influx	  in	  response	  to	  different	  duration	  AP	  waveforms,	  and	  while	  Navβ4	  peptide	  enhances	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apparent	  recovery	  from	  inactivation,	  it	  does	  not	  protect	  channels	  from	  undergoing	  use-­‐dependent	   reduction.	   These	   findings	   provide	   novel	   insight	   into	   the	   potential	  roles	  of	  these	  two	  channel	  isoforms	  as	  well	  as	  the	  potential	  role	  of	  Navβ4	  peptide	  in	  maintaining	  a	  fast	  firing	  phenotype.	  	  	  
	   B. Materials	  and	  methods	  	  1. cDNA	  constructs	  
	   Optimized	  human	  constructs	  for	  Nav1.1	  and	  Nav1.6	  were	  designed	  in-­‐house,	  purchased	   from	   Genscript	   (Piscataway,	   NJ)	   and	   subsequently	   hNav1.1	   was	  subcloned	   into	   pTarget	   using	   XhoI	   and	   SalI	   restriction	   sites	   and	   hNav1.6	   was	  subcloned	   into	   pcDNA3.1+	   using	   KpnI	   and	   XbaI	   restriction	   sites.	   The	   amino	   acid	  sequences	   for	   the	   synthesized,	   human	   Nav1.1	   and	   Nav1.6	   cDNA	   constructs	  correspond	  with	  BAC21102.1	  and	  NP_055006.1	  in	  the	  NCBI	  database,	  respectively.	  	   2. Cell	  cultures	  and	  transfections	  
	   The	  use	  of	  HEK293T	  cells	  [153]	  was	  approved	  by	  the	  Institutional	  Biosafety	  Committee	  and	  followed	  the	  ethical	  guidelines	  for	  the	  National	  Institutes	  of	  Health	  for	  the	  use	  of	  human-­‐derived	  cell	  lines.	  HEK293T	  cells	  were	  grown	  under	  standard	  tissue	  culture	  conditions	  (5%	  CO2;	  37°C)	  with	  DMEM	  supplemented	  with	  10%	  fetal	  bovine	   serum.	   HEK293T	   cells	   were	   transiently	   transfected	   using	   the	   calcium	  
	   34	  
phosphate	  precipitation	  method.	  Briefly,	  a	  calcium	  phosphate-­‐DNA	  mixture	  (4.5	  μg	  channel	  construct	  and	  0.5	  μg	  enhanced	  green	  florescent	  protein	  (EGFP))	  was	  added	  to	   cells	   in	   serum-­‐free	   media	   for	   4-­‐5	   hours	   and	   subsequently	   washed	   with	   fresh	  media.	   12-­‐24	   hours	   post-­‐transfection,	   cells	   were	   split	   onto	   laminin-­‐coated	   glass	  coverslips.	   Cells	   were	   identified	   by	   expression	   of	   EGFP	   using	   a	   fluorescent	  microscope	  and	  whole-­‐cell	  patch	  clamp	  recordings	  were	  obtained	  36-­‐72	  hours	  post-­‐transfection.	  
	   3. Whole-­‐cell	  patch	  clamp	  recordings	  
	   Whole-­‐cell	   patch	   clamp	   recordings	   were	   obtained	   at	   room	   temperature	  (~23°C)	   using	   a	   HEKA	   EPC-­‐10	   amplifier,	   and	   the	   Pulse	   program	   (v	   8.80,	   HEKA	  Electronic,	  Germany)	  was	  used	  for	  data	  acquisition.	  	  	  Voltage-­‐clamp	  data	  (except	  for	  that	   obtained	   with	   AP	   waveforms)	   were	   digitized	   at	   20kHz	   and	   filtered	   at	   5kHz.	  Electrodes	   were	   fabricated	   from	   1.7mm	   capillary	   glass	   and	   fire-­‐polished	   to	   a	  resistance	   of	   0.9-­‐1.3MΩ	   using	   a	   Sutter	   P-­‐97	   puller	   (Sutter	   Instrument	   Company,	  Novato,	   CA).	   All	   voltage	   protocols	  were	   started	   5	  minutes	   after	   obtaining	   a	   gigaΩ	  seal	  and	  entering	  the	  whole-­‐cell	  configuration,	  which	  controlled	  for	  time-­‐dependent	  shifts	   in	  channel	  properties	  and	  allowed	  time	  for	  diffusion	  of	  Navβ4	  peptide	  when	  used.	   Voltage	   errors	   were	   minimized	   to	   less	   than	   5mV	   using	   series	   resistance	  compensation	   and	   passive	   leak	   currents	   were	   cancelled	   by	   P/-­‐5	   subtraction.	   The	  bath	  solution	  contained	   in	  (mM):	  140	  NaCl,	  1	  MgCl2,	  3	  KCl,	  1	  CaCl2,	  and	  10	  Hepes,	  adjusted	   to	   a	  pH	  of	  7.30	  with	  NaOH.	  The	  pipette	   solution	   contained	   in	   (mM):	  140	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CsF,	  10	  NaCl,	  1.1	  EGTA,	  and	  10	  Hepes,	  adjusted	  to	  a	  pH	  of	  7.30	  with	  CsOH.	  	  Fluoride	  was	   used	   in	   part	   because	   it	   increased	   the	   stability	   of	   the	   recordings	   over	   time.	  	  Fluoride	   can	   also	   reduce	   persistent	   sodium	   current	   components	   [154],	   which	  enhanced	  our	  ability	  to	  compare	  resurgent	  current	  amplitudes.	  To	  induce	  resurgent	  currents	   in	   HEK293T	   cells,	   200μM	   Navβ4	   peptide	   (KKLITFILKKTREK-­‐OH)	  (Biopeptide	  Co.,	  San	  Diego,	  CA),	  a	  peptide	  that	  corresponds	  to	  part	  of	  the	  sequence	  of	   the	  C-­‐terminal	   tail	  of	   the	   full-­‐length	  Navβ4	  subunit,	  was	   included	   in	   the	  pipette	  solution	   when	   specified.	   Resurgent	   currents	   are	   not	   detectable	   in	   HEK293T	   cells	  without	  Navβ4	  peptide	  in	  the	  pipette	  solution.	  	  
	  4. Modeling	  AP	  waveforms	  
	   Fast	   spiking	   interneurons	   have	   substantially	   narrower	   AP	  waveforms	   than	  pyramidal	  neurons	  [155,	  156],	  therefore	  we	  developed	  fast	  and	  slow	  AP	  waveforms	  to	   elicit	   currents	   in	   voltage-­‐clamp	   experiments.	   	   The	  AP	  waveforms	  were	   initially	  generated	   in	   the	   NEURON	   simulation	   environment	   [157]	   using	   previously	  developed	  computational	  models	  of	  pyramidal	  and	  fast-­‐spiking	  GABAergic	  neurons	  [158].	   	   The	   slow	   (pyramidal)	   and	   fast	   (fast	   spiking	   GABAergic)	   waveforms	   were	  then	  digitally	  modified	  to	  have	  identical	  initial	  membrane	  potentials,	  peak	  potentials	  and	  after-­‐hyperpolarization	  potentials.	  Thus,	  the	  major	  differences	  were	  the	  rate	  of	  rise,	   the	   rate	   of	   repolarization	   and	   the	  overall	   duration	  of	   the	  AP.	  The	  mid-­‐height	  duration	  of	   the	   fast	  AP	  waveform	   (modeled	   at	   37	   °C)	  was	  0.29ms	   and	   that	   of	   the	  slow	  AP	  waveform	  was	  1.0ms,	  which	  are	  similar	  to	  the	  durations	  measured	  for	  fast	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Table	  1.	  Modeled	  Action	  Potential	  Parameters.	  
	  










Max	  rate	  of	  rise	  (V/s)	   542.5	   180.8	   1234.0	   411.3	  
Max	  rate	  of	  decay	  (V/s)	   -­‐109.5	   -­‐36.5	   -­‐367.5	   -­‐122.5	  
Overshoot	  Amplitude	  (mV)	   39.3	   39.3	   39.3	   39.3	  
Width	  at	  -­‐20mV	  (ms)	   1.0	   3.0	   0.29	   0.87	  
Peak	  AHP	  (mV)	  	   -­‐84.9	   -­‐84.9	   -­‐84.9	   -­‐84.9	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Figure	  3.	  Waveform	  command	  protocol	  for	  trains	  of	  33Hz	  and	  8Hz	  of	  fast	  and	  
slow	  action	  potentials.	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5. Data	  analysis	  
	   Electrophysiological	   data	   were	   analyzed	   using	   Pulsefit	   (v	   8.67	   HEKA	  Electronic,	  Germany),	  Microsoft	  Excel,	  Origin	  (v	  8.0,	  OriginLab	  Corp,	  Northhampton,	  MA),	  and	  Prism	  (v	  6.0,	  Graphpad	  Software	  Inc.,	  La	  Jolla,	  CA).	  Steady-­‐state	  activation	  and	   inactivation	   curves	   were	   fit	   to	   a	   Boltzmann	   function	   to	   obtain	  midpoint	   and	  slope	  values.	  Quantification	  of	  the	  area	  under	  the	  curve	  was	  measured	  from	  20ms	  to	  35ms	  and	  baseline	  was	  set	  to	  zero.	  All	  data	  points	  are	  presented	  as	  mean	  ±	  SEM	  and	  
n	   is	   the	   number	   of	   experimental	   cells	   from	   which	   recordings	   were	   obtained.	  Statistical	  significance	  was	  assessed	  using	  an	  unpaired	  t-­‐test	  or	  a	  one-­‐way	  ANOVA	  as	  indicated.	  	   C. Results	  
	  1. hNav1.1	  and	  hNav1.6	  have	  differential	  biophysical	  properties	  	   To	   compare	   the	   biophysical	   properties	   of	   human	   Nav1.1	   and	   Nav1.6	  (hNav1.1	  and	  hNav1.6),	  we	  transiently	  transfected	  HEK293T	  cells	  with	  each	  channel	  isoform	  and	  obtained	  whole-­‐cell	  patch	  clamp	  recordings.	  hNav1.1	  and	  hNav1.6	  have	  a	   similar	   current-­‐voltage	   relationship	   for	   peak	   sodium	   current	   (Fig.	   4A,B).	  Correspondingly,	   these	  two	  channel	   isoforms	  show	  no	  differences	   in	  their	  voltage-­‐dependence	  of	  steady-­‐state	  activation	  (Fig.	  4C).	  Gating	  parameters	  are	  summarized	  in	   Table	   2.	   We	   then	   examined	   the	   kinetics	   of	   deactivation	   by	   applying	   a	   brief	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(0.5ms)	   depolarizing	   step	   pulse	   to	   +10mV	   followed	   by	   a	   repolarizing	   step	   to	  voltages	  ranging	  from	  -­‐60mV	  to	  -­‐100mV	  for	  50ms	  eliciting	  tail	  currents	  that	  were	  fit	  to	  a	  single	  exponential	  function	  (Fig.	  4D,	  inset).	  Representative	  traces	  of	  deactivation	  tail	   current	   can	   be	   seen	   in	   Figure	   4D.	   The	   time	   constants	   for	   the	   kinetics	   of	  deactivation	  were	  similar	  for	  both	  channel	   isoforms	  across	  all	  voltages	  tested	  (Fig.	  4E).	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Figure	   4.	   No	   differences	   in	   the	   current-­‐voltage	   relationship,	   voltage-­‐
dependence	   of	   steady-­‐state	   activation	   and	   deactivation	   kinetics	   of	   hNav1.1	  
and	   hNav1.6.	   A,	   Representative	   current	   traces	   recorded	   from	   hNav1.1	   (left)	   and	  hNav1.6	  (right)	  expressed	  in	  HEK293T	  cells.	  The	  currents	  were	  elicited	  by	  applying	  50ms	   step-­‐depolarization	   to	   potentials	   ranging	   from	   -­‐80mV	   to	   +80mV	   from	   a	  holding	  potential	  of	  -­‐100mV.	  Inset,	  Protocol	  used	  to	  obtain	  current-­‐voltage	  traces.	  B,	  Normalized	   peak	   current-­‐voltage	   relationship	   for	   hNav1.1	   (black	   squares;	   n=14)	  and	  hNav1.6	   (blue	  circles;	  n=14).	  C,	  Voltage-­‐dependence	  of	   steady-­‐state	  activation	  shows	   no	   difference	   in	   conductance	   between	   hNav1.1	   and	   hNav1.6.	   D,	  Representative	  traces	  showing	  hNav1.1	  (black)	  and	  hNav1.6	  (blue)	  deactivation	  tail	  currents	   at	   -­‐70mV.	   Inset,	   Protocol	  used	   to	   elicit	   deactivation	   tail	   currents.	  E,	  Time	  constants	  of	  channel	  deactivation	  were	  similar	  for	  hNav1.1	  and	  hNav1.6	  at	  voltages	  ranging	   from	   -­‐100mV	   to	   -­‐60mV.	   Time	   constants	   were	   obtained	   by	   a	   brief	   0.5ms	  depolarization	  to	  +10mV	  followed	  by	  a	  series	  of	  repolarizations	  to	  potentials	  from	  -­‐100mV	  to	  -­‐60mV	  eliciting	  tail	  currents	  that	  were	  fit	  to	  a	  single	  exponential	  function.	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Table	  2.	  Summary	  of	  activation	  and	  inactivation	  gating	  parameters.	  
	   	   Activation	   Inactivation	   	  	   V1/2	   Slope	   V1/2	   Slope	   n	  
hNav1.1	   -­‐34.8	  ±	  1.8	   6.7	  ±	  0.3	   -­‐67.2	  ±	  1.7	   4.7	  ±	  0.1	   14	  
hNav1.6	   -­‐32.6	  ±	  1.1	   6.5	  ±	  0.1	   -­‐71.9	  ±	  1.3*	   5.9	  ±	  0.1*	   14	  *	  p	  <	  0.05	  Compared	  to	  hNav1.1	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Next,	   we	   examined	   the	   voltage-­‐dependence	   of	   steady-­‐state	   inactivation	   by	  holding	   cells	   at	   voltages	   ranging	   from	   -­‐120mV	   to	   +30mV	   for	   500ms	   and	   then	  applying	  a	  20ms	  test	  pulse	  to	  +10mV	  to	  determine	  the	  fraction	  of	  current	  available	  (Fig.	   5A,	   inset).	   hNav1.6	   had	   a	   small	   but	   significant	   hyperpolarizing	   shift	   in	   the	  midpoint	  (-­‐72	  ±	  1mV;	  n	  =	  14)	  of	  the	  voltage-­‐dependence	  of	  steady-­‐state	  inactivation	  curve	  compared	  to	  hNav1.1	  (-­‐67	  ±	  2mV;	  n	  =	  14)	  (Fig.	  5A,	  Table	  2).	  To	  explore	  what	  was	   underlying	   the	   shift	   in	   inactivation	  we	   examined	   the	   development	   of	   closed-­‐state	  inactivation,	  which	  reflects	  the	  direct	  transition	  of	  channels	  from	  a	  closed	  into	  an	  inactivated	  state.	  Development	  of	  closed-­‐state	  inactivation	  was	  measured	  using	  a	  voltage	   protocol	   in	   which	   cells	   were	   held	   at	   -­‐100mV	   and	   stepped	   to	   a	   prepulse	  potential	   ranging	   from	   -­‐100mV	   to	   -­‐50mV	   for	   increasing	   durations	   immediately	  followed	  by	  a	  test	  pulse	  to	  0mV	  to	  assess	  the	  fraction	  of	  current	  inactivated	  during	  the	   prepulse	   (Fig.	   5C,	   inset).	   The	   data	  were	   plotted	   (peak	   current	   amplitude	   as	   a	  function	   of	   inactivation	   duration)	   and	   fit	   to	   a	   single	   exponential	   function	   to	  determine	  the	  time	  constants	  for	  development	  of	  closed	  state	  inactivation	  as	  seen	  in	  Figure	   5B.	   We	   found	   that	   hNav1.6	   had	   statistically	   smaller	   tau	   values	   for	  development	  of	  closed	  state	  inactivation	  at	  voltages	  ranging	  from	  -­‐80mV	  to	  -­‐60mV	  compared	   to	   hNav1.1	   (Fig.	   5C).	   Specifically,	   at	   voltages	   near	   typical	   resting	  potentials	   in	   neurons	   such	   as	   -­‐70mV,	   hNav1.1	   (τ	   =	   56.5	   ±	   12.1ms;	   n	  =	   9)	   had	   a	  slower	  rate	  of	  closed-­‐state	  inactivation	  development	  compared	  to	  hNav1.6	  (τ	  =	  26.0	  ±	   2.0ms;	  n	  =	   8),	  which	  would	   allow	   it	   to	   be	  more	   resistant	   to	   inactivation	   during	  slow	   sub-­‐threshold	   depolarizations	   [162].	   This	   would	   result	   in	   greater	   channel	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availability	   for	   hNav1.1	   to	   open	   once	   the	   membrane	   is	   depolarized	   to	   threshold	  potentials	  for	  firing	  an	  AP.	  We	   also	   compared	   recovery	   from	   fast	   inactivation	   (repriming),	   a	   property	  that	  can	  limit	  the	  channels	  ability	  to	  sustain	  high	  firing	  frequencies.	  To	  do	  this,	  we	  held	   cells	   at	   -­‐100mV	   and	   applied	   a	   prepulse	   to	   0mV	   for	   20ms	   to	   induce	   fast	  inactivation	   and	   then	   allowed	   the	   channels	   to	   recover	   for	   increasing	   durations	   at	  potentials	  ranging	   from	  -­‐100mV	  to	   -­‐70mV	  before	  applying	  a	   test	  pulse	   to	  0mV	  for	  20ms	   to	  measure	   the	   available	   channels	   (Fig.	   6A,	   inset).	   Representative	   traces	   of	  recovery	  from	  fast	  inactivation	  at	  -­‐70mV	  are	  depicted	  in	  Figure	  6A.	  Each	  test	  pulse	  current	  was	  normalized	  to	  the	  maximal	  current	  at	  each	  time	  point	  and	  plotted	  as	  a	  function	   of	   time	   for	   each	   recovery	   voltage	   (Fig.7).	   Time	   constants	   for	   repriming	  kinetics	  were	  estimated	  using	   single	  exponential	   fits	   and	   these	   time	  constants	  are	  plotted	  as	  a	   function	  of	  recovery	  voltage	   in	  Figure	  6B.	  We	  found	  that	  hNav1.1	  and	  hNav1.6	  had	  similar	  time	  constant	  values	  for	  recovery	  from	  inactivation	  at	  voltages	  ranging	  from	  -­‐100mV	  to	  -­‐80mV.	  However,	  at	  -­‐70mV	  hNav1.6	  (τ	  =	  22.3	  ±	  1.1ms;	  n	  =	  17)	   had	   significantly	   faster	   repriming	   kinetics	   compared	   to	   hNav1.1	   (τ	   =	   33.1	   ±	  2.1ms;	   n	  =	   19).	   It	   is	   important	   to	   note	   that	   the	   maximal	   fraction	   recovered	   was	  greater	   for	   hNav1.1	   compared	   to	   hNav1.6	   at	   recovery	   voltages	   from	   -­‐90mV	   to	   -­‐70mV	  (Fig.	  6C),	  consistent	  with	  the	  differences	  observed	  in	  the	  voltage-­‐dependence	  of	  steady-­‐state	  inactivation.	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Figure	   5.	   Voltage-­‐dependence	   of	   steady-­‐state	   inactivation	   and	   kinetics	   of	  
development	   of	   closed-­‐state	   inactivation	   are	   different	   for	   hNav1.1	   and	  
hNav1.6.	  A,	  To	  examine	   the	  voltage-­‐dependence	  of	  steady-­‐state	   fast	   inactivation	  a	  series	   of	   500ms	   steps	   from	   -­‐120mV	   to	   +30mV	   followed	   by	   a	   20ms	   step	   pulse	   to	  +10mV	   was	   used	   to	   measure	   channel	   availability.	   Midpoints	   of	   the	   voltage-­‐dependence	  of	   steady-­‐state	   fast	   inactivation	  were	  estimated	  by	   fitting	  data	  with	   a	  Boltzmann	  function	  and	  was	  more	  hyperpolarized	  for	  hNav1.6	  (blue	  circles;	  n	  =	  14)	  compared	   to	   hNav1.1	   (black	   squares;	   n	  =	   14)(Unpaired	   t-­‐test,	   p	   <	   0.05).	   Table	   2	  summarizes	   gating	   parameters.	   Inset,	   Protocol	   used	   to	   measure	   steady-­‐state	  inactivation.	  B,	  Top:	  Representative	   family	  of	  current	   traces	  generated	  by	  hNav1.1	  (left)	  and	  hNav1.6	  (right)	  showing	  the	  rate	  of	  development	  of	  inactivation	  at	  -­‐70mV.	  Bottom:	   Plots	   for	   the	   time	   course	   of	   development	   of	   inactivation	   for	   the	   peak	  current	   from	   the	   corresponding	   cell	   above.	   C,	   Time	   constants	   for	   development	   of	  closed-­‐state	   inactivation	  are	  smaller	   for	  hNav1.6	   (blue	  circles;	  n	  =	  8)	  compared	   to	  hNav1.1	   (black	   squares;	   n	   =9)	   (Unpaired	   t-­‐test,	   *p	   <	   0.05).	   Time	   constants	   were	  determined	  by	   single	   exponential	   fits	   to	   time	   courses	  measured	  using	   the	   voltage	  protocol	  depicted	  in	  the	  inset.	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Figure	  6.	  Rate	  and	  fraction	  of	  recovery	  from	  fast	  inactivation	  are	  different	  for	  
hNav1.1	   and	  hNav1.6.	  A,	  Representative	  traces	  of	  recovery	  from	  fast	   inactivation	  measured	  by	  first	  inducing	  fast	  inactivation	  from	  a	  holding	  potential	  of	  -­‐100mV	  with	  a	  20ms	  step	  pulse	  to	  0mV	  and	  then	  applying	  a	  20ms	  test	  pulse	  to	  0mV	  subsequent	  to	  various	  recovery	  times	  at	  -­‐70mV.	  Inset,	  Protocol	  used	  to	  measure	  recovery	  from	  fast	  inactivation.	   B,	   hNav1.6	   (blue	   circles;	   n	   =	   17)	   has	   a	   smaller	   time	   constant	   for	  recovery	  at	  -­‐70mV	  compared	  to	  hNav1.1	  (black	  squares;	  n	  =	  19).	  C,	  Maximal	  fraction	  recovered	  from	  fast	   inactivation	  was	  greater	  for	  hNav1.1	  at	  voltage	  ranging	  from	  -­‐90mV	  to	  -­‐70mV	  compared	  to	  hNav1.6	  (Unpaired	  t-­‐test,	  *p	  <	  0.05).	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Figure	  7.	  Time	  courses	  of	  recovery	   from	  fast	   inactivation	  at	  voltages	  ranging	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2. hNav1.6	  has	  a	  greater	  propensity	  to	  generate	  resurgent	  currents	  than	  hNav1.1	  
	   We	   next	   asked	   whether	   there	   was	   an	   intrinsic	   difference	   in	   the	   ability	   of	  hNav1.1	   and	   hNav1.6	   to	   generate	   resurgent	   sodium	   currents.	   We	   examined	  resurgent	  current	  generation	  by	  hNav1.1	  and	  hNav1.6	  in	  HEK293T	  cells	  by	  inclusion	  of	  a	  peptide	  (Navβ4	  peptide)	  corresponding	  to	  a	  portion	  of	  the	  C-­‐terminal	  tail	  of	  the	  Navβ4	  auxiliary	  subunit	  in	  the	  pipette	  solution,	  which	  has	  been	  previously	  shown	  to	  induce	  resurgent	  currents	   in	   this	  cell	   type	   [163-­‐165].	  Figure	  8A	  shows	  a	   family	  of	  representative	   resurgent	   current	   traces	   generated	   from	   cells	   expressing	   either	  hNav1.1	  or	  hNav1.6	  obtained	  by	  applying	  an	  initial	  depolarizing	  step	  to	  +60mV	  for	  20ms	  from	  a	  holding	  potential	  of	   -­‐100mV	  followed	  by	  a	  50ms	  step	  to	  repolarizing	  voltages	   ranging	   from	   +25mV	   to	   -­‐80mV	   (Fig.	   8B).	   Resurgent	   currents	   were	  quantified	  by	  dividing	  the	  peak	  resurgent	  current	  amplitude	  measured	  after	  1.5ms	  into	   the	   repolarizing	   step	   (to	  prevent	   contamination	  by	   tail	   currents)	  by	   the	  peak	  transient	   current	  measured	  with	  a	  20ms	   test	  pulse	  at	  +10mV	  and	  are	   shown	  as	   a	  percentage	   of	   the	   peak	   transient	   current	   amplitude.	   hNav1.6	   demonstrated	   a	  greater	   propensity	   to	   generate	   resurgent	   currents	  within	   voltages	   ranging	   from	   -­‐45mV	   to	   +25mV	   compared	   to	   hNav1.1	   (Fig.	   8C).	   The	   peak	   resurgent	   current	  was	  more	   than	  2-­‐fold	  greater	   for	  hNav1.6	   (15.9	  ±	  2.4%;	  n	  =	  15)	   compared	   to	  hNav1.1	  (7.4	  ±	  1.3%;	  n	  =	  15)	  and	  occurred	  at	  -­‐35mV	  and	  -­‐45mV,	  respectively.	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One	  of	  the	  major	  determinants	  of	  resurgent	  current	  generation	  is	  the	  rate	  of	  inactivation	   because	   the	   Navβ4	   peptide	   is	   thought	   to	   directly	   compete	   with	   the	  ability	   of	   the	   intrinsic	   fast	   inactivation	   gate	   to	   bind	   the	   channel.	   Therefore,	   we	  examined	   the	   kinetics	   of	   fast	   inactivation	   of	   peak	   transient	   sodium	   currents	   by	  fitting	  the	  decay	  phase	  of	  macroscopic	  currents	  elicited	  with	  test	  potential	  steps	  to	  voltages	   ranging	   from	   -­‐20mV	   to	  +20mV	  with	  a	   single	  exponential	   function.	  Figure	  8D	  shows	  representative	  normalized	  traces	  elicited	  by	  a	  voltage	  step	  from	  -­‐100mV	  to	  -­‐10mV	  demonstrating	  the	  slower	  decay	  phase	  of	  hNav1.6	  compared	  to	  hNav1.1.	  We	   found	   that	   hNav1.6	   has	   significantly	   larger	   time	   constants	   for	   kinetics	   of	  inactivation	   compared	   to	   hNav1.1	   at	   all	   the	   voltages	   tested	   (Fig.	   8E).	   The	   slower	  kinetics	  of	   inactivation	   for	  hNav1.6	  corresponded	   to	   its	  greater	  ability	   to	  generate	  resurgent	   currents.	   We	   did	   not	   observe	   any	   differences	   in	   the	   kinetics	   of	  inactivation	  with	  and	  without	  of	  Navβ4	  peptide	  for	  either	  channel	  isoform	  (Fig.	  9).	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Figure	   8.	   Resurgent	   current	   generation	   is	   increased	   and	   kinetics	   of	  
inactivation	   are	   slowed	   for	   hNav1.6	   compared	   to	   hNav1.1.	   A,	   Representative	  family	   of	   resurgent	   current	   traces	   from	   hNav1.1	   (left)	   and	   hNav1.6	   (right)	   with	  Navβ4	  peptide	   in	   the	  pipette	   solution.	  Currents	  were	   elicited	  by	  depolarization	   to	  +60mV	  for	  20ms	  followed	  by	  repolarization	  to	  potentials	  ranging	  from	  +25mV	  to	  -­‐80mV	  for	  50ms.	  B,	  Protocol	  used	  to	  measure	  resurgent	  currents.	  C,	  Current-­‐voltage	  curve	  of	  peak	  resurgent	  current	  normalized	  to	  peak	  transient	  current	  measured	  at	  +10mV	  by	  hNav1.1	  (purple	  squares;	  n	  =	  15)	  and	  hNav1.6	  (green	  circles;	  n	  =	  15).	  D,	  Representative	   normalized	   current	   traces	   elicited	   by	   a	   step	   depolarization	   from	   -­‐100mV	  to	  -­‐10mV	  by	  hNav1.1	  (black)	  and	  hNav1.6	  (blue)	  without	  Navβ4	  peptide	  in	  the	   pipette	   solution.	   E,	   Averaged	   decay	   time	   constants	   measured	   at	   potentials	  ranging	   from	   -­‐20mV	   to	   +20mV	   from	  hNav1.1	   (black	   square;	  n	  =	  14)	   and	   hNav1.6	  (blue	  circles;	  n	  =	  14)	  (Unpaired	  t-­‐test,	  *p	  <	  0.05).	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Figure	  9.	  No	  different	   in	   the	  kinetics	  of	   fast	   inactivation	   in	   the	  presence	  and	  
absence	  of	  the	  Navβ4	  peptide	  for	  hNav1.1	  and	  hNav1.6.	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3. Sodium	  influx	  through	  hNav1.1	  and	  hNav1.6	  in	  response	  to	  slow	  and	  fast	  AP	  waveforms	  is	  altered	  in	  the	  presence	  of	  Navβ4	  peptide	  	   AP	   waveforms	   vary	   with	   cell	   type	   and	   one	   of	   the	  major	   differences	   is	   the	  width	  of	  the	  action	  potential	  [137,	  166].	  It	   is	  unknown	  if	  and	  where	  during	  the	  AP	  waveform	  resurgent	  sodium	  current	  generated	  by	  hNav1.1	  or	  hNav1.6	  would	  result	  in	   an	   increase	   in	   sodium	   influx.	  We	   therefore	  wanted	   to	   examine	   the	   influence	   of	  resurgent	   current	   generation	   on	   sodium	   influx	   in	   response	   to	   a	   slow	   and	   fast	   AP	  waveform.	  To	  do	  this,	  we	  first	  modeled	  AP	  waveforms	  from	  fast-­‐spiking	  GABAergic	  (fast	  AP)	  and	  pyramidal	  (slow	  AP)	  neurons	  using	  the	  simulation	  program	  NEURON	  (Fig.	  10A)	  [27].	  We	  adjusted	  the	  initial	  resting	  membrane	  potential,	  peak	  amplitude	  and	   the	   after-­‐hyperpolarization	   potential	   of	   the	   AP	   waveforms	   to	   be	   identical	   in	  order	  to	  focus	  on	  implications	  of	  the	  difference	  in	  the	  AP	  width	  observed	  between	  these	   two	  different	   types	  of	  neurons.	  We	   then	  used	   the	  AP	  waveform	  as	  a	  voltage	  command	  waveform	  to	  elicit	  sodium	  currents.	  	  Figure	   10C,E	   show	   the	   responses	   of	   hNav1.1	   and	   hNav1.6	   to	   the	   fast	   AP	  waveform	   (superimposed	   for	   comparison	   in	   a	   dotted	   line)	   as	   an	   average	   of	  normalized	  traces	  plotted	  versus	  time.	  Note	  that	  not	  all	  traces	  reach	  a	  value	  of	  one	  because	  the	  peak	  does	  not	  occur	  at	  the	  same	  exact	  time	  in	  each	  cell,	  therefore	  after	  averaging	  the	  normalized	  traces	  from	  each	  cell	  the	  averaged	  peak	  value	  is	  less	  than	  one.	  The	  second	  peak,	  or	  hump,	  in	  the	  decaying	  phase	  of	  the	  sodium	  current	  is	  likely	  generated	  by	   the	   fraction	  of	   channels	   that	  do	  not	  undergo	   fast	   inactivation	  during	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the	   upstroke	   of	   the	   action	   potential.	   	   hNav1.1	   mediated	   sodium	   influx	   was	  significantly	  decreased	  between	  25.2	  and	  25.5ms	  and	   increased	  during	  the	  second	  non-­‐inactivating	   component	   of	   the	   current	   between	   26.1	   and	   28ms	   by	   Navβ4	  peptide,	   as	   highlighted	   by	   the	   grey	   shaded	   boxes.	   Similarly,	   hNav1.6	   mediated	  sodium	  influx	  in	  the	  presence	  of	  Navβ4	  peptide	  was	  significantly	  decreased	  between	  25.4	  and	  25.6ms	  and	  increased	  between	  26.0	  and	  27.3ms.	  The	  decrease	  in	  sodium	  influx	  likely	  reflects	  binding	  of	  Navβ4	  peptide	  to	  the	  channel	  while	  the	  unbinding	  of	  Navβ4	   peptide	   increased	   the	   duration	   of	   the	   second	   non-­‐inactivating	   component.	  Responses	   to	   the	   slow	   AP	   waveform	   exhibited	   a	   smaller	   second	   non-­‐inactivating	  component	   compared	   to	   the	   fast	   AP	  waveform.	  However,	   just	   as	  with	   the	   fast	   AP	  waveform,	  Navβ4	  peptide	   significantly	   increased	   sodium	   influx	   during	   the	   second	  non-­‐inactivating	   component	   for	   hNav1.1	   between	   27.3	   and	   31.4ms	   and	   hNav1.6	  between	   27.7	   and	   30.4ms,	   increasing	   both	   the	   duration	   of	   sodium	   influx	   and	  amplitude	  of	   the	   second	  non-­‐inactivating	   component	   (Fig.	   10D,F).	  Unlike	  with	   the	  fast	  AP	  waveform,	  the	  sodium	  influx	   in	  response	  to	  the	  slow	  AP	  waveform	  did	  not	  show	   the	   same	   decrease	   in	   current	   following	   the	   initial	   peak	   in	   the	   presence	   of	  Navβ4	  peptide.	  Overall,	  there	  was	  a	  statistically	  greater	  sodium	  influx	  mediated	  by	  hNav1.6	   compared	   to	   hNav1.1	   as	   measured	   by	   the	   area	   under	   the	   curve	   in	   the	  presence	  and	  absence	  of	  Navβ4	  peptide	  with	  both	  the	  slow	  and	  fast	  AP	  waveforms	  (Fig.	  10B;	  Fig.	  11).	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Figure	   10.	   Sodium	   influx	   in	   response	   to	   fast	   and	   slow	   AP	   waveforms	   are	  
altered	  in	  the	  presence	  of	  the	  Navβ4	  peptide.	  A,	  Fast	  and	  slow	  voltage	  command	  waveforms	  modeled	  using	  NEURON.	  B,	  Area	  under	  the	  curve	  for	  currents	  elicited	  by	  the	   fast	   (left)	   and	   slow	   waveform	   (right)	   from	   cells	   expressing	   hNav1.1	   (purple	  bars)	  and	  hNav1.6	  (green	  bars)	  measured	  between	  20	  and	  35ms	  (Unpaired	  t-­‐test,	  *p	  <	   0.05).	   Currents	   generated	   in	   response	   to	   fast	   and	   slow	   AP	   waveforms	   were	  normalized	  and	  then	  averaged.	  C,	  hNav1.1	  generated	  sodium	  current	  in	  response	  to	  a	   fast	   voltage	   command	   waveform	   in	   the	   absence	   (black	   traces;	   n	   =	   17)	   and	  presence	  (purple	  traces;	  n	  =	  14)	  of	  Navβ4	  peptide.	  D,	  Response	  of	  hNav1.1	  to	  a	  slow	  voltage	  command	  waveform.	  E,	  hNav1.6	  generated	  sodium	  current	  in	  response	  to	  a	  fast	  voltage	   command	  waveform	   in	   the	  absence	   (blue	   trace;	  n	  =	  14)	  and	  presence	  (green	   trace;	  n	  =	   15)	   of	  Navβ4	   peptide.	   F,	   Response	   of	   hNav1.6	   to	   a	   slow	   voltage	  command	   waveform.	   Grey	   boxes	   represent	   regions	   of	   statistically	   significant	  differences	  (Unpaired	  t-­‐test,	  p	  <	  0.05).	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Figure	   11.	   Sodium	   influx	   in	   response	   to	   a	   fast	   and	   slow	   action	   potential	  
waveform	   in	   the	   absence	   of	   the	   Navβ4	   peptide	   is	   greater	   for	   hNav1.6	  
compared	  to	  hNav1.1.	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4. Navβ4	  peptide	  mediated	  open-­‐channel	  block	  allows	  channels	  to	  recover	  faster	  
	   The	   open-­‐channel	   blocker	   responsible	   for	   mediating	   the	   generation	   of	  resurgent	   current	   is	   thought	   to	   allow	   channels	   to	   bypass	   classic	   inactivation	   and	  enhance	  recovery	  [62].	  	  We	  therefore	  tested	  whether	  Navβ4	  peptide	  mediated	  open-­‐channel	  block	   allows	   channels	   to	   recover	   faster.	  To	  do	   this	  we	  used	   two	  different	  voltage	   command	   protocols	   (adapted	   from	   Raman	   and	   Bean,	   2001)	   in	   which	   we	  applied	   either	   a	   brief,	   5ms	   pulse	   to	   +30mV	   or	   a	   longer,	   40ms	   pulse	   to	   -­‐30mV	   to	  accumulate	   channels	   in	   an	   open-­‐blocked	   or	   inactivated	   state,	   respectively,	   and	  subsequently	  allowed	  channels	  to	  recover	  at	  -­‐70mV	  for	  increasing	  durations	  before	  applying	   a	   test	   pulse	   to	   0mV	   to	   measure	   the	   fraction	   of	   channels	   available	   (Fig.	  12A,B).	   We	   found	   that	   both	   hNav1.1	   and	   hNav1.6	   channels	   have	   smaller	   time	  constants	   following	   recovery	   from	   an	   open-­‐blocked	   state	   (hNav1.1:	   τ	   =	   7.0ms;	  hNav1.6:	   τ	   =	   6.2ms)	   compared	   to	   an	   inactivated	   state	   (hNav1.1:	   τ	   =	   26.1ms;	  hNav1.6:	  τ	  =	  28.5ms)	   (Fig.	  12C,D).	   It	   is	   important	   to	  note	   that	  we	  did	  not	  observe	  any	   differences	   in	   the	   time	   course	   for	   recovery	   with	   these	   two	   protocols	   in	   the	  absence	  of	  Navβ4	  peptide	  (Figure	  13),	  which	  indicates	  that	  in	  the	  absence	  of	  Navβ4	  peptide	   the	   two	   distinct	   depolarizing	   pulses	   (5ms	   at	   +30	  mV	   versus	   40ms	   at	   -­‐30	  mV)	  induce	  similar	  inactivation	  states	  for	  the	  sodium	  channels.	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Figure	   12.	   Recovery	   of	   channels	   is	   faster	   from	   open-­‐blocked	   versus	  
inactivated	  states	  for	  hNav1.1	  and	  hNav1.6.	  A,	  Recovery	  at	  -­‐70mV	  for	  increasing	  durations	  following	  a	  brief,	  5ms	  pulse	  to	  +30mV	  to	  allow	  channels	  to	  enter	  an	  open-­‐blocked	   state	   (top).	   Representative	   traces	   for	   the	   time	   courses	   of	   recovery	  generated	   by	   hNav1.1	   (middle)	   and	   hNav1.6	   (bottom).	   B,	   Recovery	   at	   -­‐70mV	   for	  increasing	  durations	  following	  a	  40ms	  pulse	  to	  -­‐30mV	  to	  allow	  channels	  to	  enter	  an	  inactivated	  state.	  Representative	  traces	  for	  the	  time	  courses	  of	  recovery	  generated	  by	   hNav1.1	   (middle)	   and	   hNav1.6	   (bottom).	   C	   and	  D,	   Summary	   data	   showing	   the	  fraction	  available	  after	  a	  5ms	  pulse	  to	  +30mV	  (filled)	  versus	  a	  40ms	  pulse	  to	  -­‐30mV	  (open)	  plotted	  against	  the	  recovery	  time	  for	  hNav1.1	  (squares;	  n	  =	  21)	  and	  hNav1.6	  (circles;	  n	  =	  14).	  Fraction	  available	  was	  calculated	  by	  normalizing	  the	  peak	  current	  elicited	  by	  the	  test	  pulse	  to	  the	  peak	  current	  elicited	  by	  a	  step	  depolarization	  from	  -­‐100mV	  to	  0mV	  at	  the	  beginning	  of	  the	  protocol.	  Data	  are	  fit	  to	  a	  single	  exponential	  function.	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Figure	   13.	   Recovery	   from	   open-­‐blocked	   (+30mV)	   and	   inactivated	   (-­‐30mV)	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5. Navβ4	  peptide	  does	  not	  protect	  hNav1.1	  or	  hNav1.6	  from	  use-­‐dependent	  reduction	  with	  10Hz	  step-­‐pulses	  
	  Since	   Navβ4	   peptide	   mediated	   open-­‐channel	   block	   enhances	   recovery,	   we	  predicted	   that	   the	   presence	   of	   the	   open	   channel	   blocker	  would	   allow	   channels	   to	  better	   follow	   a	   10Hz	   step-­‐pulse	   stimulus	   by	   protecting	   channels	   from	  undergoing	  use-­‐dependent	   reduction	   that	   is	   entering	   accumulating	   in	   inactivated	   states	   will	  trains	  of	   stimuluation.	  We	  used	  a	  protocol	   in	  which	  we	  assessed	   the	  peak	  current	  with	   an	   initial	   20ms	   step	   pulse	   to	   -­‐10mV	   from	   -­‐80mV	   followed	   by	   19	   step-­‐depolarizations	  (at	  10	  Hz)	  from	  -­‐80mV	  to	  either	  +30mV	  or	  +60mV	  for	  20ms	  before	  a	  final	   test	  pulse	   to	   -­‐10mV	   for	  20ms	   to	  determine	   the	   remaining	   channels	   available	  (Fig.	   14A,B,	   inset).	  Two	  depolarization	  voltages	  were	  used	  because	  Navβ4	  peptide	  binds	   more	   stably	   to	   the	   channel	   at	   higher	   depolarization	   voltages	   [167].	   We	  calculated	  the	  percent	  current	  reduced	  between	  the	  initial	  and	  final	  test	  pulses	  and	  found	   that	  hNav1.6	  undergoes	  approximately	  15%	  more	  use-­‐dependent	   reduction	  compared	  to	  hNav1.1	  (Fig.	  14B).	  The	  presence	  of	  Navβ4	  peptide	  did	  not	  alter	  use-­‐dependent	  reduction	  with	  10Hz	  step-­‐pulses	  to	  +30mV	  or	  +60mV	  by	  either	  channel	  isoform.	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Figure	   14.	   The	   Navβ4	   peptide	   does	   not	   effect	   use-­‐dependent	   reduction	   of	  
hNav1.1	   or	   hNav1.6	   with	   10Hz	   stimulation.	   A,	   Representative	   traces	   of	   use-­‐dependent	  reduction	   traces	  generated	  by	  hNav1.1	  (left)	  and	  hNav1.6	  (right)	  when	  pulsed	  at	  +30mV.	  Use-­‐dependent	  reduction	  was	  examined	  with	  an	   initial	  and	   final	  20ms	   step	  pulse	   to	   -­‐10mV	   from	   -­‐80mV	   to	   assess	   the	   current	   available	  before	   and	  after	  19	  consecutive	  step	  depolarization	  from	  -­‐80mV	  for	  80ms	  to	  +30mV	  or	  +60mV	  for	  20ms.	  B,	  Percent	  inhibition	  was	  calculated	  between	  the	  initial	  and	  final	  currents	  for	   cells	   in	   the	   absence	   (dark	   grey	   bars)	   and	   presence	   (light	   grey	   bars)	   of	  Navβ4	  peptide	   (n	   =	   8-­‐9).	   Inset,	   Abbreviated	   protocol	   used	   to	   measure	   use-­‐dependent	  reduction.	  *p	  <	  0.05	  compared	  to	  corresponding	  hNav1.1	  group.	  
	  	  
	   61	  
One	   possibility	   is	   that	   the	   use-­‐dependent	   reduction	   in	   current	   was	  independent	  of	  fast	  inactivation	  processes,	  but	  rather	  reflected	  slow	  inactivation	  of	  hNav1.1	  and	  hNav1.6	  channels.	  To	  evaluate	  entry	  into	  slow	  inactivated	  states	  during	  the	   10Hz	   trains,	   we	   measured	   the	   fraction	   of	   channels	   that	   recover	   from	   fast	  inactivation	   after	   the	   10Hz	   stimulus	   protocol	   by	   applying	   a	   20ms	   step	   pulse	   to	   -­‐120mV	   following	   the	   last	   step	   depolarization	   to	   +60mV	   (allowing	   channels	   to	  recover	   from	  fast	  but	  not	  slow	   inactivation)	  and	  used	  a	  subsequent	   test	  pulse	   to	   -­‐10mV	  to	  measure	  channel	  availability.	  We	  found	  that	  both	  hNav1.1	  (91.56	  ±	  1.6	  %	  availability)	   and	   hNav1.6	   (112.3	   ±	   7.4	   %	   availability)	   nearly	   or	   completely	  recovered	   during	   this	   brief	   recovery	   pulse,	   suggesting	   channels	   (particularly	  hNav1.6	  channels)	  are	  not	  undergoing	  slow	  inactivation.	  	  	  The	   lack	   of	   an	   effect	   of	   Navβ4	   peptide	   on	   use-­‐dependent	   reduction	   was	  surprising	   since	   Navβ4	   peptide	   allows	   from	   fraction	   of	   the	   channels	   to	   bypass	  classic	   fast	   inactivation	   and	   increasing	   recovery	   from	   apparent	   inactivation.	   	   In	  order	   to	   further	  explore	   this,	  we	  also	  used	   trains	  of	  action	  potential	  waveforms,	  a	  more	   physiological	   stimulus,	   to	   elicit	   use-­‐dependent	   reduction.	   Figure	   15A	   shows	  the	   command	  waveform	   for	   the	   train	   of	   20	   slow	  APs	   at	   33Hz	   and	   representative	  traces	  generated	   in	  response	   to	   the	  command	  waveform	  by	  hNav1.1	  and	  hNav1.6.	  Voltage	  command	  waveforms	  for	  33Hz	  fast	  AP	  and	  8Hz	  slow	  and	  fast	  AP	  trains	  can	  be	   seen	   in	   Figure	   3.	   The	   higher	   frequency	   trains	   elicited	   more	   use-­‐dependent	  reduction	  than	  low	  frequency	  trains	  (one-­‐way	  ANOVA;	  p	  <	  0.05).	  	  However,	  addition	  of	  Navβ4	  peptide	  did	  not	  significantly	   impact	  use-­‐dependent	  reduction	  with	  either	  
	   62	  
hNav1.1	  or	  hNav1.6	   at	   any	   combination	  of	   frequency	   and	  AP	  waveform	   type	   (Fig.	  15B).	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Figure	   15.	   The	   Navβ4	   peptide	   does	   not	   effect	   use-­‐dependent	   reduction	   of	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D. Discussion	  	   In	  this	  study	  we	  show	  that	  hNav1.1	  and	  hNav1.6	  exhibit	  distinct	  biophysical	  properties.	  hNav1.6	  has	  a	  more	  hyperpolarized	  voltage-­‐dependence	  of	  steady-­‐state	  inactivation,	   faster	   development	   of	   closed-­‐state	   inactivation,	   slower	   kinetics	   of	  open-­‐channel	  inactivation	  and	  a	  greater	  propensity	  to	  generate	  resurgent	  currents.	  The	  presence	  of	  Navβ4	  peptide	  mediated	  resurgent	  current	  generation	  by	  hNav1.1	  and	  hNav1.6	  allowed	  for	  a	  greater	  influx	  of	  sodium	  in	  response	  to	  a	  fast	  and	  slow	  AP	  waveform	   with	   an	   overall	   greater	   sodium	   influx	   mediated	   by	   hNav1.6.	   However,	  Navβ4	   peptide	   did	   not	   protect	   against	   use-­‐dependent	   reduction	   of	   either	   channel	  isoform.	  	  	  The	   localization	  of	  Nav1.1,	  Nav1.6	  and	  Navβ4	  in	  the	  axon	   initial	  segment	  of	  parvalbumin-­‐positive	   GABAergic	   neurons	   suggests	   their	   importance	   in	   sustaining	  high	   frequency	   firing.	   Three	   critical	   properties	   of	   VGSCs	   in	   cells	  with	   a	   fast-­‐firing	  phenotype	   that	   likely	   contribute	   to	   fast	   firing	   include:	   slow	   development	   of	  inactivation	   during	   depolarizing	   potentials	   in	   the	   inter-­‐spike	   interval,	   rapid	  recovery	  of	  channels	  after	  an	  AP	  spike	  and	  incomplete	  inactivation	  during	  APs	  [168,	  169].	   Our	   data	   indicate	   that	   Nav1.1	   and	   Nav1.6	   exhibit	   interesting	   differences	   in	  these	   potentially	   crucial	   biophysical	   properties	   suggesting	   that	   both	   channel	  isoforms	   are	   likely	   to	   be	   important	   for	   a	   fast	   firing	   phenotype.	   The	   slower	  development	  of	  closed-­‐state	  inactivation	  that	  we	  observed	  with	  Nav1.1	  should	  allow	  it	   to	  be	  more	  resistant	  to	   inactivation	  during	  slow	  subthreshold	  depolarizations	   in	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the	   interspike	   interval	   compared	   to	   Nav1.6.	   Consequently,	   more	   Nav1.1	   channels	  would	  be	  available	  to	  open	  once	  the	  membrane	  voltage	  reaches	  threshold	  for	  firing	  an	   AP.	   In	   contrast,	   we	   would	   predict	   that	   Nav1.6	   contributes	   more	   to	   the	   rapid	  recovery	  of	  channels	  after	  an	  AP	  spike	  and	  incomplete	  inactivation	  during	  APs	  due	  to	  its	  greater	  propensity	  to	  generate	  resurgent	  current	  since	  Navβ4	  mediated	  block	  allows	   channels	   to	   bypass	   classical	   inactivation	   and	   enhances	   recovery	   of	   the	  channels.	   Moreover,	   Nav1.6	   showed	   faster	   repriming	   kinetics	   at	   -­‐70mV	   although	  Nav1.1	  had	  an	  overall	  greater	  fraction	  of	  recovery	  at	  voltages	  ranging	  from	  -­‐90mV	  to	  -­‐70mV.	  	  	  Firing	  frequency	  correlates	  strongly	  with	  AP	  width	  [137,	  166].	  The	  width	  of	  the	   AP	   in	   many	   neurons	   is	   primarily	   controlled	   by	   repolarization	   mediated	   by	  potassium	  channels	  [169,	  170].	  Our	  data	  shows	  that	  the	  width	  of	  the	  AP	  waveform	  can	   greatly	   alter	   sodium	   current	   kinetics	   generated	   by	   Nav1.1	   and	   Nav1.6.	   Both	  channel	  isoforms	  produced	  a	  larger	  second	  non-­‐inactivating	  component	  in	  response	  to	  a	  fast	  AP	  waveform,	  which	  is	  consistent	  with	  observations	  in	  neurons	  [155,	  169].	  However,	   Nav1.6	   showed	   a	   much	   greater	   second	   non-­‐inactivating	   component	  compared	   to	   Nav1.1	   in	   response	   to	   the	   fast	   AP	   possibly	   due	   to	   its	   slower	   rate	   of	  inactivation.	  The	  duration	  of	  the	  second	  non-­‐inactivating	  component	  in	  response	  to	  the	  fast	  AP	  is	  increased	  by	  Navβ4	  peptide	  for	  both	  isoforms	  although	  Nav1.6	  carried	  the	   greatest	   overall	   sodium	   influx.	   Sodium	   currents	   in	   response	   to	   the	   slow	   AP	  waveform	   produced	   a	   smaller	   second	   non-­‐inactivating	   component	   with	   both	  channel	   isoforms,	   but	   Navβ4	   peptide	   increased	   both	   the	   duration	   as	   well	   as	   the	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amplitude	   of	   the	   second	   non-­‐inactivating	   component.	   Since	   the	   second	   non-­‐inactivating	   component	   occurs	   during	   the	   down	   stroke	   of	   the	   AP	   waveform,	   we	  would	   predict	   that	   Navβ4	   peptide	   would	   increase	   the	   number	   of	   non-­‐inactivated	  (open)	   channels	   available	   immediately	   following	   an	   AP	   spike,	   which	   may	   enable	  burst	   firing	   [84].	   Notably,	   the	   Navβ4	   peptide	   produced	   a	   longer	   duration	   of	  increased	  sodium	   influx	   in	   response	   to	   the	   slow	  AP	  compared	   to	   the	   fast	  AP.	  This	  may	  reflect	  the	  ability	  of	  Navβ4	  peptide	  to	  play	  a	  more	  prominent	  role	   in	  neurons	  with	  slow	  AP	  waveforms.	  Indeed,	  in	  neurons	  with	  fast	  AP	  waveforms,	  where	  the	  Kv3	  family	   of	   channels	   predominantly	   mediate	   repolarization,	   VGSCs	   channels	   are	  primarily	  protected	  from	  inactivation	  by	  the	  fast	  kinetics	  of	  Kv3	  channels	  that	  force	  VGSCs	   to	   transition	   directly	   from	   open	   into	   closed	   states	   rather	   than	   by	   open-­‐channel	   block	   producing	   resurgent	   current	   [169].	   Dynamic	   clamp	   studies	   have	  shown	   that	  Kv3	   currents	   and	   resurgent	   sodium	   currents	   can	   synergize	   to	   protect	  channels	   from	   inactivation	   during	   the	   interspike	   interval	   of	   spontaneously	   firing	  Purkinje	  neurons	  [85].	   	  Our	  data	  shows	  that	  Navβ4	  peptide	  mediates	  a	  decrease	  in	  sodium	  current	  during	  the	  initial	  repolarization	  phase	  of	  the	  fast	  waveform	  (see	  Fig.	  10C,	  E).	   	  A	  decrease	   in	  sodium	  flux	  at	   this	  point	  during	  a	   fast	  AP	  would	   likely	  also	  synergize	  with	  Kv3	  currents	  and	  contribute	  to	  shorter	  AP	  durations.	  	  	  	  Auxiliary	   β	   subunits	   of	   VGSCs	   are	   known	   to	   modulate	   the	   biophysical	  properties	   of	   principal	   α	   subunits	   [164,	   171].	   Navβ4	   mediates	   the	   generation	   of	  resurgent	   sodium	   currents	   and	   allows	   channels	   to	   bypass	   classic	   inactivation.	  Though	  Nav1.6	  has	  a	  greater	  intrinsic	  ability	  to	  generate	  resurgent	  currents,	  Scn8a	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knockout	  animals	  demonstrate	  that	  the	  contribution	  of	  Nav1.6	  to	  resurgent	  current	  generation	  can	  vary	  between	  neuronal	  populations	  suggesting	  that	  other	  factors	  can	  influence	  which	  isoform	  is	  predominantly	  generating	  resurgent	  current	  [87,	  91,	  172,	  173].	   It	   has	   previously	   been	   shown	   that	   there	   is	   a	   good	   correlation	   between	  resurgent	   current	   amplitude	   and	   the	   rate	   of	   inactivation,	   suggesting	   that	   Navβ4	  competes	  with	  the	  intrinsic	  inactivation	  particle	  to	  bind	  the	  channel	  pore	  [63,	  163].	  	  Resurgent	  currents	  are	  expected	  to	  correlate	  with	  enhanced	  recovery	  of	  VGSCs	  from	  inactivation	   [84].	   We	   found	   that	   Navβ4	   peptide	   can	   correspondingly	   enhance	  recovery	   from	   an	   open-­‐blocked	   versus	   inactivated	   state.	   We	   therefore	   predicted	  that	   Navβ4	   peptide	   would	   protect	   channels	   from	   undergoing	   use-­‐dependent	  reduction,	  which	  is	  the	  result	  of	  channels	  accumulating	  into	  an	  inactivated	  state	  and	  that	  this	  would	  be	  greater	  for	  Nav1.6	  compared	  to	  Nav1.1.	  Unexpectedly,	  we	  found	  that	  Navβ4	  peptide	  does	  not	  protect	   either	  Nav1.1	  or	  Nav1.6	   from	  use-­‐dependent	  reduction	   with	   a	   10Hz	   stimulus.	   	   Furthermore,	   stimulation	   with	   trains	   of	   fast	   or	  slow	  action	  potentials	  also	  did	  not	  uncover	  a	  detectable	  difference	  in	  use-­‐dependent	  reduction	   in	   the	   presence	   of	   Navβ4	   peptide.	   	   	   Therefore,	   at	   least	   under	   our	  experimental	   conditions,	   Navβ4	   peptide	   does	   not	   appear	   to	   compete	   with	   the	  intrinsic	  mechanisms	  for	  use-­‐dependent	  current	  reduction.	  	  This	  might	  be	  explained	  in	   part	   by	   proximity	   of	   the	   inactivation	   particle	   compared	   to	   the	   diffuse	   Navβ4	  peptide	  to	  the	  channel	  and	  thus	  may	  not	  hold	  true	  for	  the	  full-­‐length	  Navβ4	  (which	  unfortunately	  does	  not	  produce	  resurgent	  sodium	  currents	  in	  HEK293T	  cells).	  It	  is	  important	   to	   note,	   full-­‐length	   Navβ4	   is	   a	   critical	   mediator	   for	   the	   generation	   of	  resurgent	   current	   in	   DRG	   neurons	   as	   knockdown	   and	   overexpression	   of	   Navβ4	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decreases	   and	   increases	   resurgent	   current,	   respectively	   [69].	   	   Mutating	   key	  positively	   charged	   residues	   in	   the	   C-­‐terminal	   of	   Navβ4	   prevents	   the	   increase	   in	  resurgent	   current	   [69],	   suggesting	   the	   appropriate	   use	   of	   the	   Navβ4	   peptide	   to	  study	  resurgent	  current	  generation.	  We	  therefore	  tested	  the	  full-­‐length	  Navβ4	  in	  a	  DRG	   expression	   system	   and	   did	   not	   observe	   any	   differences	   in	   use-­‐dependent	  reduction	  of	  Nav1.6	   currents	   (Fig.	   16),	   suggesting	   that	   our	   results	   are	  not	   a	  mere	  artifact	   of	   the	   peptide.	   Indeed,	   in	   a	   recent	   study	   comparing	   striatal	   neurons	   from	  Navβ4	   null	   and	  wildtype	  mice,	   no	   difference	  was	   observed	   in	   the	   number	   of	   APs	  evoked	  by	  high-­‐frequency	  stimulation	  trains	  for	  the	  two	  genotypes	  [67].	  	  However,	  recent	  evidence	  indicates	  that	  A-­‐type	  isoforms	  of	  FHFs	  mediate	  fast-­‐onset	  long-­‐term	  inactivation	  of	   sodium	  channels	   in	  hippocampal	  neurons	   [174].	   	   	   FHFs	  and	  Navβ4	  have	   been	   proposed	   to	   differentially	   regulate	   neuronal	   activity	   [75],	   and	   thus	  we	  cannot	   rule	   out	   the	   possibility	   that	   Navβ4	   might	   reduce	   use-­‐dependent	   current	  reduction	  in	  some	  neurons	  by	  competing	  with	  the	  effect	  of	  FHFs	  on	  sodium	  channel	  inactivation.	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Figure	  16.	  No	  difference	  in	  the	  use-­‐dependent	  reduction	  of	  Nav1.6	  generated	  
currents	   in	  DRG	   for	   control	   (black;	  n	  =	  17)	   and	   full-­‐length	  Navβ4	   (grey;	  n	   =	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   Subcellular	   regions	   within	   a	   neuron	   serve	   different	   functions:	   dendrites	  provide	  graded	  electrical	  potentials	  that	  sum	  in	  the	  soma,	  the	  axon	  initial	  segment	  typically	  initiates	  action	  potentials	  and	  the	  nodes	  of	  ranvier	  and	  axon	  propagate	  the	  action	   potentials.	   As	   mentioned	   in	   the	   introduction	   of	   this	   chapter,	   Nav1.1	   and	  Nav1.6	  are	  reported	  to	  have	  distinct	  subcellular	  distributions.	  	  While	  the	  molecular	  determinants	  of	  this	  differential	  localization	  are	  not	  known,	  the	  distinct	  biophysical	  properties	   of	   these	   channels	  may	   be	   ‘tuned’	   for	   specific	   contributions	   in	   different	  cellular	  regions	  as	  well	  as	  neuronal	  populations	  as	  has	  been	  shown	  with	  Nav1.2	  and	  Nav1.6	  in	  the	  proximal	  and	  distal	  axon	  initial	  segment	  of	  excitatory,	  pyramidal	  cells	  [150].	  	  
	   Our	   data	   shows	   that	   hNav1.6	   undergoes	   more	   use-­‐dependent	   reduction	  compared	   to	   hNav1.1	   and	   this	   is	   consistent	   with	   the	   proposal	   that	   Nav1.1	   likely	  plays	   a	  major	   role	   in	  maintenance	   of	   fast	   firing,	   especially	   in	   inhibitory	   neurons.	  hNav1.6	  currents	  exhibit	  slower	  rates	  of	  open-­‐channel	  inactivation	  (Fig.	  8E),	  larger	  resurgent	   currents	   (Fig.	   8C)	   and	  quicker	   recovery	   from	  open-­‐channel	   inactivation	  (Fig.	  6B)	   than	  hNav1.1	   currents,	   indicating	   that	  open-­‐channel	   inactivation	   is	  not	  a	  major	  determinant	  of	  the	  use-­‐dependent	  reduction	  that	  we	  observed.	  Although	  slow	  inactivation	   might	   contribute	   to	   use-­‐dependent	   current	   reduction	   under	   some	  conditions	  [175,	  176],	  our	  data	  and	  that	  of	  others	  indicate	  that	  Nav1.6	  channels	  are	  less	  susceptible	  to	  slow	  inactivation	  than	  Nav1.1	  channels	  [167].	  hNav1.6	  channels	  do	   exhibit	   enhanced	   closed-­‐state	   inactivation	   compared	   to	   hNav1.1	   channels	  (reflected	   by	   a	  more	   negative	   voltage-­‐dependence	   of	   inactivation	   and	  more	   rapid	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development	  of	  closed-­‐state	   inactivation	   for	  hNav1.6),	  suggesting	  that	  closed-­‐state	  inactivation	  may	  play	  an	  important	  role	  in	  the	  use-­‐dependent	  current	  reduction	  that	  we	  measured.	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E. ABERRANT	  EPILEPSY-­‐ASSOCIATED	  MUTANT	  NAV1.6	  SODIUM	  CHANNEL	  ACTIVITY	  CAN	  BE	  TARGETED	  WITH	  CANNABIDIOL	  	  This	  chapter	  is	  adapted	  from	  a	  manuscript	  published	  in	  Brain.	  	  Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Tatiana	  Brustovetsky,	  Nickolay	  Brustovetsky	  and	  Theodore	  R.	  Cummins	  	  R.	  R.	  Patel	  designed	  experiments,	  conducted	  all	  electrophysiological	  experiments,	  analyzed	  and	  interpreted	  the	  data	  and	  drafted	  the	  manuscript.	  	  A. Introduction	  
	   There	   are	   over	   700	   mutations	   identified	   in	   brain	   isoforms	   of	   VGSCs	   in	  patients	  with	  distinct	  epileptic	  phenotypes.	  The	  majority	  of	  these	  mutations	  occur	  in	  the	  Scn1a	  gene	  encoding	  for	  Nav1.1	  and	  result	  in	  a	  phenotype	  known	  as	  Generalized	  Epilepsy	  with	  Febrile	  Seizures	  Plus	   (GEFS+)	  or	  a	  more	  severe	   form	  of	   this	   termed	  Dravet	  Syndrome.	  The	  majority	  of	  mutations	   lead	  to	  protein	  truncation	  and	  amino	  acid	  substitutions	  that	  occur	  throughout	  the	  channel	  protein.	  Functionally,	  they	  are	  primarily	   thought	   to	   cause	   loss	   of	   channel	   activity.	   In	   accordance	   with	   the	  prominent	   role	   of	   Nav1.1	   in	   parvalbumin	   positive	   GABAergic	   neurons,	   the	  prevailing	   hypothesized	   mechanism	   underlying	   Dravet	   Syndrome	   is	   the	   loss	   of	  Nav1.1	  channel	  activity	  leading	  to	  decreased	  excitability	  of	  GABAergic	  neurons	  and	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consequently	  a	  disinhibition	  in	  circuit	  excitability	  [145,	  177-­‐180].	  Indeed,	  selective	  deletion	  of	  Nav1.1	  in	  parvalbumin	  positive	  GABAergic	  neurons	  can	  lead	  to	  seizures	  and	  mimic	  a	  Dravet	  Syndrome	  phenotype	  [179,	  181-­‐183].	  Moreover,	  Higurashi	  et	  al.	  have	   observed	   reduced	   excitability	   of	   GABAergic	   neurons	   differentiated	   from	  pluripotent	  stem	  cells	  derived	  from	  a	  human	  patient	  with	  Dravet	  Syndrome	  [184].	  However,	   it	   is	   important	   to	   note	   that	   recent	   data	   from	   human	   patient-­‐derived	  induced	  pluripotent	  stem	  cells	  challenges	   this	  hypothesis	  and	  suggests	   that	   rather	  there	  is	  an	  overall	  upregulation	  of	  VGSC	  activity	  leading	  to	  increased	  excitability	  of	  both	   excitatory	   and	   inhibitory	   neurons	   [121,	   122].	   Recently,	   there	   have	   been	  mutations	   identified	   in	   Scn8a	   (coding	   for	   Nav1.6)	   in	   patients	   with	   a	   severe	   EIEE	  [123,	   124,	   185-­‐188].	   Of	   the	   Nav1.6	   mutations	   characterized	   in	   heterologous	  expression	  systems,	  it	  has	  been	  found	  that	  most	  of	  these	  mutations	  result	  in	  gain-­‐of-­‐function	  in	  channel	  properties	  [123,	  189],	  although	  putative	  loss-­‐of-­‐function	  effects	  on	   channel	   properties	   have	   also	   been	   reported	   for	   Nav1.6	   mutations	   [187,	   190,	  191].	  Mutations	  in	  these	  two	  isoforms	  cause	  phenotypically	  distinct	  syndromes	  and	  understanding	   the	   functional	   consequences	   of	   these	   mutations	   can	   provide	  invaluable	   insight	   into	   the	   potential	   role	   of	   these	   channels	   in	   physiological	   and	  pathophysiological	  conditions.	  	  	  Approximately	   30%	   of	   people	   with	   epilepsy	   are	   refractory	   to	   treatment;	  therefore	   there	   is	   a	   great	   need	   for	   the	   development	   of	   alternative	   anti-­‐epileptic	  medications.	   CBD	   has	   recently	   received	   attention	   for	   its	   potential	   efficacy	   in	   the	  treatment	   of	   childhood	   epilepsies	   [192],	   although	   more	   studies	   are	   needed	   to	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confirm	  this	  finding.	  Resurgent	  current	  is	  an	  atypical	  current	  predicted	  to	  enhance	  neuronal	   excitability	   [84,	   193].	  Mechanistically,	   these	   currents	   arise	   from	   channel	  reopening	  during	  the	  repolarization	  phase	  of	  the	  action	  potential	  due	  to	  unbinding	  of	   an	  open-­‐channel	   blocker	   [92].	   Therefore,	   these	   currents	  provide	   a	  depolarizing	  drive	   to	   approach	   threshold	   for	   firing	   additional	   action	  potentials.	   These	   currents	  have	  been	  observed	  to	  be	  dysregulated	  in	  both	  acquired	  and	  inherited	  disorders	  of	  excitability.	  Resurgent	  currents	  are	  increased	  in	  a	  kindling	  model	  of	  temporal	   lobe	  epilepsy	   as	   well	   as	   by	   mutations	   in	   VGSCs	   associated	   with	   pain,	   myotonia	   and	  cardiac	   arrhythmias	   [64,	   80,	   194,	   195].	   Targeting	   resurgent	   sodium	   current	   is	   a	  potentially	   novel	   therapeutic	   strategy	   for	   the	   treatment	   of	   multiple	   epilepsy	  syndromes.	   	   Intriguingly,	  endogenous,	  exogenous	  and	  synthetic	  cannabinoids	  have	  been	   shown	   to	   target	   peak	   transient	   currents	   generated	   by	   VGSCs	   [81,	   139,	   196-­‐198].	  In	  addition,	  our	  lab	  has	  previously	  shown	  that	  with	  Nav1.7,	  which	  is	  present	  in	  DRG	  neurons	  but	  not	  expressed	   in	   the	  brain,	  AEA	  can	  selectively	   inhibit	  resurgent	  current	   over	   peak	   transient	   current	   [81].	   Furthermore,	   Foadi	   et	   al.	   found	   that	   a	  synthetic	  derivative	  of	  Δ9-­‐tetrahydrocannabinol,	  ajulemic	  acid,	  can	  inhibit	  resurgent	  currents	  generated	  by	  Nav1.5,	  although	  this	  isoform	  is	  predominantly	  expressed	  in	  the	  heart.	  	  	  	  Here	  we	  focused	  on	  mutations	  in	  Nav1.1	  and	  Nav1.6	  because	  of	  the	  severity	  of	  the	  clinical	  phenotypes	  associated	  with	  these	  mutations	  [199].	  We	  asked	  whether	  epilepsy-­‐associated	   mutations	   in	   these	   channel	   isoforms	   alter	   resurgent	   sodium	  current	   generation,	   and	   whether	   we	   can	   preferentially	   inhibit	   resurgent	   sodium	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current	  over	  peak	   transient	   current	  generated	  by	   these	   two	  channel	   isoforms.	  We	  found	   that	   epilepsy-­‐associated	   mutations	   in	   Nav1.6	   dramatically	   enhanced	  resurgent	   current	   generation	   while	   mutations	   in	   Nav1.1	   did	   not,	   suggesting	   that	  mutations	   in	   these	   channel	   isoforms	   are	   acting	   by	   distinct	  mechanisms	   to	   induce	  epileptogenesis.	  Moreover,	  CBD	  can	  selectively	  inhibit	  resurgent	  current	  over	  peak	  transient	  current	  generated	  by	  wildtype	  Nav1.6	  as	  well	  as	  aberrant	   resurgent	  and	  persistent	  current	  generated	  by	  Nav1.6	  mutant	  channels.	  We	  further	  validated	  our	  findings	   using	   endogenous	   sodium	   currents	   from	   striatal	   neurons	   and	   found	   that	  indeed	   CBD	   inhibits	   endogenous	   resurgent	   and	   persistent	   current	   in	   neurons.	  Furthermore,	   we	   found	   that	   excitability	   of	   striatal	   neurons	   is	   reduced	   in	   the	  presence	  of	  CBD.	  Therefore,	  CBD	  could	  be	  exerting	  its	  anti-­‐epileptic	  effects,	  at	  least	  in	  part,	  through	  its	  action	  on	  aberrant	  activity	  in	  VGSCs.	  	   B. Materials	  and	  methods	  	  1. cDNA	  constructs	  
	   Optimized	  human	  constructs	   for	  Nav1.1	  and	  Nav1.6	  (hNav1.1	  and	  hNav1.6)	  were	   designed	   in-­‐house	   and	   purchased	   from	   Genscript	   (Piscataway,	   NJ).	   cDNA	  constructs	   for	   wildtype	   Nav1.1	   and	   Nav1.6	   channels	   encode	   for	   amino	   acid	  sequences	  corresponding	  to	  the	  accession	  numbers	  BAC21102.1	  and	  NP_055006.1	  in	  the	  NCBI	  database,	  respectively.	  Mutations	  were	  introduced	  into	  wildtype	  cDNA	  constructs	  (hNav1.1	  R1648H,	  hNav1.1	  N1788K,	  hNav1.1	  N1788D,	  hNav1.6	  L1331V,	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hNav1.6	  N1768D,	   and	   hNav1.6	  N1768K)	   using	   the	  QuikChange	   II	   XL	   site-­‐directed	  mutagenesis	   kit	   from	   Agilent	   Technologies	   (Santa	   Clara,	   CA)	   according	   to	   the	  manufacture’s	  instructions.	  Mutant	  channel	  constructs	  were	  fully	  sequenced	  (ACGT,	  Inc.,	  Wheeling,	   IL)	   to	  confirm	  the	  presence	  of	   the	  correct	  mutation	  and	  absence	  of	  additional	  mutations.	   	  2. Cell	  cultures	  and	  transfections	  
	   The	  use	  of	  HEK293T	  cells	  [153]	  was	  approved	  by	  the	  Institutional	  Biosafety	  Committee	  and	  followed	  the	  ethical	  guidelines	  for	  the	  National	  Institutes	  of	  Health	  for	  the	  use	  of	  human-­‐derived	  cell	  lines.	  HEK293T	  cells	  were	  grown	  under	  standard	  tissue	   culture	   conditions.	   HEK293T	   cells	   were	   transiently	   transfected	   using	   the	  calcium	   phosphate	   precipitation	  method.	   Briefly,	   calcium	   phosphate-­‐DNA	  mixture	  (4.5	  μg	  channel	  construct	  and	  0.5	  μg	  EGFP)	  was	  added	  to	  cells	  in	  serum-­‐free	  media	  for	  four	  to	  five	  hours,	  after	  which	  it	  was	  replaced	  with	  normal	  media.	  12-­‐24	  hours	  post-­‐transfection,	   cells	  were	   split	   onto	   laminin-­‐coated	   glass	   coverslips.	   Cells	  were	  identified	   by	   expression	   of	   EGFP	   using	   a	   fluorescent	   microscope	   and	   whole-­‐cell	  patch	  clamp	  recordings	  were	  obtained	  36-­‐72	  hours	  post-­‐transfection.	  Wildtype	  and	  mutant	   Nav1.6	   channels	   were	   incubated	   at	   29°C	   overnight	   to	   increase	   protein	  surface	  expression.	  
	   3. Striatal	  neuron	  cultures	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Procedures	  with	  mice	  were	  performed	   in	   accordance	  with	   the	   Institutional	  Animal	  Care	  and	  Use	  Committee	  approved	  protocol.	  FVB/NJ	  mice	  were	  purchased	  from	   Jackson	   Laboratories	   (Bar	   Harbor,	   ME,	   USA)	   and	   breeding	   colonies	   were	  established.	   The	  mice	  were	  housed	  under	   standard	   conditions	  with	   free	   access	   to	  water	  and	  food.	  Striatal	  neuronal	  cultures	  were	  prepared	  from	  individual	  striata	  of	  postnatal	  day	  1	  (PN1)	  wildtype	  FVB/NJ	  mice	  of	  both	  sexes.	  We	  used	  neuronal-­‐glial	  co-­‐cultures	   derived	   from	   PN1	   mouse	   pups	   because	   it	   is	   more	   physiologically	  relevant	  and	  allows	  for	  the	  study	  of	  more	  mature,	  better	  developed	  cells	  than	  pure	  neuronal	   cultures	   derived	   from	   embryonic	   animals.	   For	   all	   platings,	   35	   mg/mL	  uridine	  plus	  15	  mg/mL	  5-­‐ﬂuoro-­‐20-­‐deoxyuridine	  were	  added	  24	  hours	  after	  plating	  to	   inhibit	  proliferation	  of	  non-­‐neuronal	   cells.	  Neurons	  were	   cultured	   in	  a	  5%	  CO2	  atmosphere	   at	   37°C	   in	   Neurobasal	   medium	   with	   B27	   supplement	   (Life	  Technologies).	  	  Cultures	  were	  used	  for	  electrophysiological	  recordings	  at	  7-­‐12	  days.	  	  
	  4. Chemicals	  and	  solutions	  
	   AEA	   and	   CBD	  were	   purchased	   from	   Sigma	   Aldrich	   Co.	   (St.	   Louis,	   MO)	   and	  Cayman	   Chemical	   Company	   (Ann	   Arbor,	   MI),	   respectively.	   AEA	   was	   dissolved	   in	  ethanol	   to	   a	   stock	   concentration	   of	   138.3mM,	   aliquoted	   and	   stored	   at	   -­‐20°C.	   CBD	  was	  dissolved	  in	  methanol	  to	  a	  stock	  concentration	  of	  31.8mM,	  aliquoted	  into	  tubes	  topped	  will	   argon	   gas	   and	   stored	   at	   -­‐80°C.	   A	   fresh	   aliquot	   of	   drug	  was	   used	   and	  diluted	  with	  the	  extracellular	  patch	  clamp	  solution	  to	  desired	  concentration	  for	  each	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experiment.	  Control	  data	  was	  collected	  in	  the	  presence	  of	  the	  corresponding	  vehicle	  used	  to	  dissolve	  the	  drug.	  	  
	   5. Whole-­‐cell	  patch	  clamp	  recordings	  
	   All	  whole-­‐cell	   patch	   clamp	   recordings	  were	   obtained	   at	   room	   temperature	  (~23°C)	   using	   a	   HEKA	   EPC-­‐10	   amplifier	   and	   the	   Pulse	   program	   (v	   8.80,	   HEKA	  Electronic,	  Germany)	  was	  used	  for	  data	  acquisition.	  For	  experiments	  with	  HEK293T	  cells,	  electrodes	  were	  fabricated	  from	  1.7	  mm	  capillary	  glass	  and	  fire-­‐polished	  to	  a	  resistance	   of	   0.9-­‐1.3	  MΩ	   using	   a	   Sutter	   P-­‐97	   puller	   (Sutter	   Instrument	   Company,	  Novato,	  CA).	  All	  voltage	  protocols	  were	  started	  five	  minutes	  after	  obtaining	  a	  gigaΩ	  seal	  and	  entering	  the	  whole-­‐cell	  configuration,	  which	  controlled	  for	  time-­‐dependent	  shifts	   in	   channel	   properties	   and	   allowed	   time	   for	   diffusion	   of	   the	   Navβ4	   peptide.	  Voltage	   errors	   were	   minimized	   to	   less	   than	   5mV	   using	   series	   resistance	  compensation	   and	   passive	   leak	   currents	   were	   cancelled	   by	   P/-­‐5	   subtraction.	   The	  bath	  solution	  contained	  (in	  mM):	  140	  NaCl,	  1	  MgCl2,	  3	  KCl,	  1	  CaCl2,	  and	  10	  Hepes,	  adjusted	   to	   a	  pH	  of	  7.30	  with	  NaOH.	  The	  pipette	   solution	   contained	   (in	  mM):	  140	  CsF,	  10	  NaCl,	  1.1	  EGTA,	  and	  10	  Hepes,	  adjusted	  to	  a	  pH	  of	  7.30	  with	  CsOH.	  To	  induce	  resurgent	  currents	  in	  HEK293T	  cells,	  200μM	  Navβ4	  peptide	  (KKLITFILKKTREK-­‐OH)	  (Biopeptide	  Co.,	  San	  Diego,	  CA),	  a	  peptide	  that	  corresponds	  to	  the	  sequence	  of	  part	  of	   the	  C-­‐terminal	   tail	  of	   the	   full-­‐length	  Navβ4	  subunit,	  was	   included	   in	   the	  pipette	  solution.	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For	  recordings	  obtained	  from	  striatal	  neurons,	  pipettes	  were	  fabricated	  from	  1.5	   mm	   borosilicate	   glass	   and	   fire-­‐polished	   to	   a	   resistance	   of	   2-­‐4	   MΩ.	   Series	  resistance	   was	   compensated	   by	   70	   to	   85%.	   For	   voltage	   clamp	   recordings,	   the	  striatal	   neuron	   bath	   solution	   contained	   (in	   mM):	   130	   NaCl,	   30	   TEA-­‐Cl,	   3	   KCl,	   1	  MgCl2,	  1	  CaCl2,	  0.05	  CdCl2,	  5	  4-­‐aminopyridine	  and	  10	  Hepes,	  adjusted	  to	  a	  pH	  of	  7.3	  with	  NaOH.	  The	  pipette	   solution	  was	   the	   same	  CsF	  containing	  solution	  mentioned	  above	  but	  did	  not	  contain	  the	  Navβ4	  peptide.	  For	  current	  clamp	  recordings,	  the	  bath	  solution	  contained	  (in	  mM):	  140	  NaCl,	  3	  KCl,	  2	  MgCl2,	  2	  CaCl2	  and	  10	  HEPES	  adjusted	  to	   a	   pH	   of	   7.3	   with	   NaOH.	   The	   pipette	   solution	   contained	   (in	   mM):	   140	   KCl,	   0.5	  EGTA,	  5	  HEPES	  and	  3	  Mg-­‐ATP	  adjusted	  to	  a	  pH	  of	  7.3	  with	  KOH.	  Recordings	  were	  all	  started	  two	  minutes	  after	  establishing	  the	  whole-­‐cell	  configuration.	  Only	  cells	  with	  a	  stable	   resting	   membrane	   potential	   more	   negative	   than	   -­‐35mV	   were	   used.	   To	  eliminate	  variation	  between	  cells,	  cells	  were	  held	  at	  -­‐60mV	  or	  -­‐80mV.	  	  	  For	  all	  experiments	  involving	  drugs,	  recordings	  were	  made	  in	  the	  presence	  of	  extracellular	   bath	   solution	   containing	   either	   the	   drug	   or	   vehicle	   control.	   Each	  coverslip	  was	  recorded	  from	  for	  up	  to	  one	  and	  half	  hours	  before	  discarding.	  	   6. Data	  analysis	  
	   Electrophysiological	   data	   were	   analyzed	   using	   Pulsefit	   (v	   8.67	   HEKA	  Electronic,	  Germany),	  Microsoft	  Excel,	  Origin	  (v	  8.0,	  OriginLab	  Corp,	  Northhampton,	  MA),	  and	  Prism	  (v	  6.0,	  Graphpad	  Software	  Inc.,	  La	  Jolla,	  CA).	  Steady-­‐state	  activation	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and	   inactivation	  curves	  were	   fit	   to	  a	  Boltzmann	  function	  to	  obtain	  midpoint	  (V1/2)	  and	   slope	   values.	   Time	   constants	   for	   recovery	  were	   obtained	   by	   fitting	   data	   from	  each	  cell	   to	  a	   first	  order	  exponential	   function	  and	  averaging	  time	  constants	  across	  cells.	   Input	   resistance	   was	   calculated	   from	   the	   change	   in	   voltage	   at	   the	   end	   of	   a	  200ms,	   -­‐200pA	   current	   stimulus	   using	   the	   equation	   V	   =	   I/R.	   All	   data	   points	   are	  presented	   as	  mean	   ±	   SEM	   and	  n	   is	   the	   number	   of	   experimental	   cells	   from	  which	  recordings	  were	  obtained.	  Statistical	  significance	  was	  assessed	  using	  an	  unpaired	  t-­‐test,	   one-­‐way	   ANOVA	   with	   Dunnett	   post	   hoc	   test	   or	   a	   two-­‐way	   ANOVA	   with	  Bonferroni	  post	  hoc	  test.	  
	   C. Results	  	  1. Epilepsy-­‐associated	  mutations	  in	  Nav1.1	  resulting	  in	  GEFS+	  or	  Dravet	  Syndrome	  did	  not	  alter	  peak	  resurgent	  current	  	   We	  examined	  an	  arginine	   (R)	   to	  histidine	   (H)	  mutation	  at	  position	  1648	   in	  Nav1.1,	  which	  is	  located	  in	  the	  S4	  segment	  of	  domain	  IV,	  identified	  in	  patients	  with	  GEFS+	   (Fig.	   17A)	   [200].	   This	  mutation	   has	   been	   previously	   characterized	   in	   both	  heterologous	   expression	   systems	   and	   mouse	   models	   and	   from	   the	   reported	  biophysical	  defects	  that	  this	  mutation	  confers	  we	  predicted	  it	  would	  alter	  resurgent	  current	   generation	   [201-­‐205].	   Additionally,	   we	   examined	   an	   asparagine	   (N)	   to	  lysine	  (K)	  mutation	  at	  position	  1788	  in	  Nav1.1,	  which	  is	  located	  at	  the	  end	  of	  the	  S6	  segment	   of	   domain	   IV,	   identified	   in	   a	   patient	   with	   Dravet	   Syndrome	   (Fig.	   17A).	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Coincidentally,	  this	  mutation	  occurs	  at	  the	  exact	  same	  position	  as	  the	  first	  epilepsy-­‐associated	  mutation	  identified	  in	  human	  Nav1.6	  [123]	  and	  has	  not	  been	  previously	  characterized	   (Fig.	   20A).	   We	   characterized	   the	   biophysical	   properties	   of	   the	  wildtype	   and	   mutant	   hNav1.1	   channels	   with	   whole-­‐cell	   patch	   clamp	   recordings	  from	   transiently	   transfected	   HEK293T	   cells.	   Representative	   families	   of	   current	  traces	   from	  wildtype	   and	  mutant	   channels,	   elicited	   by	   applying	   depolarizing	   step	  pulses	  ranging	  from	  –80mV	  to	  +80mV	  for	  50ms	  from	  a	  holding	  potential	  of	  -­‐100mV,	  are	  shown	  in	  Figure	  18B.	  Current	  density	  curves	  were	  obtained	  by	  normalizing	  peak	  current	   at	   each	   voltage	   by	   the	   cell	   capacitance.	   hNav1.1	   R1648H	   and	   hNav1.1	  N1788K	   have	   significantly	   (p<0.05;	   two-­‐way	   ANOVA)	   reduced	   current	   densities	  compared	  to	  hNav1.1	  WT	  (Fig.	  17C).	  We	  next	  examined	  the	  voltage	  dependence	  of	  channel	   activation	   and	   steady-­‐state	   inactivation	   (Fig.	   17D;	   Table	   3).	   hNav1.1	  N1788K	   has	   a	   significantly	   (p<0.05;	   one-­‐way	   ANOVA)	   more	   depolarized	   V1/2	   of	  channel	   activation	   and	   steady-­‐state	   inactivation	   compared	   to	   wildtype	   hNav1.1	  	  (Table	  3).	  hNav1.1	  R1648H	  did	  not	  show	  significant	  changes	   in	  channel	  activation	  but	   has	   a	   significantly	   (p<0.001;	   one-­‐way	   ANOVA)	   hyperpolarized	   voltage-­‐dependence	   of	   steady-­‐state	   inactivation	   (-­‐73.0	   ±	   2.2mV;	   n	   =	   10)	   compared	   to	  wildtype	   hNav1.1	   (-­‐61.6	   ±	   1.7mV;	   n	   =	   20).	   We	   also	   examined	   persistent	   current	  generation	  by	  wildtype	  and	  mutant	  channels	  using	  a	  protocol	  in	  which	  incremental	  step	  pulses	  from	  -­‐80mV	  to	  +30mV	  were	  applied	  from	  a	  holding	  potential	  of	  -­‐100mV	  for	  200ms	  (Fig.	  17E,	  inset).	  Persistent	  current	  is	  a	  non-­‐inactivating	  (or	  very	  slowly-­‐inactivating)	  current	  and	  was	  measured	  at	   the	  end	  of	  a	   long	  (200ms)	  depolarizing	  step	   pulse.	   These	   currents	   can	   amplify	   subthreshold	   currents	   and	   facilitate	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repetitive	   firing	   [206,	   207].	   We	   found	   that	   neither	   the	   hNav1.1	   R1648H	   nor	   the	  hNav1.1	  N1788K	  mutant	  channel	  significantly	  altered	  persistent	  current	  (Fig.	  17E).	  Additionally,	   we	   examined	   steady-­‐state	   slow	   inactivation,	   recovery	   from	   slow	  inactivation	   as	  well	   as	   development	   of	   slow	   inactivation.	  We	   found	   no	   significant	  effects	   of	   hNav1.1	   mutant	   channels	   on	   steady-­‐state	   slow	   inactivation	   or	  development	   of	   slow	   inactivation.	   hNav1.1	   N1788K	   significantly	   (p<0.0001;	   one-­‐way	   ANOVA)	   slowed	   recovery	   from	   slow	   inactivation	   compared	   to	   wildtype	  hNav1.1	   (Fig.	   18A-­‐C;	   Table	   4).	   	   From	   these	   findings,	   it	   appears	   that	   both	   hNav1.1	  R1648H	   and	   hNav1.1	   N1788K	   mutants	   have	   loss-­‐of-­‐function	   effects	   on	   some	  channel	  properties.	  	  	  We	   next	   asked	   whether	   epilepsy-­‐associated	   mutations	   in	   hNav1.1	   alter	  resurgent	  sodium	  current	  generation.	  Resurgent	  currents	  are	  predicted	  to	  increase	  neuronal	   excitability	   and	   therefore	   alterations	   in	   these	   currents	   could	   potentially	  underlie	   the	  hyperexcitability	   seen	   in	  epilepsy.	  Resurgent	   currents	  were	  observed	  by	  applying	  an	   initial	  depolarizing	   step	   to	  +60mV	   from	   -­‐100mV	  and	  subsequently	  repolarizing	   incrementally	   from	   +25mV	   to	   -­‐80mV	   (Fig.	   17F).	   Representative	  families	  of	  resurgent	  current	  traces	  from	  hNav1.1	  wildtype	  and	  mutant	  channels	  can	  be	   seen	   in	   Fig.	   17G.	   Peak	   resurgent	   current	   was	   measured	   after	   1.5ms	   into	   the	  repolarization	  step	  to	  bypass	   fast	   tail	  currents.	  The	  percent	  resurgent	  current	  was	  reported	  after	  normalizing	  the	  peak	  resurgent	  current	  at	  each	  repolarizing	  voltage	  step	  to	  a	  single	  measure	  of	   the	  peak	  transient	  current	  amplitude	   in	  each	  cell.	   	  The	  estimate	   of	   peak	   transient	   current	   amplitude	   in	   each	   cell	   was	   obtained	   from	   a	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depolarization	  step	  to	  +10mV	  from	  -­‐120mV.	  	  This	  provides	  a	  consistent	  and	  reliable	  peak	   transient	   current	   value	   for	   each	   cell,	   and	   normalizing	   the	   peak	   resurgent	  current	  values	  to	  this	  measure	  of	  peak	  transient	  current	  greatly	  helps	  to	  control	  for	  variability	   in	   channel	   expression	   in	   HEK293T	   cells.	   We	   found	   that	   there	   was	   no	  significant	   difference	   in	   the	   normalized	  magnitude	   of	   the	   peak	   resurgent	   current	  generated	  by	  mutant	  hNav1.1	   channels	   compared	   to	  wildtype	  hNav1.1	   (Fig.	   17H).	  Although	  there	  appears	  to	  be	  a	  shift	  in	  the	  voltage-­‐dependence	  of	  resurgent	  current	  for	   mutant	   hNav1.1	   channels,	   these	   shifts	   correspond	   with	   shifts	   in	   channel	  activation	   seen	   in	   Figure	   17D.	   Therefore,	   it	   is	   plausible	   that	   these	   shifts	   are	   a	  consequence	   of	   alterations	   in	   channel	   activation	   rather	   than	   direct	   effects	   of	   the	  mutation	   on	   the	   channels’	   ability	   to	   generate	   resurgent	   current.	   It	  was	   surprising	  that	  the	  hNav1.1	  R1648H	  mutant	  channel	  did	  not	  alter	  peak	  resurgent	  current	  since	  it	  demonstrated	  a	  faster	  rate	  of	  inactivation	  (data	  not	  shown).	  However,	  from	  these	  data	  is	  appears	  that	  peak	  resurgent	  currents	  are	  not	  altered	  by	  epilepsy-­‐associated	  mutant	  Nav1.1	  R1648H	  and	  N1788K	  channels.	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Figure	  17.	  	  Biophysical	  characterization	  of	  hNav1.1	  WT,	  R1648H	  and	  N1788K	  
mutant	   channels.	   A,	   Linear	   schematic	   of	   the	   structure	   of	   the	   VGSC	   α-­‐	   subunit	  depicting	  the	  locations	  of	  the	  hNav1.1	  R1648H	  (green	  circle)	  and	  hNav1.1	  N1788K	  (orange	   circle)	  mutations.	  B,	  Representative	   family	  of	   current	   traces	  generated	  by	  hNav1.1	   WT,	   R1648H	   and	   N1788K	   expressing	   HEK293T	   cells.	   Currents	   were	  elicited	  with	   step	  depolarizations	   ranging	   from	   -­‐80mV	   to	  +80mV	   for	  50ms	   from	  a	  holding	   potential	   of	   -­‐100mV.	   Peak	   current	   traces	   are	   bolded.	   C,	   Current	   density	   –	  voltage	  curve	  for	  hNav1.1	  WT	  (blue	  squares),	  R1648H	  (green	  circles)	  and	  N1788K	  (orange	  triangles).	  Current	  density	  values	  were	  calculated	  by	  normalizing	  the	  peak	  sodium	  current	   at	   each	  voltage	   to	   the	   cell	   capacitance	  and	   subsequently	  averaged	  across	   cells.	   D,	   Voltage	   dependence	   of	   steady-­‐state	   activation	   and	   inactivation	  curves	  fit	  with	  a	  Boltzmann	  function.	  Steady-­‐state	  inactivation	  was	  measured	  using	  a	  protocol	   in	  which	  cells	  were	  held	  at	  a	  series	  of	  voltages	  ranging	  from	  -­‐120mV	  to	  +30mV	   for	   500ms	   followed	   by	   a	   20ms	   step	   pulse	   to	   +10mV	   to	  measure	   channel	  availability	  (inset).	  E,	  Persistent	  current	  amplitude	  plotted	  as	  a	   function	  of	  voltage.	  Persistent	   current	   was	   measured	   at	   180ms	   into	   current	   traces	   elicited	   by	   step	  depolarizations	  ranging	  from	  -­‐80mV	  to	  +30mV	  from	  a	  holding	  potential	  of	  -­‐100mV	  (inset).	   F,	   Step	  depolarization	   from	   -­‐100mV	   to	   +60mV	   for	   20ms	   to	   open	   channels	  allowing	   them	   to	   undergo	   open-­‐channel	   block	   and	   subsequently	   repolarizing	   to	   a	  series	  of	  potentials	  ranging	  from	  +25mV	  to	  -­‐80mV	  for	  50ms	  to	  allow	  the	  blocker	  to	  unbind.	  G,	  Representative	  family	  of	  resurgent	  current	  traces	  generated	  by	  hNav1.1	  
	   85	  























	   86	  
Table	  3.	  Summary	  of	  gating	  parameters	  of	  hNav1.1	  and	  hNav1.6	  wildtype	  and	  
mutant	  channels.	  
	  	   Activation	   Inactivation	   	  	   V1/2	  (mV)	   slope	   V1/2	  (mV)	   slope	   n	  hNav1.1	  WT	   -­‐28.9	  ±	  1.5	  	   6.7	  	   -­‐61.6	  ±	  1.7	  	   5.0	  	   20	  	  hNav1.1	  R1648H	   -­‐33.6	  ±	  2.1	  	   7.2	  	   -­‐73.0	  ±	  2.2#	  	   5.4	  	   10	  	  hNav1.1	  N1788K	   -­‐19.3	  ±	  2.3**	  	   7.5*	  	   -­‐54.1	  ±	  2.2*	  	   6.5##	  	   11	  	  	  hNav1.6	  WT	   -­‐29.2	  ±	  1.2	  	   6.2	  	   -­‐71.1	  ±	  1.8	  	   6.4	  	   18	  	  hNav1.6	  L1331V	   -­‐31.6	  ±	  1.9	  	   8.4##	  	   -­‐78.2	  ±	  2.8	  	   6.8	  	   9	  	  hNav1.6	  N1768D	   -­‐24.8	  ±	  2.2	  	   6.6	  	   -­‐58.5	  ±	  2.7#	  	   7.6##	  	   14	  	  *,	   p	   <	   0.05,	   **,	   p	   <	   0.01,	   #	   ,	   p	   <	   0.001	   and	   ##,	   p<0.0001	   as	   compared	   to	   the	  corresponding	  wildtype	  group	  with	  a	  one-­‐way	  ANOVA	  with	  Dunnett	  post	  hoc.	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Figure	   18.	   Steady-­‐state,	   recovery	   and	   development	   of	   slow	   inactivation	   of	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Table	   4.	   Summary	   of	   steady-­‐state,	   recovery,	   and	   development	   of	   slow	  
inactivation	  for	  wildtype	  and	  mutant	  channels.	  	  	  




	   Slow	  Inactivation	   Recovery	   Development	   	  	   V1/2	  (mV)	   slope	   τ	  (s)	   τ	  (s)	   n	  hNav1.1	  WT	  	   -­‐35.3	  ±	  3.0	   10.8	   0.43	  ±	  0.04	   11.6	  ±	  2.7	   12	  hNav1.1	  R1648H	  	   -­‐41.8	  ±	  3.9	   10.8	   0.51	  ±	  0.04	   11.1	  ±	  3.8	   	  	  	  12	  hNav1.1	  N1788K	  	   -­‐36.7	  ±	  4.5	   11.2	   1.48	  ±	  0.21##	   14.1	  ±	  4.7	   9	  	   	   	   	   	   	  hNav1.6	  WT	  	   -­‐38.8	  ±	  6.1	   15.7	   1.07	  ±	  0.19	   12.5	  ±	  2.3	   12	  hNav1.6	  L1331V	  	   -­‐17.6	  ±	  6.4*	  	   15.6	   1.84	  ±	  0.47	   21.8	  ±	  3.5*	   14	  hNav1.6	  N1768D	  	   -­‐59.0	  ±	  2.8*	   7.1##	   5.65	  ±	  2.06*	   3.3	  ±	  0.32*	   12	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2. Epilepsy-­‐associated	  mutations	  in	  Nav1.6	  resulting	  in	  an	  epileptic	  encephalopathy	  increase	  peak	  resurgent	  current	  
	   Epilepsy-­‐associated	   mutations	   in	   Nav1.6	   are	   phenotypically	   distinct	   from	  those	   in	   Nav1.1	   [199,	   208].	   Therefore	   we	   examined	   how	   epilepsy-­‐associated	  mutations	  in	  Nav1.6	  alter	  biophysical	  characteristics	  of	  the	  channel.	  We	  examined	  a	  leucine	  (L)	   to	  valine	  (V)	  mutation	  at	  position	  1331	   in	  hNav1.6,	  which	   is	   located	   in	  the	  S4-­‐S5	  linker	  in	  domain	  III,	  identified	  in	  a	  patient	  with	  an	  EIEE	  (Fig.	  19A)	  [186].	  This	  mutation	   is	   in	  a	  region	  of	   the	  channel	   important	   for	  coordinating	  the	  binding	  site	   for	   the	   intrinsic	   fast	   inactivation	   particle	   of	   the	   channel	   [209,	   210].	   Although	  this	  mutation	  has	  not	  yet	  been	  characterized,	  we	  predicted	  it	  would	  alter	  resurgent	  current	  generation	  based	  on	   its	   location.	  Additionally,	  we	  examined	  an	  asparagine	  to	   aspartic	   acid	   (D)	  mutation	  at	  position	  1768	   in	  hNav1.6,	  which	   is	   located	  at	   the	  end	  of	   the	  S6	  segment	  of	  domain	   IV,	   identified	   in	  a	  patient	  with	  a	  severe	  epileptic	  encephalopathy	  (Fig.	  19A)	  [211].	  As	  mentioned	  previously,	  this	  mutation	  (hNav1.6	  N1768D)	  occurs	  at	   the	   same	  position	  as	   the	  Dravet	  Syndrome-­‐associated	  hNav1.1	  N1788K	   mutation	   (Fig.	   20A).	   Representative	   families	   of	   peak	   transient	   current	  traces	   from	  hNav1.6	  wildtype	  and	  mutant	  channels	  can	  be	  seen	  in	  Figure	  19B.	  We	  did	  not	  observe	  significant	  differences	  in	  peak	  current	  density	  or	  the	  V1/2	  of	  channel	  activation	  of	  mutant	  channels	  compared	  to	  wildtype	  hNav1.6	  (Fig.	  19C,D;	  Table	  3).	  Peak	   current	   density	  was	  measured	   from	   hNav1.6	  wildtype	   and	  mutant	   channels	  from	   HEK293T	   cells	   that	   had	   been	   cultured	   at	   30°C	   overnight	   prior	   to	   obtaining	  patch	   clamp	   recordings.	   This	   procedure	   can	   boost	   channel	   expression	   at	   the	   cell	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plasma	  membrane	  possibly	  by	  rescuing	  expression	  of	  mutant	  channels	  with	  folding	  or	   trafficking	   defects	   as	   has	   been	   reported	   by	   others	   [212-­‐215].	  While	  we	   do	   not	  know	   how	   specific	   disease	   mutations	   might	   alter	   functional	   channel	   density	   in	  patients,	   it	   is	   important	  to	  note	  that	  this	  methodological	  procedure	  does	  not	  effect	  the	   voltage-­‐dependence	   of	   channel	   activation	   or	   inactivation	   [190].	   The	   voltage	  dependence	  of	  steady-­‐state	  inactivation	  is	  significantly	  (p<0.001;	  one-­‐way	  ANOVA)	  depolarized	   for	   hNav1.6	   N1768D	   (-­‐58.5	   ±	   2.7mV;	   n	   =	   14)	   compared	   to	   wildtype	  hNav1.6	   (-­‐71.1	   ±	   1.8mV;	   n	   =	   18).	   Both	   mutations	   in	   hNav1.6	   impaired	   fast	  inactivation	  as	  evidenced	  by	  incomplete	  inactivation	  in	  the	  steady-­‐state	  inactivation	  curve	  (Fig.	  19D,	  inset).	  We	  next	  examined	  persistent	  current	  and	  found	  that	  hNav1.6	  N1768D	  produces	  a	  very	  large	  persistent	  current	  while	  hNav1.6	  L1331V	  has	  similar	  persistent	  current	  amplitudes	  as	  wildtype	  (Fig.	  19E).	  hNav1.6	  mutant	  channels	  had	  opposing	  effects	  on	  slow	  inactivation	  (Fig.	  18D-­‐F;	  Table	  4).	  hNav1.6	  L1331V	  had	  a	  significantly	   (p<0.05;	  one-­‐way	  ANOVA)	  more	  depolarized	  V1/2	  of	   slow	   inactivation	  and	   was	   slower	   to	   develop	   slow	   inactivation	   compared	   to	   wildtype	   hNav1.6.	  hNav1.6	   N1768D	   had	   a	   significantly	   (p<0.05;	   one-­‐way	   ANOVA)	   more	  hyperpolarized	   V1/2	   of	   slow	   inactivation,	   was	   slower	   to	   recover	   from	   slow	  inactivation	  and	  faster	  to	  develop	  slow	  inactivation	  (Fig.	  18D-­‐F).	  It	  is	  not	  clear	  how	  these	   effects	   on	   slow	   inactivation	   would	   impact	   excitability	   since	   the	   prolonged	  depolarizations	   that	   are	   needed	   to	   induce	   slow	   inactivation	  may	   not	   occur	   under	  normal	  physiological	  conditions	  and	  the	  temperature	  sensitivity	  of	  slow	  inactivation	  is	  unclear.	  However,	  slow	  inactivation	  could	  be	  a	  factor	  during	  seizure	  activity	  due	  to	   the	   sustained	   depolarization	   of	   some	   neurons	   during	   this	   hyperactivity.	   	   Our	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findings	  on	  hNav1.6	  N1768D	  mutant	  channels	  are	  consistent	  with	  previous	  reports	  and	   clearly	   demonstrate	   that	   this	   mutation	   results	   in	   gain-­‐of-­‐function	   [123].	   In	  contrast,	  biophysical	  defects	  conferred	  by	  the	  hNav1.6	  L1331V	  mutation	  are	  subtler	  but	  (at	  this	  point	  in	  the	  analysis)	  could	  be	  characterized	  as	  loss-­‐of-­‐function.	  	  To	   further	   explore	   the	   biophysical	   consequences	   of	   the	   hNav1.6	   epilepsy-­‐associated	   mutations,	   we	   examined	   resurgent	   sodium	   current	   generation.	  Representative	   families	   of	   resurgent	   current	   traces	   generated	   by	   wildtype	   and	  mutant	  channels	  can	  be	  seen	  in	  Figure	  19F.	  We	  found	  that	  both	  hNav1.6	  L1331V	  and	  hNav1.6	  N1768D	  have	  a	   greater	  propensity	   to	  generate	   resurgent	   sodium	  current	  compared	  to	  wildtype	  hNav1.6.	  The	  peak	  resurgent	  current	  amplitude	  generated	  by	  hNav1.6	  L1331V	  and	  hNav1.6	  N1768D	   is	  nearly	   tripled	  and	  doubled,	   respectively,	  compared	   to	   wildtype	   hNav1.6	   (Fig.	   19G).	   This	   finding	   clearly	   demonstrates	   that	  both	  mutations	  in	  hNav1.6	  have	  gain-­‐of-­‐function	  effects	  on	  some	  channel	  properties	  which	   is	   in	   contrast	   to	   the	   mutations	   we	   examined	   in	   hNav1.1,	   suggesting	   that	  epilepsy-­‐associated	   mutations	   in	   these	   two	   channel	   isoforms	   act	   by	   distinct	  mechanisms	  and	  consequently	  result	  in	  different	  phenotypes.	  	  
	   92	  
	  	  
Figure	  19.	  Biophysical	   characterization	  of	  hNav1.6	  WT,	  L1331V	  and	  N1768D	  
mutant	   channels.	   A,	   Linear	   schematic	   of	   the	   structure	   of	   the	   VGSC	   α-­‐	   subunit	  depicting	  the	  locations	  of	  the	  hNav1.6	  L1331V	  (purple	  circle)	  and	  N1768D	  (magenta	  circle)	  mutations.	  B,	  Representative	  family	  of	  current	  traces	  generated	  by	  HEK293T	  cells	  expressing	  hNav1.6	  WT,	  L1331V	  and	  N1768D	  channels.	  Peak	  current	  traces	  are	  bolded.	   C,	   Plot	   of	   current	   density	   versus	   voltage.	   D,	   Steady-­‐state	   inactivation	   and	  activation	  curves	  fit	  with	  a	  Boltzmann	  function.	  Inset,	  Magnification	  of	  the	  voltage-­‐dependence	   of	   inactivation	   curve	   between	   -­‐20mV	   to	   +30mV	  depicting	   incomplete	  inactivation	  of	  mutant	   channels.	  E,	  Peak	  persistent	   current	   amplitude	  plotted	  as	   a	  function	  of	  voltage.	  F,	  Representative	   family	  of	  resurgent	  current	   traces	  generated	  by	   hNav1.6	   WT	   (top),	   L1331V	   (middle)	   and	   N1768D	   (bottom).	   Peak	   resurgent	  current	  traces	  are	  bolded.	  G,	  Percent	  resurgent	  current	  plotted	  as	  a	  function	  of	  the	  repolarization	   voltage	   for	   hNav1.6	   WT	   (black	   squares;	   n	   =	   20),	   L1331V	   (purple	  triangles;	  n	  =	  11)	  and	  N1768D	  (magenta	  circles;	  n	  =	  14).	  *,	  p<0.05;	  two-­‐way	  ANOVA.	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3. Alterations	  in	  peak	  resurgent	  and	  persistent	  current	  conferred	  by	  the	  mutation	  are	  independent	  of	  channel	  isoform	  	   Nav1.6	   N1768D	   was	   the	   first	   human	   epilepsy-­‐associated	   mutation	   to	   be	  reported	  in	  the	  Nav1.6	  isoform	  and	  coincidentally	  occurs	  at	  the	  same	  position	  as	  a	  previously	   identified	   Dravet	   Syndrome-­‐associated	   mutation	   in	   Nav1.1	   (Nav1.1	  N1788K)	   (Fig.	  20A)	   [123,	  216].	  This	  gave	  us	  a	  unique	  opportunity	   to	  ask	  whether	  disease	  mutations	   confer	   the	   same	   biophysical	   consequences	   to	   different	   channel	  isoforms.	   To	   address	   this	   we	   created	   the	   reciprocal	   mutations	   in	   the	   non-­‐native	  channel	   isoform	  (hNav1.1	  N1788D	  and	  hNav1.6	  N1768K).	  We	  measured	  resurgent	  and	   persistent	   sodium	   current	   generation	   by	   these	   mutant	   channels	   since	   we	  observed	  dramatic	  changes	  in	  these	  properties	  with	  the	  epilepsy-­‐associated	  mutant	  channels.	  It	  is	  noteworthy	  that	  these	  disease	  mutations	  result	  in	  oppositely	  charged	  residue	   substitutions.	   We	   found	   similar	   alterations	   in	   resurgent	   and	   persistent	  current	  for	  the	  reciprocal	  mutations	  in	  the	  non-­‐native	  channel	  isoform,	  although	  the	  magnitudes	  of	  the	  changes	  varied.	  In	  hNav1.1	  the	  N1788D	  mutation	  increases	  both	  resurgent	   and	   persistent	   current,	   similar	   to	   the	   epilepsy-­‐associated	   hNav1.6	  N1768D	  mutant	   (Fig.	   20B,C).	   In	   hNav1.6	   the	  N1768K	  mutation	  did	   not	   alter	   peak	  resurgent	  current	  or	  persistent	  current	  amplitude,	  similar	  to	  the	  epilepsy-­‐associated	  hNav1.1	   N1788K	   mutant	   (Fig.	   20D,E).	   These	   data	   show	   that	   epilepsy-­‐associated	  mutations	   cause	   similar	   alterations	   in	   channel	   properties	   independent	   of	   channel	  isoform	   and	   that	   different	   amino	   acid	   substitutions	   at	   the	   same	   position	   in	   the	  channel	  can	  cause	  significantly	  different	  effects	  on	  channel	  properties.	  This	  suggests	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that	   distinct	   phenotypes	   likely	   arise	   from	   not	   only	   differences	   in	   the	   expression	  pattern	  and	  regulation	  of	   the	  channel	   isoform	   in	  which	   the	  mutation	  occurs	  but	   is	  also	  dependent	  on	  the	  amino	  acid	  residue	  itself.	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Figure	   20.	   Resurgent	   and	   persistent	   current	   generation	   by	   reciprocal	  
epilepsy-­‐associated	   mutation	   in	   non-­‐native	   channel	   isoform.	   A,	   Position	   of	  epilepsy-­‐associated	  mutations	  in	  the	  linear	  schematic	  of	  the	  VGSC	  α-­‐	  subunit	  and	  in	  the	  sequence	  alignment	  of	  hNav1.1	  and	  hNav1.6.	  B	  and	  C,	  Percent	  resurgent	  current	  and	   peak	   persistent	   current	   amplitude	   generated	   by	   hNav1.1	  WT	   (blue	   squares),	  hNav1.1	  N1788K	  (orange	  triangles)	  and	  the	  reciprocal	  N1788D	  mutation	  in	  hNav1.1	  (open,	   magenta	   circles).	   D	   and	   E,	   Percent	   resurgent	   current	   and	   peak	   persistent	  current	   amplitude	   generated	   by	   hNav1.6	   WT	   (black	   squares),	   hNav1.6	   N1768D	  (magenta	   circles)	   and	   the	   reciprocal	   N1768K	  mutation	   in	   hNav1.6	   (open,	   orange	  triangles).	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4. Cannabidiol	  selectively	  inhibits	  peak	  resurgent	  sodium	  current	  generated	  by	  wildtype	  Nav1.6	  	   Targeting	  resurgent	  currents	  is	  a	  novel	  strategy	  for	  the	  treatment	  of	  epilepsy.	  However,	   there	   are	   currently	   no	   selective	   pharmacological	   inhibitors	   for	   brain	  isoforms	   of	   VGSCs.	   It	   has	   been	   shown	   that	   AEA	   and	   ajulemic	   acid	   can	   inhibit	  resurgent	  current	  generated	  by	  Nav1.7	  and	  Nav1.5	  [81,	  139],	  respectively,	  but	  these	  isoforms	   are	   not	   present	   at	   significant	   levels	   in	   the	   brain.	   We	   therefore	   asked	  whether	  AEA	  could	  similarly	   inhibit	  resurgent	  current	  over	  peak	  transient	  current	  generated	   by	   hNav1.1	   and	   hNav1.6.	   Additionally,	  we	   examined	   the	   effects	   of	   CBD	  due	   to	   its	   potential	   efficacy	   in	   the	   treatment	   of	   pediatric	   epilepsies	   [192]	   and	  similarity	   in	   structure	   to	   ajulemic	   acid.	  We	   found	   that	   neither	   5μM	  AEA	   nor	   1μM	  CBD	  had	   any	   significant	   effect	   on	   peak	   current	   density	   or	   peak	   resurgent	   current	  generated	   by	   hNav1.1	   (Fig.	   21A,B).	   Peak	   current	   density	   of	   hNav1.6	   was	  significantly	   (p<0.05;	   unpaired	   t-­‐test)	   inhibited	   by	   5μM	   AEA,	   but	   peak	   resurgent	  current	  was	   not	   preferentially	   altered	   by	   5μM	  AEA	   in	   our	   preparation	   (Fig.	   21C).	  Remarkably,	   1μM	   CBD	   significantly	   (p<0.01;	   unpaired	   test)	   inhibited	   the	   peak	  resurgent	   current	   generated	   by	   hNav1.6	   (measured	   as	   a	   percentage	   of	   the	   peak	  transient	   current	   in	   each	   cell)	   while	   having	   no	   significant	   effect	   on	   peak	   current	  density	   (Fig.	   21C,D).	   	   This	   finding	   identifies	   a	   novel	   target	   (i.e.	   resurgent	   sodium	  current)	  and	  mechanism	  underlying	  the	  anti-­‐convulsant	  properties	  of	  CBD.	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Figure	   21.	   Effects	   of	   AEA	   and	   CBD	   on	   peak	   current	   density	   and	   resurgent	  
current	   generated	   by	  WT	   hNav1.1	   and	   hNav1.6	   channels.	   A	   and	   B,	   Effects	   of	  5μM	  AEA	   (n	  =	  14)	   and	   1μM	  CBD	   (n	  =	  26	   -­‐	   28)	   on	   peak	   current	   density	   and	   peak	  resurgent	  current	  generated	  by	  wildtype	  hNav1.1.	  C	  and	  D,	  Effects	  of	  5μM	  AEA	  (n	  =	  12	   -­‐	   13)	   and	  1μM	  CBD	   (n	  =	  26	   -­‐	   30)	   on	  peak	   current	   density	   and	  peak	   resurgent	  current	  generated	  by	  hNav1.6.	  *,	  p<0.05	  and	  	  **,	  p<0.01;	  unpaired	  t-­‐test.	  	  	  	  	  	  	  
	   98	  
5. Cannabidiol	  inhibits	  aberrant	  resurgent	  and	  persistent	  current	  generated	  by	  mutant	  Nav1.6	  channels	  
	   	  One	  of	   the	  major	  biophysical	  defects	  we	  observed	  with	   epilepsy-­‐associated	  mutations	   in	   hNav1.6	  was	   increased	   resurgent	   current;	   we	   therefore	   asked	   if	   we	  could	   target	   this	  aberrant	  activity	  with	  CBD.	  We	   first	  examined	   the	  effects	  of	  1μM	  CBD	  on	  hNav1.6	  L1331V	  generated	  currents.	  CBD	  did	  not	  significantly	  inhibit	  peak	  current	  density	  at	  this	  concentration	  (Fig.	  22A,B).	  However,	  peak	  resurgent	  current	  was	  significantly	  (p<0.05;	  two-­‐way	  ANOVA)	  inhibited	  by	  CBD,	  similar	  to	  CBD	  effects	  on	  wildtype	  hNav1.6	   (Fig.	  22C,D).	  We	  also	  examined	  gating	  properties	  of	  hNav1.6	  L1331V	  in	  the	  presence	  of	  CBD	  and	  found	  a	  slight	  but	  significant	  (p<0.05;	  unpaired	  t-­‐test)	  depolarizing	  shift	   in	  channel	  activation	  (-­‐28.6	  ±	  1.4mV;	  n	  =10)	  compared	  to	  hNav1.6	   L1331V	   in	   the	   presence	   of	   vehicle	   (-­‐33.8	   ±	   1.7mV;	   n	   =9)	   (Fig.	   22E).	  Additionally,	  we	  measured	  channel	  recovery	  from	  inactivation	  at	  -­‐80mV	  (Fig.	  22F).	  To	   do	   this,	   we	   used	   a	   voltage	   command	   protocol	   in	   which	  we	   assessed	   the	   peak	  current	  by	  an	  initial	  depolarizing	  step	  to	  0mV	  and	  allowed	  channels	  to	  recover	  from	  inactivation	  for	  increasing	  durations	  at	  -­‐80mV	  before	  measuring	  channel	  availability	  with	  a	  test	  pulse	  to	  0mV	  (Fig.	  22F,	  inset).	  Unexpectedly,	  CBD	  significantly	  (p<0.001;	  unpaired	   t-­‐test)	   slowed	   hNav1.6	   L1331V	   (τ	   =	   32.1	   ±	   2.5ms)	   recovery	   from	  inactivation	  compared	  to	  vehicle	  (τ	  =	  16.8	  ±	  1.6ms),	  which	  was	  not	  observed	  with	  wildtype	  hNav1.6	  (data	  not	  shown).	  We	  also	  examined	  persistent	  current	  and	  found	  no	  difference	  in	  the	  presence	  of	  CBD	  (Fig.	  22G).	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Figure	  22.	  1µM	  cannabidiol	  decreases	   resurgent	   current,	  hyperpolarizes	   the	  
voltage-­‐dependence	  of	  activation	  curve	  and	  slows	  recover	  of	  hNav1.6	  L1331V	  
channels.	  A,	  Representative	  family	  of	  current	  traces	  generated	  by	  hNav1.6	  L1331V	  in	  presence	  of	  vehicle	  (left)	  and	  1μM	  CBD	  (right)	  B,	  Current	  density	  curve	  showing	  no	   statistical	   difference	   in	   the	   peak	   current	   density	   between	   vehicle	   (purple	  triangles;	   n	   =	   9)	   and	   CBD	   (black	   triangles;	   n	   =	   10).	   C,	   Representative	   family	   of	  resurgent	  current	  traces	  generated	  by	  hNav1.6	  L1331V	  in	  presence	  of	  vehicle	  (left)	  and	   1μM	   CBD	   (right).	   Peak	   resurgent	   current	   traces	   are	   bolded.	   	   D,	   Percent	  resurgent	  current	  plotted	  against	  voltage.	  E,	  Steady-­‐state	  activation	  and	  inactivation	  curves	  fit	  with	  a	  Boltzmann	  function.	  F,	  Normalized	  available	  current	  plotted	  against	  recovery	   duration	   and	   fit	   with	   an	   exponential	   function.	   Recovery	   from	   fast	  inactivation	  was	  measured	  by	  applying	  an	  initial	  depolarizing	  step	  to	  0mV	  to	  assess	  the	  peak	  current	  and	  then	  repolarizing	  to	  -­‐80mV	  for	  increasing	  durations	  followed	  by	   a	   final	   test	   pulse	   0mV	   to	   measure	   channel	   availability	   (inset).	   G,	   Persistent	  current	  amplitude	  plotted	  versus	  voltage.	  *,	  p<0.05;	  two-­‐way	  ANOVA.	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We	   next	   examined	   CBD	   effects	   on	   hNav1.6	   N1768D	   generated	   currents.	  Again,	  we	  found	  no	  significant	  difference	  in	  peak	  current	  density	  in	  the	  presence	  of	  1μM	  CBD	  (Fig.	  23A,B).	  CBD	  did	  significantly	  (p<0.05;	  two	  way	  ANOVA)	  inhibit	  peak	  resurgent	   current	   generated	   by	   the	   hNav1.6	   N1768D	  mutant	   (Fig.	   23C,D).	   Unlike	  with	   the	   hNav1.6	   L1331V	   mutant,	   CBD	   did	   not	   alter	   the	   voltage	   dependence	   of	  activation	   of	   hNav1.6	   N1768D	   channels	   (Fig.	   23E).	   However,	   recovery	   from	  inactivation	   at	   -­‐80mV	   was	   significantly	   (p<0.05;	   unpaired	   t-­‐test)	   slowed	   in	   the	  presence	  of	  CBD	  (τ	  =	  9.7	  ±	  1.0ms;	  n	  =	  10)	  compared	  to	  vehicle	  (τ	  =	  6.5	  ±	  0.9ms;	  n	  =	  9)	   (Fig.	   23F).	   Surprisingly,	   we	   found	   that	   CBD	   inhibited	   peak	   persistent	   current	  generated	   by	   the	   hNav1.6	   N1768D	   mutant.	   The	   inhibition	   of	   persistent	   current	  occurs	  within	   the	  same	  voltage	  range	  as	   the	   inhibition	  of	  resurgent	  current	  and	   is	  likely	  contributing	  to	  the	  reduction	  in	  resurgent	  current.	  It	  is	  important	  to	  note	  that	  resurgent	   current	   is	  measured	   relative	   to	   the	   peak	   transient	   current	   in	   each	   cell.	  	  Thus	  while	  there	  is	  a	  slight,	  but	  non-­‐significant,	  decrease	  in	  peak	  transient	  currents,	  the	   reported	   decrease	   in	   resurgent	   current	   is	   in	   addition	   to	   this	   effect	   of	   CBD.	  Overall,	   CBD	   alters	   multiple	   biophysical	   properties	   of	   Nav1.6	  mutant	   channels	   in	  ways	  that	  are	  all	  consistent	  with	  decreasing	  channel	  activity.	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Figure	   23.	   1µM	  cannabidiol	   decreases	   resurgent	   and	   persistent	   current	   and	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6. Cannabidiol	  inhibits	  endogenous	  resurgent	  and	  persistent	  current	  and	  decrease	  excitability	  of	  striatal	  neurons	  	   CBD	  inhibited	  Nav1.6	  resurgent	  currents	  in	  HEK293T	  cells.	   	  However,	  these	  currents	   were	   elicited	   with	   the	   aid	   of	   the	   Navβ4	   peptide,	   not	   full-­‐length	   Navβ4.	  	  Therefore	   to	   further	   verify	   our	   findings,	   we	   examined	   the	   effects	   of	   CBD	   on	  endogenous	   sodium	   currents	   from	   striatal	   neurons.	   Striatal	   neurons	   have	   a	   very	  high	  expression	  of	  Navβ4	  and	  generate	  resurgent	  sodium	  current	  [67].	  This	  allowed	  us	   to	   determine	   if	   CBD	   can	   influence	   resurgent	   currents	   dependent	   on	   full-­‐length	  Navβ4.	  As	  we	  observed	  in	  HEK293T	  cells	  expressing	  hNav1.6,	  1μM	  CBD	  did	  not	  have	  a	  significant	  effect	  on	  peak	  transient	  current,	  estimated	  with	  a	  test	  pulse	  to	  +10mV	  from	  a	  holding	  potential	  of	  -­‐80mV	  (Fig.	  24A;	  Fig.	  25A).	  We	  next	  examined	  resurgent	  currents	   using	   a	   standard	   protocol	   (Fig.	   24B,	   inset).	   Representative	   resurgent	  current	   traces	   can	   be	   seen	   in	   Figure	   24B.	   CBD	   significantly	   (p<0.05;	   two	   way	  ANOVA)	   decreased	   peak	   resurgent	   current	   in	   striatal	   neurons	   (Fig.	   24C).	  	  Additionally,	   we	   found	   that	   the	   presence	   of	   1μM	   CBD	   slightly	   but	   significantly	  (p<0.05;	   unpaired	   t-­‐test)	   shifted	   the	   V1/2	   of	   steady-­‐state	   inactivation	   to	   more	  hyperpolarizing	  potentials	  (-­‐52.5	  ±	  1.14mV;	  n	  =	  23)	  compared	  to	  vehicle	  control	  (-­‐48.4	   ±	   1.1mV;	  n	   =	   24)	   but	   did	   not	   alter	   steady-­‐state	   activation	   or	   the	   rate	   of	   fast	  inactivation	   (Fig.	   24D;	   Fig.	   25B,C).	   However,	   we	   examined	   recovery	   from	   fast	  inactivation	  at	  -­‐80mV	  and	  found	  that	  indeed	  CBD	  significantly	  (p<0.05;	  unpaired	  t-­‐test)	  slows	  recovery	  (τ	  =	  7.5	  ±	  1.0ms;	  n	  =	  22)	  compared	  to	  vehicle	  control	  (τ	  =	  4.4	  ±	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0.3ms;	   n	   =	   24)	   (Fig.	   24E).	   Moreover,	   persistent	   current	   was	   also	   significantly	  (p<0.05;	  two-­‐way	  ANOVA)	  reduced	  by	  CBD	  (Fig.	  24F).	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Figure	   24.	   1µM	   cannabidiol	   decreases	   resurgent	   and	   persistent	   current,	  
hyperpolarized	   the	   voltage-­‐dependence	   of	   inactivation	   curve,	   and	   slows	  
recovery	   of	   endogenous	   sodium	   currents	   recorded	   from	   striatal	   neurons.	  A,	  Peak	   transient	   current	   for	   vehicle	   (red)	   and	   1μM	   CBD	   (black).	   Peak	   transient	  current	  was	  measured	  with	   a	   step	   pulse	   from	   -­‐80mV	   to	   +10mV	   from	   the	   steady-­‐state	   inactivation	   protocol.	   B,	   Representative	   family	   of	   resurgent	   current	   traces	  from	   striatal	   neurons	   in	   the	   presence	   of	   vehicle	   (left)	   and	   1μM	  CBD	   (right).	   Peak	  resurgent	   current	   traces	   are	   bolded	   and	   magnified	   below.	   To	   elicit	   resurgent	  current	  in	  striatal	  neurons	  an	  initial	  prepulse	  to	  +30mV	  for	  20ms	  was	  applied	  and	  followed	  by	  repolarizing	  steps	  ranging	  from	  +25mV	  to	  -­‐90mV	  for	  200ms	  (inset).	  C,	  Percent	  resurgent	  current	  plotted	  versus	  the	  repolarization	  voltage.	  D,	  Steady-­‐state	  inactivation	   curve	   fit	   with	   a	   Boltzmann	   function.	   Steady-­‐state	   inactivation	   was	  measured	  using	  a	  prepulse	  ranging	  from	  -­‐80mV	  to	  +30mV	  for	  500ms	  followed	  by	  a	  test	  pulse	  to	  +10mV	  to	  measure	  channel	  availability	  (inset).	  E,	  Normalized	  available	  current	   plotted	   versus	   recovery	   duration	   and	   fit	   with	   an	   exponential	   function.	   F,	  Persistent	   current	   amplitude	   plotted	   as	   a	   function	   of	   voltage.	   *,	   p<0.05;	   two-­‐way	  ANOVA;	  n	  values	  are	  depicted	  in	  bars.	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Figure	   25.	   There	   is	   no	   difference	   in	   current-­‐voltage,	   steady-­‐state	   activation	  
and	  rate	  of	   fast	   inactivation	  of	  sodium	  currents	  in	  striatal	  neurons	  with	  1μM	  
cannabidiol.	  A,	  Current-­‐voltage	  curve	  for	  sodium	  currents	  in	  striatal	  neurons	  in	  the	  presence	   of	   vehicle	   (red	   squares;	   n	   =	   10)	   or	   1μM	   CBD	   (black	   cirlces;	   n	   =	   14).	  Current-­‐voltage	   curves	   were	   obtained	   by	   isolating	   somatic	   sodium	   current	   by	  applying	  a	  4.5ms	  prepulse	   to	   -­‐40mV	   followed	  by	  a	   short	   step	   to	   -­‐55mV	   for	  0.5ms	  before	   applying	   incremental	   steps	   from	   -­‐80mV	   to	   +60mV	   for	   50ms	   as	   has	   been	  previously	  described	  and	  validated	  [217].	  Only	  cells	  with	  good	  voltage	  control	  over	  axial	  sodium	  currents	  were	  included	  for	  analysis	  of	  current-­‐voltage	  relationship	  and	  steady-­‐state	   activation.	   B,	   Steady-­‐state	   activation	   curves	   fit	   with	   a	   Boltzmann	  function.	  C,	  Rate	  of	  fast	  inactivation	  measured	  by	  applying	  a	  single	  exponential	  fit	  to	  the	  decay	  phase	  of	   the	  peak	  macroscopic	   current	  measured	   from	   the	   steady-­‐state	  inactivation	  protocol.	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To	  further	  explore	  the	  implications	  of	  cannabidiol	  actions	  on	  excitability,	  we	  obtained	  current	  clamp	  recordings	  from	  striatal	  neurons.	  Striatal	  neurons	  were	  not	  spontaneously	  active	  and	  therefore	  evoked	  activity	  was	  measured.	  We	  observed	  no	  differences	   in	   the	   resting	   membrane	   potential	   or	   input	   resistance	   from	   striatal	  neurons	   in	   the	   presence	   of	   vehicle	   or	   cannabidiol	   (Fig.	   26B,C).	   With	   a	   holding	  potential	   of	   −60mV,	  we	   found	   that	   the	   number	   of	   action	   potentials	   fired	   during	   a	  200	   ms	   stimulus	   with	   increasing	   intensity	   was	   significantly	   (P	   <	   0.05;	   two-­‐way	  ANOVA)	   reduced	   in	   the	   presence	   of	   cannabidiol	   (Fig.	   26A	   and	   D).	   Peak	   action	  potential	  amplitude	  and	  current	  threshold	  for	  action	  potential	  firing	  from	  a	  holding	  potential	   of	   -­‐60	  mV	  was	  measured	  with	   a	   1	  ms	   stimulus	   increasing	   incrementally	  from	  0	  pA	  to	  1	  nA	  in	  20	  pA	  steps.	  Cannabidiol	  reduced	  (P	  <	  0.0001;	  unpaired	  t-­‐test)	  the	   peak	   action	   potential	   amplitude	   (20.9	  mV	   ±	   3.6;	  n	   =	   12)	   compared	   to	   vehicle	  control	  (48.7	  mV	  ±	  2.8;	  n	  =	  14)	  (Fig.	  26E).	  Moreover,	  cannabidiol	  significantly	  (P	  <	  0.01;	   unpaired	   t-­‐test)	   increases	   the	   threshold	   current	   needed	   to	   elicit	   an	   action	  potential	  compared	  to	  vehicle	  (from	  587.7	  ±	  48.2	  pA	  to	  776	  	  ±	  31	  pA)	  (Fig.	  26F).	  To	  determine	   if	   the	   effects	   on	   action	   potential	   number,	   amplitude	   and	   current	  threshold	   were	   due	   to	   the	   hyperpolarizing	   shift	   in	   the	   voltage-­‐dependence	   of	  inactivation	   (Fig.	   24D),	   we	   additionally	   examined	   the	   effects	   of	   cannabidiol	   on	  striatal	   neuron	   excitability	  with	   a	   holding	   potential	   of	   −80mV.	  We	   found	   that	   the	  number	   of	   action	   potentials	   fired	   with	   increasing	   stimulus	   intensity	   was	   still	  substantially	   reduced	   in	   the	   presence	   of	   cannabidiol	   with	   a	   holding	   potential	   of	  −80mV	   (Fig.	   26A	   and	  G).	  We	   then	  measured	   peak	   action	   potential	   amplitude	   and	  current	  threshold	  from	  a	  holding	  potential	  of	  -­‐80mV	  with	  a	  1ms	  stimulus	  increasing	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incrementally	  from	  0	  pA	  to	  2	  nA	  in	  40	  pA	  steps.	  Cannabidiol	  did	  not	  significantly	  (n	  =	  33)	  change	  peak	  action	  potential	  amplitude	  or	  current	  threshold	  with	  this	  holding	  potential	   (Fig.	   26H	  and	   I).	   	  Overall,	   our	  data	   shows	   that	   1μM	   cannabidiol	   reduces	  excitability	  of	  striatal	  neurons.	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Figure	   26.	   1µM	   cannabidiol	   reduces	   excitability	   of	   striatal	   neurons.	   A,	  Representative	  traces	  of	  activity	  evoked	  with	  a	  200ms	  stimulus	  of	  100pA	  and	  200pA	  for	   vehicle	   (top)	   and	   1μM	  CBD	   (bottom)	   from	   a	   holding	   potential	   of	   -­‐60mV	   (grey	  and	  black	  traces)	  and	  -­‐80mV	  (red	  and	  black	  traces).	  B,	  Resting	  membrane	  potential	  of	  striatal	  neurons	  in	  the	  presence	  of	  vehicle	  (open,	  red)	  and	  1μM	  CBD	  (open,	  black)	  from	  all	  recorded	  cells	  (n	  =	  45	  –	  47).	  C,	  Input	  resistance	  calculated	  from	  the	  change	  in	  voltage	  with	  a	  200ms,	  −200pA	  stimulus	  according	  to	  V	  =	  IR	  for	  vehicle	  (open,	  red)	  and	   1μM	   CBD	   (open,	   black).	   D,	   Number	   of	   action	   potentials	   elicited	   by	   a	   200ms	  stimulus	  of	   increasing	  intensity	  from	  20pA	  to	  200pA	  in	  20pA	  steps	  from	  a	  holding	  potential	  of	  −60mV	  for	  vehicle	  (grey	  circles;	  n	  =	  14)	  and	  CBD	  (black	  squares;	  n	  =	  12).	  E,	   Action	   potential	   peak	   was	   measured	   at	   the	   current	   threshold	   with	   a	   holding	  potential	   of	   −60mV	   for	   vehicle	   (grey)	   and	   1μM	   CBD	   (black).	   F,	   Current	   threshold	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measured	  using	  a	  1ms	  stimulus	  increasing	  incrementally	  from	  0pA	  to	  1nA	  in	  20pA	  steps	  with	  a	  holding	  potential	  of	  −60mV.	  G,	  Number	  of	  action	  potentials	  elicited	  by	  a	  200ms	  stimulus	  of	   increasing	   intensity	   from	  20pA	   to	  200pA	   in	  20pA	  steps	   from	  a	  holding	  potential	  of	  −80mV	  for	  vehicle	  (red	  circles;	  n	  =	  33)	  and	  CBD	  (black	  squares;	  
n	   =	   33).	   H,	   Action	   potential	   peak	   was	   measured	   at	   the	   current	   threshold	   with	   a	  holding	   potential	   of	   −80mV	   for	   vehicle	   (red)	   and	   1μM	   CBD	   (black).	   I,	   Current	  threshold	  measured	  using	  a	  1ms	  stimulus	  increasing	  incrementally	  from	  0pA	  to	  2nA	  in	   40pA	   steps	   with	   a	   holding	   potential	   of	   −80mV.	   *,	   p<0.05,	   **,	   p<0.01	   and	   ##,	  
p<0.0001;	  unpaired	  t-­‐test	  and	  two-­‐way	  ANOVA.	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D. Discussion	  
	   In	   this	   study,	   we	   determined	   whether	   epilepsy-­‐associated	   mutations	   in	  Nav1.1	  and	  Nav1.6	  alter	  biophysical	  properties	  of	   these	  channels	  compared	   to	   the	  wildtype	   protein.	   Although	   several	   biophysical	   properties	   were	   altered	   by	   the	  disease	   mutations,	   we	   found	   differential	   effects	   on	   resurgent	   current	   generation,	  which	   suggests	   a	   divergence	   in	   the	  mechanism	   by	  which	  mutations	   in	   these	   two	  channel	   isoforms	   induce	   epileptogenesis	   and	   consequently	   result	   in	   different	  phenotypes.	  We	  found	  that	  mutations	  in	  Nav1.1	  (R1648H	  and	  N1788K)	  that	  result	  in	  GEFS+	  or	  Dravet	  Syndrome,	  did	  not	  alter	  peak	  resurgent	  current	  and	  caused	  loss-­‐of-­‐function	  effects	  on	  other	  biophysical	  properties.	  In	  contrast,	  mutations	  in	  Nav1.6	  (L1331V	   and	   N1768D)	   that	   result	   in	   a	   severe	   EIEE,	   dramatically	   increased	   peak	  resurgent	   sodium	   current.	   These	   findings	   are	   consistent	  with	   the	   hypothesis	   that	  epilepsy-­‐associated	  mutations	   in	   Nav1.1	   are	   predominantly	   loss-­‐of-­‐function	  while	  mutations	   in	  Nav1.6	   are	   primarily	   gain-­‐of-­‐function.	  Moreover,	  we	   found	   that	   CBD	  can	   preferentially	   inhibit	  Nav1.6	   generated	   resurgent	   current	   over	   peak	   transient	  current.	  This	  led	  us	  to	  ask	  whether	  CBD	  could	  inhibit	  the	  aberrant	  activity	  generated	  by	  Nav1.6	  mutant	  channels.	  We	  found	  that,	  indeed,	  1μM	  of	  CBD	  can	  reduce	  mutant	  channel	   activity	   by:	   shifting	   the	   voltage-­‐dependence	   of	   activation	   to	   more	  depolarizing	   potentials,	   slowing	   channel	   recovery	   from	   fast	   inactivation	   and	  inhibiting	  resurgent	  and	  persistent	  current.	  We	  further	  confirmed	  our	  findings	  using	  endogenous	  sodium	  currents	   from	  striatal	  neurons,	  again	  demonstrating	   that	  CBD	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can	  inhibit	  endogenous	  resurgent	  and	  persistent	  current.	  Overall,	  CBD	  inhibits	  VGSC	  activity	  contributing	  to	  a	  decrease	  in	  neuronal	  excitability	  (Fig.	  27).	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   In	   this	   study,	   we	   focused	   on	   Nav1.1	   and	   Nav1.6	   due	   to	   the	   phenotypic	  severity	  of	  epilepsy-­‐associated	  mutations	  identified	  in	  these	  two	  channel	   isoforms.	  	  Nav1.1	  and	  Nav1.6	  only	  exhibit	  75%	  sequence	  identity	  and	  have	  distinct	  expression	  patterns	   in	   the	   brain.	   Specifically,	   Nav1.1	   is	   expressed	   in	   parvalbumin	   positive	  GABAergic	  neurons	  in	  somato-­‐dendritic	  compartments	  as	  well	  as	  the	  proximal	  axon	  initial	  segment,	  while	  Nav1.6	  is	  found	  ubiquitously	  but	  is	  highly	  concentrated	  in	  the	  distal	   axon	   initial	   segment	   [116,	   145,	   177].	   The	   expression	   pattern	   of	   these	   two	  channel	   isoforms	   is	   critical	   to	   understanding	   the	   potential	   mechanisms	   by	   which	  mutations	   in	   these	   channels	   lead	   to	   pathological	   hyperexcitability.	   Our	   findings	  show	  that,	  despite	  having	  only	  75%	  sequence	  identity,	  reciprocal	  disease	  mutations	  conferred	   similar	   biophysical	   defects	   to	   both	   channel	   isoforms;	   at	   least	   for	   this	  position,	   the	   specific	   amino	   acid	   substitution	   itself	   is	   critical	   to	   the	   biophysical	  consequences.	   Understanding	   the	   biophysical	   consequence	   of	   epilepsy-­‐associated	  mutations	   can	   give	   us	   insight	   into	   the	   potential	   mechanism	   by	   which	   different	  phenotypes	  arise.	  	  	   VGSCs	   are	   highly	   regulated	   proteins	   that	   can	   be	  modulated	   by	  many	   post-­‐translational	   processes,	   and	   therefore	   the	   cellular	   background	   in	   which	   they	   are	  expressed	  can	  greatly	  influence	  the	  biophysical	  properties	  they	  exhibit.	  This	  caveat	  is	   a	   limitation	   of	   all	   studies	   of	   mutant	   channels	   in	   expression	   systems	   and	   is	  exemplified	  by	  the	  Nav1.1	  R1648H	  mutant.	  While	  we	  replicated	  the	  impairment	  in	  inactivation	   and	   decreased	   current	   density,	   we	   did	   not	   observe	   an	   increase	   in	  persistent	  current	  or	  enhancement	  of	  slow	  inactivation	  as	  seen	  by	  some	  others	  [180,	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201,	  204,	  205,	  218,	  219].	  This	  could	  be	  due	  to	  the	  lack	  of	  co-­‐expressing	  full-­‐length	  auxiliary	  Navβ	   subunits	   in	   our	   study.	   	   Interestingly,	   enhanced	   persistent	   currents	  were	   not	   observed	   in	   interneurons	   from	   transgenic	  mice	   expressing	   the	   R1648H	  mutation	   [180,	   204,	   205,	   219],	   but	   the	   possibility	   that	   Nav1.1	   R1648H	   enhances	  persistent	  currents	   in	  specific	  neuronal	  populations	  cannot	  be	  ruled	  out.	  However,	  our	   study	   replicated	   all	   the	   biophysical	   defects	   previously	   characterized	  with	   the	  Nav1.6	   N1768D	   mutant	   including:	   increased	   persistent	   current,	   incomplete	  inactivation,	   and	   a	   depolarizing	   shift	   in	   steady-­‐state	   inactivation	   [211].	  Heterologous	  expression	  systems	  and	  animal	  models	  are	  useful,	  but	  have	  limitations	  due	   to	   extensive	   modulation	   of	   sodium	   channels	   and	   therefore	   mutant	   channels	  may	  exhibit	  distinct	  biophysical	  properties	  in	  human	  neuronal	  subtypes.	  	  	  	   Overall,	  our	  data	  suggests	  that	  mutations	  in	  Nav1.1	  and	  Nav1.6	  are	  acting	  by	  distinct	  mechanisms	  to	  induce	  epileptogenesis.	  Although	  the	  two	  Nav1.1	  mutations	  that	   we	   characterized	   were	   selected	   from	   among	   hundreds	   of	   Nav1.1	   mutations	  associated	  with	  epilepsy,	  most	  Nav1.1	  mutations	  are	  believed	  to	  be	  loss-­‐of-­‐function.	  	  There	  will	   likely	  be	  exceptions	   to	   this	  paradigm.	   	  Several	  mutations	   in	  Scn1a	  have	  been	   identified	   in	  patients	  with	  migraine	   and	   some	  of	   these	   appear	   to	  be	   gain-­‐of-­‐function	  [220].	  By	  contrast,	  far	  fewer	  Scn8a	  epilepsy	  mutations	  have	  been	  identified	  and	  characterized	   [208].	  The	   two	  Nav1.6	  mutations	   that	  we	  characterized,	   and	  an	  additional	   Nav1.6	   I1327V	   mutant	   that	   we	   characterized	   (Fig.	   28),	   had	   direct	  enhancing	  effects	  on	  resurgent	  currents.	   It	   is	  probable	  that	  not	  all	  gain-­‐of-­‐function	  mutations	  in	  Nav1.6	  will	  enhance	  resurgent	  current	  activity.	  	  Indeed,	  we	  previously	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found	  that	  painful	  Nav1.7	  mutations	  could	  be	  divided	  into	  one	  of	   two	  groups	  [65].	  Paroxysmal	   extreme	   pain	   disorder	   mutations	   impairing	   inactivation	   enhanced	  resurgent	  currents,	  while	  primary	  erythromelalgia	  mutations	  enhancing	  activation	  did	  not	  alter	  resurgent	  currents.	  Mutations	  in	  domains	  III	  and	  IV	  or	  the	  C-­‐terminus	  of	   the	   channel	   Nav1.6	   most	   likely	   impair	   inactivation	   and	   enhance	   resurgent	  currents,	  while	  mutations	  that	  enhance	  activation	  such	  as	  the	  Nav1.6	  N984K	  mutant	  [187]	   may	   not	   directly	   enhance	   resurgent	   current.	   But	   alterations	   in	   both	  biophysical	  properties	  are	  still	  possible,	  as	  we	  found	  an	  enhancement	  of	  activation	  and	  increased	  resurgent	  current	  generation	  by	  the	  Nav1.6	  I1330V	  mutant	  (Fig.	  28).	  A	  few	  apparent	  loss-­‐of-­‐function	  mutations	  have	  also	  been	  reported	  in	  Nav1.6	  [187,	  190].	   It	   is	   not	   entirely	   clear	   how	   these	  mutations	   lead	   to	   epilepsy,	   although	   since	  Nav1.6	   is	   expressed	   in	   both	   excitatory	   and	   inhibitory	   neurons,	   there	   could	   be	  important	   reductions	   in	   inhibitory	   tone	   with	   loss-­‐of-­‐function	   Nav1.6	   mutations.	  Interestingly,	  enhanced	  Nav1.6	  resurgent	  currents	  have	  been	  observed	  in	  an	  animal	  model	   of	   induced	   temporal	   lobe	   epilepsy	   [194,	   195].	   This	   raises	   the	   intriguing	  possibility	  that	  Nav1.6	  resurgent	  currents	  may	  be	  increased	  in	  epilepsy	  syndromes	  caused	  by	  brain	  injury	  and	  of	  other	  etiologies.	  	  
	   116	  
	  
Figure	   28.	   hNav1.6	   I1330V	  mutant	   channels	   demonstrate	   a	   hyperpolarizing	  
shift	   in	   the	   steady-­‐state	   activation	   curve	   and	   generate	   larger	   resurgent	   and	  
persistent	  current.	  A,	  Current	  density	  curve	  for	  hNav1.6	  WT	  (black	  circles;	  n	  =	  9)	  and	  hNav1.6	  I1330V	  (light	  blue	  squares;	  n	  =	  9).	  B,	  Voltage-­‐dependence	  of	  activation	  and	  inactivation	  curves	  for	  hNav1.6	  WT	  and	  hNav1.6	  I1330V.	  C,	  Percent	  resurgent	  current	  plotted	  against	  repolarization	  voltage.	  D,	  Persistent	  current	  amplitude	  as	  a	  function	  of	  voltage.	  *,	  p<0.05	  two-­‐way	  ANOVA.	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It	   is	   likely	   that	   the	   clinical	   phenotypes	  manifested	   by	  mutations	   in	   Nav1.1	  and	   Nav1.6	   will	   require	   tailored	   treatment	   strategies	   to	   achieve	  maximal	   seizure	  control	   in	   different	   patients.	   	   It	   has	   been	   observed	   that	   many	   VGSC	   blockers	  exacerbate	   seizure	   severity	   in	   patients	  with	   Dravet	   Syndrome	  while	   they	  may	   be	  efficacious	   in	   patients	  with	  mutations	   in	  Nav1.6	   [186,	   188,	   221-­‐223].	   This	   can	   be	  expected	  due	   to	   the	  primary	   role	   of	  Nav1.1	   in	   inhibitory	  neurons	   and	   the	   loss-­‐of-­‐function	   effects	   of	   Dravet	   Syndrome-­‐associated	   mutations	   in	   Nav1.1.	   Further	  inhibition	   of	   inhibitory	   neuron	   excitability	   by	   non-­‐selective	   VGSC	   blockers	   would	  not	   be	   expected	   to	   restore	   inhibitory-­‐excitatory	   balance.	   In	   contrast	  mutations	   in	  Nav1.6	  appear	  to	  be	  primarily	  gain-­‐of-­‐function	  and	  would	  lead	  to	  an	  overall	  increase	  in	   excitability	   of	   all	   neurons	   due	   to	   Nav1.6’s	   ubiquitous	   expression;	   broadly	  inhibiting	   VGSC	   activity	   in	   this	   case	   could	   help	   dampen	   the	   overall	   increase	   in	  excitability.	  In	  this	  study,	  we	  found	  that	  CBD	  can	  inhibit	  VGSC	  activity,	  however	  CBD	  has	   shown	   some	   efficacy	   in	   the	   treatment	   of	   Dravet	   Syndrome	   as	   well	   as	   other	  epilepsy	  syndromes	  [192,	  224,	  225].	  This	  may	  seem	  contradictory	  to	  our	  previous	  discussion,	  but	  we	  posit	  that	  CBD’s	  efficacy	  lies	  in	  its	  specificity.	  At	  a	  concentration	  of	  1μM,	  CBD	  appears	  to	  be	  specific	  for	  Nav1.6	  over	  Nav1.1	  generated	  currents.	  More	  specifically,	   CBD	   is	   selective	   for	   resurgent	   sodium	   current	   over	   peak	   transient	  currents	   generated	   by	   Nav1.6.	   	   Resurgent	   sodium	   currents	   are	   expressed	   in	  subpopulations	  of	  neuronal	  subtypes,	  many	  of	  which	  are	  in	  key	  circuits	   implicated	  in	   epilepsy	   syndromes	   such	   as	   striatal	  medium	   spiny	   neurons,	   perirhinal	   layer	   II	  pyramidal	   neurons,	   hippocampal	   dentate	   gyrus,	   ventral	   CA1	   pyramidal	   neurons,	  globus	   pallidus,	   subthalamic	   nuclei,	   and	  medial	   entorhinal	   cortex	   [92].	   Moreover,	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these	   currents	   are	   thought	   to	   occur	   at	   the	   axon	   initial	   segment	   and	   therefore	   can	  directly	   influence	   action	   potential	   initiation	   [152].	   In	   addition,	   there	   is	   the	  possibility	   that	   seizure	   activity	   itself	   can	   lead	   to	   increased	   Nav1.6	   resurgent	  currents	   in	   excitatory	   neurons	   [194,	   195].	   Thus	   the	   selective	   expression	   of	   this	  atypical	  current	  may	  make	  it	  an	  ideal	  target	  to	  help	  rebalance	  inhibitory-­‐excitatory	  tone	   and/or	   reduce	  pathological	   hyperexcitability	   even	   if	   the	  primary	  defect	   does	  not	  directly	  enhance	  Nav1.6	  resurgent	  current	  activity.	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Figure	   29.	   500nM	   CBD	   decreases	   peak	   resurgent	   current	   generated	   by	  
wildtype	   hNav1.6.	  Percent	  resurgent	  sodium	  current	  recorded	   in	   the	  presence	  of	  vehicle	   (black;	   n	   =	   13)	   and	   500nM	   CBD	   (grey;	   n	   =	   12)	   plotted	   against	   the	  repolarization	  voltage.	  *,	  p<0.05;	  two-­‐way	  ANOVA.	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In	   this	   study,	   we	   used	   a	   low	   concentration	   (1µM)	   of	   CBD	   to	   mimic	   the	  concentrations	  achievable	  in	  vivo	  [226,	  227].	  	  We	  also	  tested	  a	  500nM	  concentration	  of	   CBD	   and	   found	   a	   similar	   inhibition	   of	   peak	   resurgent	   current	   generated	   by	  wildtype	  Nav1.6	  (Fig.	  29).	  Hill	  et	  al.	  have	  found	  that	  high	  concentrations	  (10-­‐30µM)	  of	   CBD	   can	   inhibit	   peak	   transient	   currents	   generated	   by	   other	   VGSC	   isoforms	  including:	   Nav1.1,	   Nav1.2,	   and	   Nav1.5,	   but	   the	   physiological	   significance	   of	   those	  findings	  are	  unclear.	  It	  still	  remains	  unclear	  as	  to	  how	  and	  where	  CBD	  is	  interacting	  with	  Nav1.6.	  Since	  CBD	  had	  no	  significant	  effect	  on	  Nav1.1,	  it	  is	  likely	  not	  acting	  on	  a	  conserved	   region	   in	   these	   two	   isoforms	   i.e.	   the	   local	   anesthetic	   site,	   which	   is	  consistent	  with	  findings	  by	  Foadi	  et	  al.	  with	  ajulemic	  acid	  on	  Nav1.5.	  One	  possibility	  is	   that	  CBD	   targets	   the	  domain	   IV	  voltage-­‐sensor,	  which	   is	   critical	   for	   inactivation	  and	  can	  be	  differentially	  targeted	  by	  toxins	  and	  small	  molecules	  [140,	  228].	  We	  note	  that	   while	   we	   observed	   pronounced	   effects	   of	   CBD	   on	   resurgent	   currents	   in	  population	   studies,	   we	   did	   not	   observe	   significant	   effects	   on	   peak	   transient	   or	  resurgent	   current	   in	   perfusion	   experiments	   on	   cells	   already	   patch-­‐clamped,	  presumably	   due	   to	   disruption	   of	   the	   cytoplasmic	   milleau.	   This	   could	   suggest	   a	  possible	   indirect	  mechanism	   of	   action.	   	   Physiologically,	   it	   is	   plausible	   that	   CBD	   is	  working	  indirectly	  on	  VGSCs.	  CBD	  has	  been	  shown	  to	  inhibit	  the	  degradation	  of	  AEA	  extracellularly,	   which	   we	   and	   others	   have	   found	   can	   inhibit	   Nav1.6	   peak	   current	  density	  [196,	  229].	  In	  cultured	  striatal	  neurons	  CBD	  substantially	  reduced	  repetitive	  firing,	  which	   is	  consistent	  with	  the	   inhibition	  of	  resurgent	  and	  persistent	  currents.	  	  However,	   the	   signficant	   reduction	   in	   action	   potential	   amplitude	   from	   a	   holding	  potential	  of	  -­‐60mV	  suggests	  additional	  actions.	  CBD	  induced	  a	  small	  but	  significant	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negative	   shift	   in	   the	   voltage-­‐dependence	   of	   steady-­‐state	   inactivation	   of	   striatal	  sodium	   currents,	   which	   should	   reduce	   sodium	   channel	   availability	   and	   action	  potential	   amplitude.	   	   Indeed,	  when	   a	  more	  hyperpolarized	  membrane	  potential	   (-­‐80mV)	  was	  used	  to	  measure	  excitability,	  the	  effect	  of	  cannabidiol	  on	  action	  potential	  amplitude	  and	  current	  threhsold	  were	  eliminated	  suggesting	  that	  the	  reduction	  was	  due	   to	   inactivation	   of	   VGSCs	   at	   -­‐60mV	   by	   cannabidiol.	   The	   pronounced	   effect	   on	  excitability	  that	  we	  observed	  in	  cultured	  neurons	  may	  be	  reduced	  in	  CNS	  neurons	  in	  
vivo,	   which	   tend	   to	   have	   more	   negative	   resting	   membrane	   potentials	   (-­‐90	   mV)	  compared	  to	  our	  in	  vitro	  preparation	  (-­‐60	  mV	  or	  -­‐80mV)	  and	  larger	  overall	  sodium	  currents	   [67,	   230].	   	   Indeed,	   in	   the	   limited	   clinical	   reports	   that	   are	   available,	   CBD	  does	  not	  seem	  to	  be	  associated	  with	  major	  CNS	  depression	  [192,	  224].	  Importantly,	  a	  substantial	  decrease	  in	  action	  potentail	  number	  was	  still	  observed	  with	  the	  -­‐80mV	  holding	   potential	   and	   this	   is	   consistent	   with	   the	   reduction	   in	   resurgent	   currents	  observed	   using	   a	   -­‐80mV	   holding	   potential	   (Fig.	   26).	   While	   our	   data	   leads	   us	   to	  predict	  that	  inhibition	  of	  resurgent	  currents	  by	  low	  concentrations	  of	  CBD	  could	  be	  important	   in	   acquired	   and	   inherited	   epilepsies,	   it	   is	   likely	   that	   the	  polypharmacological	  nature	  of	  CBD	  [231]	  also	  can	  contribute	  to	  its	  ability	  to	  reduce	  seizure	  activity.	  	  	  	   In	  conclusion,	  our	  present	   findings	   further	  elucidate	  a	  potential	  mechanism	  by	   which	   epilepsy-­‐associated	   mutations	   in	   Nav1.6	   lead	   to	   pathological	  hyperexcitability,	  which	  is	  distinct	  from	  mutations	  in	  Nav1.1.	  In	  addition,	  we	  found	  that	  CBD	  can	   inhibit	   resurgent	   sodium	  current	  generated	  by	  wildtype	  and	  mutant	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Nav1.6	  channels.	  Overall,	  our	  findings	  suggest	  that	  CBD	  is	  mechanistically	  acting,	  in	  part,	  on	  VGSCs	  to	  decrease	  seizure	  activity	  and	  that	  resurgent	  sodium	  current	  may	  be	  a	  promising	  therapeutic	  target	  for	  the	  treatment	  of	  epilepsy	  syndromes.	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IV. PREFERENTIAL	  PHARMACOLOGICAL	  INHIBITION	  OF	  NAV1.6,	  BUT	  NOT	  NAV1.1,	  ABOLISHES	  EPILEPTIFORM	  ACTIVITY	  INDUCED	  BY	  4-­‐AP	  IN	  MOUSE	  CORTICAL	  BRAIN	  SLICES	  	  This	  chapter	  was	  adapted	  from	  a	  manuscript	  in	  preparation.	  	   Reesha	  R.	  Patel,	  Xingjie	  Ping,	  Shaun	  R.	  Patel,	  Jeffrey	  L.	  Krajewski,	  Jeff	  S.	  McDermott,	  Xiaoming	  Jin,	  and	  Theodore	  R.	  Cummins	  	  R.	  R.	  Patel	  designed	  experiments,	  conducted	  all	  electrophysiological	  experiments,	  analyzed	  and	  interpreted	  the	  data	  and	  drafted	  the	  manuscript.	  	   A. Introduction	  
	   Voltage-­‐gated	   sodium	  channels	   are	   critical	   for	  neuronal	   excitability	   as	   they	  are	   responsible	   for	   the	   initiation	   and	   propagation	   of	   action	   potentials.	   They	   are	  comprised	  of	   a	   large	  α	   subunit	   (Nav1.1	  –	  Nav1.9)	   that	   can	  associate	   covalently	  or	  non-­‐covalently	   with	   several	   auxiliary	   proteins	   including	   one	   or	   more	   β	   subunits	  (Navβ1	   –	   Navβ4)	   [16].	   Therefore,	   these	   channels	   function	   as	   an	   intricate	   channel	  complex	   that	   is	   highly	   regulated.	   Structurally,	   these	   channels	   consist	   of	   four	  homologous	  domains	  each	  with	  six	   transmembrane	  segments	  (S1-­‐S6)	  wherein	   the	  S1-­‐S4	   segments	   make	   up	   the	   voltage-­‐sensing	   modules	   while	   the	   S5-­‐S6	   segments	  make	  up	  the	  central	  pore	  of	  the	  channel.	  Conformational	  changes	  due	  to	  movement	  
	   124	  
of	   the	   voltage-­‐sensing	  modules	  within	   the	   protein	   lead	   to	   state	   transitions	   of	   the	  channel.	  At	  hyperpolarized,	  resting	  membrane	  potentials,	  channels	  are	  primarily	  in	  a	  closed	  (non-­‐conducting)	  state	  and	  upon	  membrane	  depolarization	  they	  transition	  to	   an	   open	   state,	   conducting	   an	   inward	   sodium	   current,	   and	   within	   milliseconds	  after	  opening	  they	  typically	  enter	  an	  inactivated	  state	  (non-­‐conducting).	  The	  inward,	  depolarizing	  current	  generated	  by	  these	  channels	  underlies	  the	  rising	  phase	  of	  the	  action	  potential,	  making	  VGSCs	  essential	  for	  the	  electrical	  signals	  by	  which	  neurons	  transmit	  information.	  	  	  There	   are	   four	   major	   VGSCs	   isoforms	   expressed	   in	   the	   central	   nervous	  system:	   Nav1.1,	   Nav1.2,	   Nav1.3,	   and	   Nav1.6	   [16].	   These	   brain	   isoforms	   of	   VGSCs	  have	  distinct	  cellular	  (i.e.	  neuronal	  populations)	  as	  well	  as	  subcellular	  (i.e.	  neuronal	  compartments)	   localization.	  Nav1.1	   is	  expressed	   in	  the	  cell	  soma,	  dendrites,	  nodes	  of	  Ranvier	  and	  the	  axon	  initial	  segment	  [93-­‐96].	  Nav1.1	  is	  predominantly	  expressed	  in	  parvalbumin	  and	  somatostatin	  positive	  GABAergic	  neurons	  [143,	  144,	  178,	  232-­‐234],	  although	  it	  has	  been	  observed	  in	  some	  excitatory	  neuronal	  populations	  [182].	  	  Nav1.2	   is	   highly	   expressed	   in	   the	   proximal	   axon	   initial	   segment,	   unmyelinated	  axons,	   and	   nerve	   terminals	   [88,	   96,	   101-­‐104].	   Specifically,	   Nav1.2	   expression	   has	  been	  observed	  in	  the	  proximal	  axon	  initial	  segment	  of	  excitatory,	  pyramidal	  neurons	  [150,	   235]	   and	   somatostatin	   positive,	   but	   not	   parvalbumin	   positive,	   GABAergic	  neurons	   [105].	   While	   Nav1.3	   mRNA	   has	   been	   detected	   during	   prenatal	  development,	  its	  expression	  diminishes	  during	  early	  postnatal	  days	  and	  is	  lost	  in	  the	  adult	   rodent	   brain	   [96,	   106].	   Nav1.6	   is	   ubiquitously	   expressed	   in	   the	   brain.	   In	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particular,	   Nav1.6	   expression	   is	   dense	   in	   the	   axon	   initial	   segment	   and	   nodes	   of	  Ranvier	   of	   many	   neuronal	   populations	   [97,	   101,	   102,	   114,	   115].	   Each	   isoforms	  function	   within	   these	   different	   regions	   is	   highly	   specialized	   as	   evidenced	   by	  disruption	  of	  their	  activity	  or	  expression	  leading	  to	  pathological	  conditions	  and/or	  premature	  lethality	  [143,	  179,	  236,	  237].	  
	  It	   is	  not	   surprising	  given	   their	   critical	   role	   in	  excitability	   that	  alterations	   in	  VGSC	  activity	  has	  been	  implicated	  in	  epilepsy.	  The	  most	  convincing	  evidence	  for	  this	  is	   that	   certain	   inherited	   epilepsies	   occur	   in	   patients	   with	   mutations	   in	   VGSCs.	  Indeed,	  mutations	  have	  been	  identified	  in	  all	  brain	  isoforms	  of	  VGSCs	  and	  result	  in	  distinct	   epileptic	   syndromes	   [119,	   124,	   238,	   239].	   Much	   insight	   into	   the	   role	   of	  VSGSs	  in	  epilepsy	  has	  been	  provided	  from	  studying	  animal	  models	  of	  these	  genetic	  epilepsies.	  To	  date,	   the	   leading	  hypothesis	   for	   the	  mechanism	  underlying	  epileptic	  phenotypes	   due	   to	   Nav1.1	   mutations	   is	   the	   decreased	   activity	   of	   inhibitory	  interneurons	  while	   little	   to	  no	  effect	  on	  excitatory	  neurons.	  Due	   to	   the	  prominent	  expression	  of	  Nav1.1	  in	  inhibitory	  neurons,	  this	  would	  lead	  to	  an	  overall	  decrease	  in	  inhibitory	   tone	   [143,	   145,	   205,	   234,	   240].	   Recently,	   the	   first	   epilepsy-­‐associated	  mutation	  in	  Nav1.6	  (N1768D)	  was	  identified	  and	  found	  to	  cause	  gain-­‐of-­‐function	  in	  heterologous	  expression	  systems	  –	   increasing	  both	  Nav1.6	  activity	  and	  excitability	  of	   hippocampal	   neurons	   [123].	   Heterozygous	   Scn8aN1768D/+	   knock-­‐in	   mice	   exhibit	  seizures	  and	  sudden	  unexpected	  death	  in	  epilepsy	  demonstrating	  the	  causal	  role	  of	  this	  mutation	   [241].	  These	   findings	   support	   the	  primary	  hypothesized	  mechanism	  by	   which	   mutations	   in	   Nav1.6	   lead	   to	   epilepsy	   is	   through	   increased	   activity	   of	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Nav1.6	   and	   a	   consequent	   increase	   in	   overall	   neuronal	   excitability.	   Interestingly,	  seizure	   thresholds	   and	   premature	   lethality	   of	  Nav1.1	   heterozygous	  mice,	   a	  model	  for	  SMEI,	  can	  be	  restored	  and	  rescued	  to	  wildtype	  levels	  by	  essentially	  eliminating	  a	  single	   Nav1.6	   allele,	   suggesting	   that	   a	   reduction	   in	   Nav1.6	   activity	   may	   decrease	  seizure	   generation	   [242].	   Indeed,	   heterozygous	   Nav1.6	   mice	   have	   increased	  thresholds	   to	   chemically	   and	   electrically	   induced	   seizures	   [242,	   243].	   Moreover,	  Nav1.6	  channel	  expression	  and	  activity	   is	   increased	   in	  kindling	  models	  of	  epilepsy	  as	  well	   as	  genetic	  epilepsies	   such	  as	   those	  due	   to	  Celf4	  deficiency	   [194,	  244-­‐246].	  The	   findings	  presented	   in	  chapter	   II	  and	  III	  suggest	   that	  broadly	   inhibiting	  Nav1.1	  activity	  could	  have	  adverse	  effects,	  while	  selectively	  inhibiting	  Nav1.6	  may	  be	  more	  beneficial	  for	  the	  treatment	  of	  epilepsy	  syndromes.	  	  The	   primary	   mechanism	   of	   action	   for	   commonly	   used	   AEDs	   such	   as	  phenytoin,	  carbamazepine,	  lamotrigine	  and	  others	  is	  to	  inhibit	  VGSC	  activity.	  These	  drugs	  bind	  to	  the	  pore	  of	  the	  channel	  with	  higher	  affinity	  for	  channels	  in	  an	  open	  or	  inactivated	  state,	  thus	  giving	  them	  with	  a	  use-­‐dependence	  property	  [31].	  Since	  the	  pore	  region	  of	  the	  channel	   is	  highly	  conserved	  among	  VGSC	  isoforms,	  classic	  AEDs	  are	   relatively	   nonselective.	  While	   classic	   AEDs	   can	   help	   control	   seizures	   in	   some	  patients,	  approximately	  20	  to	  40%	  of	  epilepsy	  patients	  are	  refractory	  to	  treatment.	  Therefore,	   there	   is	   a	   need	   to	   develop	   novel	   AEDs.	   From	   animal	  model	   studies,	   it	  seems	  plausible	  that	  selectively	  targeting	  specific	  isoforms	  of	  VGSCs	  may	  be	  a	  more	  efficacious	  strategy	  for	  the	  treatment	  of	  epilepsy	  syndromes.	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   Here	  we	  focus	  on	  the	  contribution	  of	  Nav1.1,	  Nav1.2	  and	  Nav1.6	  to	  epileptic	  activity	   due	   to	   their	   distinct	   expression	   pattern	   and	   availability	   of	   selective	   small	  molecule	  inhibitors	  of	  these	  channel	  isoforms.	  We	  first	  determined	  the	  selectivity	  of	  the	   ICA-­‐121431	   (ICA	   compound)	   and	   LY-­‐03049227	   (LY	   compound)	   for	   Nav1.1,	  Nav1.2	  and	  Nav1.6	  using	  whole-­‐cell	  patch	  clamp	  recordings	   in	  HEK293T	  cells.	  We	  then	   asked	   whether	   preferential	   inhibition	   of	   Nav1.1	   or	   Nav1.6	   by	   ICA	   and	   LY	  compounds,	  respectively,	  would	  have	  differential	  effects	  on	  epileptiform	  activity.	  To	  address	  this	  question	  we	  used	  a	  4-­‐aminopyradine	  (4-­‐AP)	  model	  of	  epileptic	  activity	  [247,	   248],	   and	  multielectrode	   array	   (MEA)	   recordings	   from	  mouse	   cortical	   brain	  slices.	   We	   found	   that	   preferential	   inhibition	   of	   Nav1.6	   abolishes	   epileptiform	  activity,	  while	  inhibition	  of	  Nav1.1	  did	  not.	  This	  led	  us	  to	  ask	  if	  inhibition	  of	  Nav1.1	  alone	  could	  induce	  synchronized	  activity.	  We	  found	  that	  partial	  inhibition	  of	  Nav1.1	  activity	   in	   mouse	   cortex	   can	   increase	   basal	   activity.	   Our	   findings	   suggest	   that	  selective	   targeting	  of	  VGSC	   isoforms	  may	  be	  a	  more	  efficacious	   treatment	  strategy	  for	  epileptic	  syndromes	  than	  current	  AEDs	  that	  broadly	  inhibit	  VGSCs.	  	   	  	   B. Materials	  and	  methods	  
	  1. cDNA	  Constructs	  	  Optimized	  human	  constructs	   for	  Nav1.1,	  Nav1.2	  and	  Nav1.6	  were	  designed	  in-­‐house	   and	   purchased	   from	   Genscript	   (Piscataway,	   NJ).	   cDNA	   constructs	   for	  wildtype	   Nav1.1,	   Nav1.2	   and	   Nav1.6	   channels	   encode	   for	   amino	   acid	   sequences	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corresponding	   to	   the	   accession	   numbers	   BAC21102.1,	   NP_001035232.1	   and	  NP_055006.1	  in	  the	  NCBI	  database,	  respectively.	  	  
	  2. Cell	  cultures	  and	  transfections	  
	  	   The	  use	  of	  HEK293T	  cells	  [153]	  was	  approved	  by	  the	  Institutional	  Biosafety	  Committee	  and	  followed	  the	  ethical	  guidelines	  for	  the	  National	  Institutes	  of	  Health	  for	  the	  use	  of	  human-­‐derived	  cell	  lines.	  HEK293T	  cells	  were	  grown	  under	  standard	  tissue	  culture	  conditions	  (5%	  CO2;	  37°C)	  with	  DMEM	  supplemented	  with	  10%	  fetal	  bovine	   serum.	   HEK293T	   cells	   were	   transiently	   transfected	   using	   the	   calcium	  phosphate	   precipitation	  method.	   Briefly,	   calcium	   phosphate-­‐DNA	  mixture	   (4.5	   μg	  channel	  construct	  and	  0.5	  μg	  EGFP)	  was	  added	  to	  cells	  in	  serum-­‐free	  media	  for	  4-­‐5	  hours	   after	   which	   it	   was	   replaced	   with	   normal	   media.	   12-­‐24	   hours	   post-­‐transfection,	   cells	   were	   split	   onto	   laminin-­‐coated	   glass	   coverslips.	   Cells	   were	  identified	   by	   expression	   of	   EGFP	   using	   a	   fluorescent	   microscope	   and	   whole-­‐cell	  patch	  clamp	  recordings	  were	  obtained	  36-­‐72	  hours	  post-­‐transfection.	  
	   3. Chemicals	  and	  solutions	  
	   ICA-­‐121431	  (ICA	  compound)	  and	  4-­‐aminopyridine	  (4-­‐AP)	  was	  obtained	  from	  Sigma	  Aldrich	  Co.	  (St.	  Lousi,	  MO).	  LY-­‐03049227	  (LY	  compound)	  was	  a	  generous	  gift	  from	  Eli	  Lilly	  and	  Co.	   (Indianapolis,	   IN).	   ICA	  and	  LY	  compounds	  were	  dissolved	   in	  MPL	  to	  a	  stock	  concentration	  of	  10mM	  and	  stored	  at	  4°C.	  4-­‐AP	  was	  also	  dissolved	  in	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MPL	  to	  a	  stock	  concentration	  of	  100mM	  and	  stored	  at	  4°C.	  All	  drugs	  were	  diluted	  to	  desired	  concentration	  in	  artificial	  cerebrospinal	  fluid	  (ACSF)	  or	  extracellular	  patch-­‐clamp	  solution	  just	  prior	  to	  use.	  	  
	   4. Whole-­‐cell	  patch	  clamp	  recordings	  
	   Whole-­‐cell	   patch	   clamp	   recordings	   were	   obtained	   at	   room	   temperature	  (~23°C)	   using	   a	   HEKA	   EPC-­‐10	   amplifier	   and	   the	   Pulse	   program	   (v	   8.80,	   HEKA	  Electronic,	  Germany)	  was	  used	  for	  data	  acquisition.	  Electrodes	  were	  fabricated	  from	  1.7	  mm	  capillary	  glass	  and	  fire-­‐polished	  to	  a	  resistance	  of	  0.9-­‐1.3	  MΩ	  using	  a	  Sutter	  P-­‐97	   puller	   (Sutter	   Instrument	   Company,	   Novato,	   CA).	   All	   voltage	   protocols	  were	  started	   5	   minutes	   after	   obtaining	   a	   gigaΩ	   seal	   and	   entering	   the	   whole-­‐cell	  configuration,	   which	   controlled	   for	   time-­‐dependent	   shifts	   in	   channel	   properties.	  Voltage	   errors	   were	   minimized	   to	   less	   than	   5	   mV	   using	   series	   resistance	  compensation	   and	   passive	   leak	   currents	   were	   cancelled	   by	   P/-­‐5	   subtraction.	   The	  bath	  solution	  contained	   in	  (mM):	  140	  NaCl,	  1	  MgCl2,	  3	  KCl,	  1	  CaCl2,	  and	  10	  Hepes,	  adjusted	   to	   a	  pH	  of	  7.30	  with	  NaOH.	  The	  pipette	   solution	   contained	   in	   (mM):	  140	  CsF,	   10	   NaCl,	   1.1	   EGTA,	   and	   10	   Hepes,	   adjusted	   to	   a	   pH	   of	   7.30	   with	   CsOH.	  Recordings	  were	  made	  in	  the	  presence	  of	  extracellular	  solution	  containing	  the	  drug.	  Each	  coverslip	  was	  recorded	  from	  for	  up	  to	  one	  and	  half	  hours	  before	  discarding.	  	  
	  5. Cortical	  slice	  preparation	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Male	   and	   female	   C57BL/6	   mice	   from	   postnatal	   day	   11	   to	   16	   were	  anesthetized	   with	   ketamine	   and	   decapitated.	   Brains	   were	   quickly	   removed	   and	  placed	  in	  chilled,	  oxygenated	  dissecting	  solution	  containing	  (in	  mM):	  111	  choline-­‐Cl,	  2.5	  KCl,	  1.25	  NaH2PO4,	  10	  MgSO4,	  0.5	  CaCl2,	  26	  NaHCO3,	  and	  10	  D-­‐glucose	   (pH	  7.4	  and	  ~305mOsm).	  Brains	  were	  bisected	  along	  the	  sagittal	  plane,	  leaving	  the	  left	  and	  right	   hemispheres	   intact	   and	   coronal	   cortical	   slices	   were	   cut	   to	   a	   thickness	   of	  300µM	   using	   a	   vibratome	   (Leica	   VT1200,	   Buffalo	   Grove,	   IL).	   After	   cutting,	   slices	  were	  incubated	  in	  oxygenated	  ACSF	  for	  at	  least	  1	  hour	  at	  room	  temperature	  before	  being	  used	  for	  recording.	  ACSF	  solution	  contained	  (in	  mM):	  126	  NaCl,	  2.5	  KCl,	  1.25	  NaH2PO4,	  2	  MgSO4,	  2	  CaCl2,	  26	  NaHCO3	  and	  10	  D-­‐Glucose	  (pH	  7.4	  and	  ~315mOsms).	  	   6. Multielectrode	  array	  recordings	  
	   MEA	  recordings	  were	  performed	  similarly	   to	  methods	  previously	  described	  [249].	  Briefly,	  multielectrode	  array	  probes	  were	  coated	  with	  0.1%	  polyethylenimine	  in	  boric	  solution	  for	  approximately	  three	  hours	  and	  washed	  with	  deionized	  water.	  Slices	  were	  placed	  by	  eye	  in	  a	  manner	  that	  neocortical	  layers	  I-­‐V	  covered	  the	  array	  (Figure	   31).	   Slices	   were	   maintained	   at	   37°C	   and	   continuously	   perfused	   with	  oxygenated	  ACSF	  containing	  drugs.	  Experiments	  testing	  drug	  effects	  on	  100μM	  4-­‐AP	  induced	  hyper-­‐excitability	  were	  conducted	  as	  follows:	  one	  hour	  of	  baseline	  (100μM	  4-­‐AP	   only)	   recording	   followed	   by	   thirty	   minutes	   of	   treatment	   (100μM	   4-­‐AP	   and	  drug	  of	   interest)	  recording	  and	   lastly	  washout	  (100μM	  4-­‐AP	  only)	   to	  confirm	  slice	  viability.	   For	   experiments	   testing	   the	   effects	   of	   drugs	   on	   basal	   activity,	   a	   forty	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minute	   recording	   of	   activity	   in	   the	   presence	   of	   normal	   ACSF	   or	   drug	   alone	   was	  followed	  by	  a	  20	  minute	  recording	   in	   the	  presence	  of	  100μM	  4-­‐AP,	   to	  assure	  slice	  viability,	  was	  obtained.	  Activity	  was	  sampled	  from	  all	  sixty	  electrodes	  at	  a	  sampling	  rate	   of	   1kHz	   and	   amplified	   using	   MC_Rack	   software	   from	   Multichannel	   Systems	  (Reutlingen,	  Germany).	  Data	  was	  stored	  for	  further	  offline	  analysis.	  	  
	   7. Data	  analysis	  
	   Whole-­‐cell	   voltage	   clamp	  data	   are	   represented	   as	   the	  mean	  ±	   the	   standard	  error	   and	   n	   reflects	   the	   number	   of	   separate	   experimental	   cells.	   Concentration	  response	  curves	  were	  fit	  with	  the	  Hill	  logistic	  equation:	  y	  =	  100/(1+10^((LogIC50-­‐x)	  *	  HillSlope)))	  to	  obtain	  IC50	  values	  using	  Graphpad	  Prism	  (La	  Jolla,	  CA).	  	  	   Analysis	  of	  multielectrode	  array	  data	  was	  done	  using	  an	  in-­‐house	  generated	  MATLAB	  script.	  A	  twenty-­‐minute	  window	  in	  the	  middle	  of	  each	  recording	  was	  used	  for	   analysis	   of	   activity.	   Data	   was	   filtered	   using	   a	   second	   order	   butterworth	   filter	  with	  a	  cutoff	  frequency	  of	  15Hz	  to	  get	  rid	  of	  high	  frequency	  noise	  and	  isolate	  slow	  local	   field	   potentials	   (LFPs).	   The	   script	   returns	   peak	   values	   above	   or	   below	   a	  threshold	  set	  to	  at	  least	  six	  times	  the	  standard	  deviation	  of	  the	  noise	  (after	  filtering)	  measured	   for	  20	  seconds	  during	  which	  no	  LFPs	  occur	   for	  each	  recording.	  The	   top	  ten	   most	   active	   electrodes,	   as	   determined	   by	   the	   number	   of	   events,	   during	   the	  baseline	   recording	   from	  each	   slice	  were	  used	   for	   further	  analysis.	  Peak	  amplitude	  was	   calculated	   as	   the	   average	   of	   all	   peak	   values	   from	   a	   single	   electrode	   and	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subsequently	   averaged	   across	   the	   top	   ten	   electrodes.	   Valley	   amplitudes	   were	  calculated	   in	   a	   similar	  manner.	   The	   duration	   of	   the	   LFPs	  was	  measured	   from	   the	  mean	  waveform	   from	   each	   electrode.	   Duration	   values	  were	   then	   averaged	   across	  the	  top	  ten	  electrodes.	  The	  mean	  waveform	  was	  obtained	  by	  plotting	  LFPs	  aligned	  by	   their	  peak	  values.	  Only	  LFPs	  of	   the	  most	   common	   type,	  which	  always	   included	  interictal	   events,	  were	  used	   for	  measurement	  of	  duration.	  MATLAB	  and	  Graphpad	  Prism	   (La	   Jolla,	   CA)	   were	   used	   to	  make	   graphs.	   	   Black	   data	   points	   represent	   the	  mean	  value	  from	  each	  slice,	  while	  the	  mean	  of	  all	  slices	  in	  the	  group	  are	  represented	  in	   red	   data	   points.	   The	   sample	   number,	   n,	   signifies	   the	   number	   of	   separate	  experimental	   slices.	   Statistical	   significance	   was	   determined	   using	   either	   a	   paired,	  when	  appropriate,	  or	  unpaired	  t-­‐test.	  	  	   C. Results	  
	   1. Preferential	  inhibition	  of	  Nav1.1	  and	  Nav1.6	  by	  ICA	  and	  LY	  compounds,	  respectively	  	  
	   Recently,	  it	  was	  discovered	  that	  small	  molecule,	  aryl	  sulfonamide,	  inhibitors	  can	   selectively	   target	   VGSC	   isoforms	   [140,	   250].	   In	   this	   study,	   we	   examined	   the	  effects	   of	   the	   ICA	   compound	   and	   a	   derivative	   of	   the	   previously	   described	   PF-­‐04856262,	   the	   LY	   compound	   [140].	   The	   selectively	   of	   these	   molecules	   has	   been	  attributed	   to	   specific	  extracellularly	  accessible	  amino	  acid	   residues	  of	   the	  voltage-­‐sensing	  module	   of	   domain	   IV.	   Based	   on	   the	   conservation	   of	   these	   residues	   in	   the	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different	   isoforms,	   we	   hypothesized	   that	   these	   compounds	   would	   differentially	  inhibit	  Nav1.1	  and	  Nav1.6.	  Indeed,	  the	  ICA	  compound	  has	  previously	  been	  found	  to	  inhibit	   Nav1.3	   and	   Nav1.1	   (IC50	   =	   ~10-­‐20nM)	   greater	   than	   Nav1.2	   (IC50	   =	  ~250nM)	  and	  to	  an	  even	  greater	  degree	  than	  Nav1.6	  (IC50	  >	  10μM)	  [140].	  To	  test	  the	   selectively	   of	   these	   compounds	   on	   Nav1.1,	   Nav1.2,	   and	   Nav1.6	   activity,	   we	  obtained	  whole-­‐cell	  patch	  clamp	  recordings	  from	  transiently	  transfected	  HEK293T	  cells.	   We	   used	   a	   voltage	   command	   protocol	   in	   which	   we	   applied	   an	   initial	  conditioning	  pulse	   to	   -­‐100mV	  or	   -­‐70mV,	   to	  determine	  the	  maximum	  and	   inhibited	  current,	   respectively,	   for	   8	   seconds	   followed	   by	   a	   recovery	   pulse	   to	   -­‐100mV	   for	  100ms	   and	   a	   final	   test	   pulse	   to	   0mV	   for	   20ms	   (Figure	   30A	   inset).	   We	   generated	  concentration	   response	   curves	   for	   each	   compound	   and	   isoform	   to	   determine	   the	  apparent	   concentration	   at	   which	   fifty	   percent	   of	   activity	   was	   inhibited	   (IC50)	  (Figure	  30).	  We	  found	  that	  the	  LY	  compound	  inhibits	  Nav1.6	  (IC50	  =	  0.39μM)	  and	  Nav1.2	   (IC50	   =	   0.44μM)	   greater	   than	   Nav1.1	   (IC50	   =	   2.25μM)	   (Figure	   30A).	   In	  contrast,	   the	   ICA	   compound	   is	   preferentially	   inhibits	   for	   Nav1.1	   (IC50	   =	   0.07μM)	  over	   Nav1.2	   (IC50	   =	   0.33μM)	   and	   Nav1.6	   (IC50	   =	   2.24μM)	   (Figure	   30B).	   In	   our	  preparation,	   these	   compounds	   showed	   less	   selectivity	   compared	   to	   previously	  reported	  IC50	  values	  [140].	  This	  can	  be	  explained	   in	  part	  by	  the	  use	  of	  a	  different	  voltage	  command	  protocol	  to	  measure	  sensitivity.	  In	  this	  study,	  we	  used	  an	  8	  second	  conditioning	   pulse	   to	   -­‐70mV	   to	  mimic	   physiological	   resting	  membrane	   potentials	  and	   thus	   obtain	   a	   physiologically	   relevant	   measure	   of	   inhibition	   and	   relative	  selectivity.	   Regardless,	   the	   differential	   selectivity	   of	   these	   compounds	   gave	   us	   the	  opportunity	  to	  ask	  how	  different	  VGSC	  isoforms	  contribute	  to	  epileptic	  activity.	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2. Preferential	  inhibition	  of	  Nav1.6,	  but	  not	  Nav1.1,	  abolishes	  epileptiform	  activity	  	  We	   used	   multielectrode	   array	   recordings	   from	   mouse	   cortex	   to	   study	   the	  effects	   of	   these	   small	   molecule	   inhibitors	   of	   VGSC	   isoforms	   on	   4-­‐AP	   induced	  epileptiform	   activity	   (Figure	   31).	   We	   first	   examined	   the	   effects	   of	   continuous	  application	  of	  100μM	  4-­‐AP	  for	  1.5	  hours	  on	  cortical	  activity	  to	  determine	  if	  activity	  changes	  over	  time.	  	  Representative	  traces	  of	  activity	  recorded	  during	  the	  first	  hour	  which	   is	   referred	   to	  as	   the	  baseline	  recording	   in	   the	  presence	  of	  100μM	  4-­‐AP	  and	  the	   next	   thirty	   minutes	   which	   is	   referred	   to	   as	   the	   treatment	   recording	   in	   the	  presence	   of	   100μM	  4-­‐AP	   can	   be	   seen	   in	   Figure	   32A.	  We	   found	   that	   there	  was	   no	  significant	   change	   in	   the	   number	   of	   interictal	   LFP	   events	   between	   baseline	   and	  treatment	   recordings.	   Baseline	   activity	   induced	   by	   4-­‐AP	   was	   variable	   between	  slices;	  therefore	  we	  performed	  paired	  experiments	  and	  show	  the	  mean	  value	  from	  each	  slice	  (black	  data	  points)	  as	  well	  as	  the	  overall	  mean	  for	  each	  group	  (red	  data	  points)	  (Figure	  32B-­‐D,	  F).	  As	  seen	  in	  Figure	  32E,	  the	  interictal	  like	  LFP	  events	  were	  biphasic	  with	  an	  upstroke	  to	  a	  peak	   followed	  by	  downstroke	  to	  a	  valley.	  The	  peak	  and	  valley	  amplitudes	  as	  well	  as	  the	  duration	  of	   the	  LFPs	  remained	  the	  same	  over	  time	   (Figure	   32B-­‐F).	   This	   allowed	   us	   to	   directly	   measure	   drug	   effects	   on	   4-­‐AP	  induced	  activity	  without	  having	  to	  compensate	  for	  run	  –up	  or	  –down	  effects	  of	  the	  model.	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We	   next	   tested	   the	   effects	   of	   the	   500nM	   LY	   compound	   on	   4-­‐AP	   induced	  epileptiform	   activity,	   which	   preferentially	   inhibits	   Nav1.6	   and	   Nav1.2,	   by	  approximately	   fifty	   percent	   according	   to	   the	   apparent	   IC50	   values	   we	   observed,	  while	   having	   little	   to	   no	   effect	   on	   Nav1.1	   or	   Nav1.3	   channel	   activity	   at	   this	  concentration.	   We	   recorded	   baseline	   activity	   for	   one	   hour	   with	   100μM	   4-­‐AP	   to	  induce	   epileptiform	   activity	   and	   subsequently	   recorded	   the	   treatment	   condition	  consisting	  of	  100μM	  4-­‐AP	  with	  500nM	  LY	  compound	  for	   thirty	  minutes.	  We	  found	  that	  500nM	  LY	  compound	  completely	  abolishes	  interictal	  LFPs	  (Figure	  33A).	  We	  did	  not	  observe	  interictal	  LFPs	  in	  any	  recordings	  with	  the	  LY	  compound.	  The	  number	  of	  LFP	  events	  detected	  was	  significantly	   (p<0.05;	  paired	   t-­‐test;	  n	  =	  5)	   reduced	   in	   the	  presence	  of	  the	  LY	  compound	  (Figure	  33B).	  	  Some	  slices	  still	  displayed	  activity,	  but	  of	  much	  smaller	  amplitude	  (Figure	  33C,	  D).	  This	  activity	  did	  not	  exhibit	  the	  typical	  interictal	   LFP	   waveform	   (Figure	   33E,	   F).	   To	   confirm	   slice	   viability	   and	   intact	  attachment	   of	   the	   slice	   to	   electrodes	   after	   treatment	   perfusion,	   we	   recorded	   a	  washout	   recording	   with	   only	   100μM	   4-­‐AP	   that	   demonstrated	   activity	   could	   be	  recovered	  to	  some	  extent	  (Figure	  33A	  inset).	  These	  data	  show	  that	  partial	  inhibition	  of	  Nav1.6	  and	  Nav1.2	  by	  the	  LY	  compound	  selectively	  abolishes	  epileptiform	  activity	  induced	  by	  4-­‐AP	  but	  does	  not	  completely	  inhibit	  slice	  activity.	  	  	  	  We	   further	   investigated	   the	   effects	   of	   	   the	   125nM	   ICA	   compound,	   which	  preferentially	  inhibits	  	  Nav1.1	  and	  Nav1.3	  while	  having	  little	  to	  no	  effect	  on	  Nav1.2	  and	  Nav1.6	  at	  this	  concentration,	  on	  4-­‐AP	  induced	  activity.	  Representative	  traces	  of	  baseline	   and	   treatment	   recordings	   can	   be	   seen	   in	   Figure	   35A.	   We	   found	   no	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siginficant	  effects	  of	  125nM	  ICA	  compound	  on	  the	  number	  of	  interictal	  LFPs	  or	  peak	  or	   valley	   amplitudes	   of	   the	   LFPs	   (Figure	   	   35B-­‐D).	   Aligned	   LFPs	   from	   a	   single	  representative	   electrode	  during	  baseline	   and	   treatment	   recordings	   can	  be	   seen	   in	  Figure	  35E.	  Interestingly,	  there	  was	  a	  slight	  but	  significant	  (p<0.01;	  paired	  t-­‐test;	  n	  =	  5)	  reduction	  in	  LFP	  duration	  in	  the	  presence	  of	  125nM	  ICA	  compound.	  These	  data	  suggest	   that	   inhibition	  of	  Nav1.1	  and	  Nav1.3	  has	  minimal	  effects	  on	  4-­‐AP	   induced	  epileptiform	  activity.	  	  	  To	   further	   dissern	   the	   effects	   of	   Nav1.2	   inhibition	   on	   4-­‐AP	   induced	   hyper-­‐excitability,	   we	   asked	   whether	   partial	   inhibition	   of	   Nav1.2	   by	   the	   ICA	   compound	  would	  reduce	  activity.	  To	  address	  this,	  we	  additionally	  tested	  the	  effects	  of	  a	  higher	  concentration	  of	  the	  ICA	  compound	  (500nM)	  which	  would	  lead	  to	  inhibition	  Nav1.1,	  Nav1.3	   and	   also	   Nav1.2	   by	   approximatly	   fifty	   percent	   according	   to	   the	   apparent	  IC50	   values	  we	   observed,	  while	   having	   little	   to	   no	   effect	   on	  Nav1.6.	  We	   obtained	  similar	   results	   to	   those	   obtained	   with	   125nM	   ICA	   compound,	   with	   no	   significant	  difference	   in	   the	   number	   of	   interictal	   LFPs	   or	   peak	   and	   valley	   amplitues,	   but	   a	  signficant	  reduction	  in	  the	  duration	  of	  the	  LFPs	  (Figure	  35).	  These	  data	  suggest	  that	  partial	  inhibition	  of	  Nav1.2	  with	  the	  ICA	  cmpod	  does	  not	  overtly	  alter	  4-­‐AP	  induced	  hyper-­‐excitability,	   and	   therefore	   the	   effects	   observed	   with	   the	   LY	   compound	   are	  likey	  due	  to	  inhibition	  of	  Nav1.6.	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Figure	   32.	   100μM	   4-­‐AP	   induced	   hyper-­‐excitability	   in	   mouse	   cortical	   brain	  
slices	  does	  not	  change	  over	  time.	  A,	  Representative	  twenty	  minute	  traces	  of	  LFP	  activity	   from	   baseline	   recording	   (left)	   and	   corresponding	   treatment	   recording	  (right).	   The	   blue	   and	   red	   circles	   above	   traces	   depict	   the	   location	   of	   each	   LFP	  detected.	   B,	   Average	   number	   of	   LFPs	   detected	   from	   baseline	   and	   corresponding	  treatment	  recordings	  (n	  =	  6).	  Data	  in	  red	  represent	  the	  mean	  across	  all	  slices.	  	  C	  and	  D,	   Average	   peak	   and	   valley	   amplitude	   calculated	   from	   baseline	   and	   treatment	  recordings.	   E,	   Alignment	   of	   all	   LFPs	   from	   a	   single	   electrode	   during	   baseline	  recording	  (blue)	  and	  treatment	  recording	  (red).	  The	  bolded	  black	  traces	  represent	  the	   mean	   LFP	   waveform	   from	   which	   the	   duration	   was	   measured.	   F,	   Average	  duration	   of	   LFPs	   recorded	   during	   baseline	   and	   corresponding	   treatment	   groups.	  n.s.,	  not	  significant;	  paired	  t-­‐test.	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Figure	  33.	  500nM	  LY	  compound	  abolishes	  intericatal	  LFPs	  induced	  by	  4-­‐AP	  in	  
mouse	  cortical	  brain	  slices.	  A,	  Representative	  twenty	  minute	  traces	  of	  LFP	  activity	  from	   baseline	   recording	   with	   100μM	   4-­‐AP	   (left)	   and	   corresponding	   treatment	  recording	  with	  100μM	  4-­‐AP	  and	  500nM	  LY	  compound	  (right).	  Twenty	  minute	  trace	  of	  corresponding	  washout	  recording	  with	  100μM	  4-­‐AP	  only	  (inset).	  The	  blue	  and	  red	  circles	  above	  traces	  depict	  the	  location	  of	  each	  LFP	  detected.	  B,	  Average	  number	  of	  LFPs	  detected	  from	  baseline	  and	  corresponding	  treatment	  recordings	  (n	  =	  5).	  Data	  in	   red	   represent	   the	   mean	   across	   all	   slices.	   C	   and	   D,	   Average	   peak	   and	   valley	  amplitude	   calculated	   from	   baseline	   and	   treatment	   recordings.	   E,	   Alignment	   of	   all	  LFPs	   from	   a	   single	   electrode	   during	   baseline	   recording	   (blue).	   No	   interictal	   LFPs	  were	   detected	   during	   treatment	   recording.	   The	   bolded	   black	   trace	   represents	   the	  mean	  LFP	  waveform	  from	  which	  the	  duration	  was	  measured.	  F,	  Average	  duration	  of	  LFPs	   recorded	   during	   baseline	   and	   corresponding	   treatment	   groups.	   *p<0.05,	  **p<0.01,	  #p<0.001;	  paired	  t-­‐test.	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Figure	  34.	   125nM	   ICA	   compound	  decreases	   interictal	   LFP	  duration	  but	   does	  
not	   effect	   the	   number	   or	   amplitude	   of	   interictal	   LFPs	   induced	   by	   4-­‐AP	   in	  
mouse	  cortical	  brain	  slices.	  A,	  Representative	  twenty	  minute	  traces	  of	  LFP	  activity	  from	   baseline	   recording	   with	   100μM	   4-­‐AP	   (left)	   and	   corresponding	   treatment	  recording	  with	   100μM	   4-­‐AP	   and	   125nM	   ICA	   compound	   (right).	   The	   blue	   and	   red	  circles	  above	  traces	  depict	  the	  location	  of	  each	  LFP	  detected.	  B,	  Average	  number	  of	  LFPs	  detected	  from	  baseline	  and	  corresponding	  treatment	  recordings	  (n	  =	  5).	  Data	  in	   red	   represent	   the	   mean	   across	   all	   slices.	   C	   and	   D,	   Average	   peak	   and	   valley	  amplitude	   calculated	   from	   baseline	   and	   treatment	   recordings.	   E,	   Alignment	   of	   all	  LFPs	   from	   a	   single	   electrode	   during	   baseline	   recording	   (blue)	   and	   treatment	  recording	   (red).	   The	   bolded	   black	   traces	   represent	   the	  mean	   LFP	  waveform	   from	  which	   the	   duration	   was	   measured.	   F,	   Average	   duration	   of	   LFPs	   recorded	   during	  baseline	  and	  corresponding	  treatment	  groups.	  n.s.,	  not	  significant,	  **p<0.01;	  paired	  t-­‐test.	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Figure	  35.	   500nM	   ICA	   compound	   inhibits	   the	  duration	  of	   interictal	   LFPs	  but	  
has	  no	  effect	  on	  the	  number	  or	  amplitude	  of	  interictal	  LFPs	  induced	  by	  4-­‐AP	  in	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3. Partial	  inhibition	  of	  Nav1.1	  increases	  basal	  activity	  	  	   The	  prominent	  expression	  of	  Nav1.1	  in	  GABAergic	  neurons	  [143-­‐145]	  led	  us	  to	   ask	   whether	   partial	   inhibition	   of	   Nav1.1	   is	   sufficient	   to	   induce	   synchronized	  activity.	   To	   address	   this	   question,	   we	   recorded	   basal	   activity	   in	   the	   presence	   of	  normal	  ACSF	  or	  300nM	  ICA	  compound	  and	  subsequently	  perfused	  100uM	  4-­‐AP	  at	  the	   end	   of	   each	   recording	   to	   confirm	   slice	   viability	   (Figure	   36A).	  While	   statistical	  significance	  was	  not	  reached,	  we	  found	  a	  trend	  towards	  an	  increase	  in	  the	  number	  of	  LFPs	   in	   the	  presence	  of	  300nM	  ICA	  compound.	  Moreover,	   the	  LFPs	  recorded	   in	  the	  presence	  of	  300nM	  ICA	  compound	  were	  significantly	  larger	  in	  magnitude	  (green	  bars;	  n	  =	  5)	  (p<0.05;	  unpaired	  t-­‐test),	  both	  peak	  and	  valley	  amplitudes,	  compared	  to	  LFPs	   recorded	   in	   the	  presence	  of	   normal	  ACSF	   (black	  bars;	  n	   =	   3)(Figure	  36B-­‐D).	  This	  data	  suggests	  that	  partial	  inhibition	  of	  Nav1.1	  can	  increase	  basal	  synchronized	  activity.	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Figure	   36.	   300nM	  of	   the	   ICA	   compound	   alone	   increases	   the	   peak	   and	   valley	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D. Discussion	  	  
	   In	  this	  study,	  we	  examined	  the	  contribution	  of	  VGSC	  isoforms	  to	  epileptiform	  activity	  in	  order	  to	  further	  our	  understanding	  of	  the	  roles	  of	  specific	  isoforms	  in	  the	  brain.	  We	  tested	  the	  selectivity	  of	  newly	  discovered	  small	  molecule	   inhibitors,	   ICA	  and	   LY	   compounds,	   against	  Nav1.1,	   Nav1.2	   and	  Nav1.6	   activity	   in	  HEK293T	   cells.	  We	  found	  that	  the	  ICA	  and	  LY	  compounds	  preferentially	  inhibits	  Nav1.1	  and	  Nav1.6,	  respectively,	  which	  allowed	  us	  to	  parse	  out	  the	  roles	  of	  each	  isoform.	  To	  address	  our	  main	  question	  of	  how	  specific	  VGSCs	  isoforms	  contribute	  to	  epileptiform	  activity,	  we	  observed	   the	   effects	   of	   the	   ICA	   and	   LY	   compounds	   on	   4-­‐AP	   induced	   hyper-­‐excitability,	   an	   established	   in	   vitro	   model	   of	   epilepsy	   [247,	   248],	   with	   MEA	  recordings	   from	   mouse	   cortical	   brain	   slices.	   Interestingly,	   we	   found	   that	   brain	  isoforms	   of	   VGSCs	   play	   distinct	   roles	   during	   epileptiform	   activity.	   Inhibiting	  approximately	  half	  of	  Nav1.6	  and	  Nav1.2	  activity	  with	  500nM	  of	  the	  LY	  compound	  completely	  abolished	  interictal	  LFPs	  induced	  by	  4-­‐AP,	  but	  preserved	  slice	  activity.	  In	  contrast,	   inhibiting	  Nav1.1,	   Nav1.2	   and	  Nav1.3	  with	   500nM	   of	   the	   ICA	   compound	  had	  minimal	  effect	  on	  4-­‐AP	  induced	  hyper-­‐excitability.	  These	  findings	  are	  consistent	  with	   our	   current	   understanding	   of	   the	   localization	   of	   these	   channels	   in	   the	   brain.	  This	  led	  us	  to	  ask	  whether	  partial	  inhibition	  of	  Nav1.1	  could	  alter	  basal	  slice	  activity	  due	  to	  the	  prominent	  expression	  of	  Nav1.1	  in	  inhibitory	  neurons.	  Indeed,	  we	  found	  that	  inhibition	  of	  Nav1.1	  with	  300nM	  ICA	  compound	  increased	  the	  peak	  and	  valley	  amplitudes	  of	  basal	  LFPs	  with	  a	  trend	  toward	  an	  increase	  in	  the	  overall	  number	  of	  basal	  LFPs	  compared	  to	  normal	  ACSF	   in	   the	  absence	  of	  4-­‐AP.	  Overall,	  our	   findings	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clearly	  demonstrate	  that	  brain	  isoforms	  of	  VGSCs	  have	  distinct	  roles	  in	  epileptiform	  activity	   and	   suggest	   that	   selectively	   targeting	   Nav1.6	   activity	   may	   be	   a	   more	  efficacious	  treatment	  strategy	  for	  epileptic	  syndromes.	  	   It	   has	   been	   demonstrated	   that	   Scn1a+/-­‐	   heterozygous	   mice	   display	  spontaneous	   seizures	  mimicking	  a	   SMEI	  phenotype	   [143,	  145].	  However,	   it	   is	   still	  unclear	   if	   these	  seizures	  arise	  because	  of	   the	  direct	   loss	  of	  Nav1.1	  or	  due	   to	  other	  compensatory	  mechanisms	  that	  often	  occur	   in	  genetic	  models.	  While	  some	  studies	  have	   found	   decreased	   somatic	   sodium	   currents	   of	   GABAergic	   neurons	   in	   Scn1a+/-­‐	  heterozygous	  mice	   [145],	  others	  report	  no	  change	   in	  somatic	  sodium	  currents	  but	  still	   find	   an	   impairment	   in	   excitability	   of	   GABAergic	   neurons	   [234,	   251].	   In	   this	  study,	  we	  asked	  how	  inhibition	  of	  Nav1.1	  influences	  epileptiform	  activity	  induced	  by	  4-­‐AP	  and	  whether	  inhibition	  of	  Nav1.1	  is	  sufficient	  to	  induce	  synchronized	  activity.	  We	   did	   not	   observe	   any	   significant	   effects	   of	   inhibition	   of	  Nav1.1	   on	   epileptiform	  activity	  induced	  by	  4-­‐AP	  except	  for	  a	  slight	  decrease	  in	  the	  duration	  of	  the	  LFPs.	  We	  hypothesized	   that	   inhibition	  of	  Nav1.1	  might	   in	   fact	   increase	  epileptiform	  activity,	  however	  we	  did	  not	  observe	  this	  in	  our	  preparation.	  We	  did	  find	  that	  inhibition	  of	  Nav1.1	   with	   the	   ICA	   compound,	   in	   the	   absence	   of	   4-­‐AP,	   increased	   basal	  synchronized	  activity.	   It	   is	  possible	   that	  an	   increase	   in	  basal	   synchronized	  activity	  could	   create	   a	   circuit	   more	   susceptible	   to	   seizure	   generation	   upon	   a	   secondary	  insult.	  Indeed,	  a	  hallmark	  of	  SMEI	  due	  to	  Scn1a	  mutations	  is	  the	  initial	  development	  of	  febrile	  seizures,	  which	  later	  progress	  into	  other	  seizure	  types	  [252].	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As	   mentioned	   previously,	   Nav1.1	   is	   prominently	   expressed	   in	   inhibitory	  GABAergic	   neurons,	   specifically	   those	   that	   express	   somatostatin	   or	   parvalbumim	  [143-­‐145,	  233,	  234].	  Parvalbumin	  positive	  GABAergic	  neurons	  consist	  of	  two	  major	  subtypes,	  basket	  cells	  and	  chandelier	  cells,	  that	  provide	  strong	  synaptic	  inhibition	  to	  the	   proximal	   dendrites/soma	   and	   axon	   initial	   segment,	   respectively,	   of	   pyramidal	  neurons	  –	  placing	  them	  in	  a	  critical	  position	  for	  regulating	  circuit	  excitability	  [253].	  Impaired	   excitability	   of	   parvalbumin	   positive	   neurons	   has	   been	   associated	   with	  epilepsy	  and	  a	  number	  of	  other	  neurological	  disorders	  [254],	  possibly	  due	  to	  their	  importance	  in	  the	  generation	  of	  gamma	  oscillations	  [136,	  255].	  	  Therefore,	  avoiding	  inhibition	   of	   Nav1.1	   will	   likely	   have	   therapeutic	   benefits.	   However,	   while	   hyper-­‐synchronous	   activity	   underlying	   seizures	   is	   commonly	   attributed	   to	   either	   an	  increase	   in	   synchronized	   excitatory	   neuronal	   activity	   or	   a	   decrease	   in	   inhibition,	  there	   is	   increasing	   evidence	   that	   synchronized	   activity	   of	   GABAergic	   neurons	   can	  underlie	   epileptiform	   activity	   [256-­‐260].	   Specifically,	   the	   synchronized	   activity	   of	  somatostatin	  positive	  GABAergic	  neurons,	  which	  express	  Nav1.1	  or	  Nav1.2	  and	  1.6,	  have	  been	  shown	  to	  contribute	  to	  the	  generation	  of	  epileptiform	  activity	  with	  4-­‐AP	  application	   [261].	   In	   fact,	   optogenetic	   activation	   of	   somatostatin	   and	  parvalbumin	  positive	   GABAergic	   neurons	   in	   the	   presence	   of	   4-­‐AP	   produces	   ictal-­‐like	   events	  similar	   to	   those	   occurring	   spontaneously	   [262].	   In	   most	   of	   our	   recordings,	   we	  observed	  only	  interictal	  events	  possibly	  due	  to	  the	  location	  of	  recordings,	  species	  or	  age	  of	   animals	  used.	  This	   is	   not	   surprising	   as	   only	  6%	  of	   slices	   obtained	   from	   rat	  neocortex	  produced	   ictal-­‐like	  events	  with	  4-­‐AP	  [263].	   Indeed,	   in	  one	  recording	  we	  observed	  ictal-­‐like	  events	  that	  were	  approximately	  15	  seconds	  in	  length	  (Fig.	  37A).	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Interestingly,	  500nM	  ICA	  cmpd,	  presumably	   inhibiting	  Nav1.1,	  Nav1.2	  and	  Nav1.3,	  inhibited	   the	   low	   voltage,	   high	   frequency	   phase	   of	   the	   ictal-­‐like	   event	   (Fig.	   37B).	  While	  we	  have	  a	   limited	  sample	  number,	  our	  data	  is	   in	  accordance	  with	  inhibitory	  activity	  underlying	   some	   types	  of	   synchronized	  activity	   induced	  by	  4-­‐AP.	   	  Overall,	  inhibition	  of	  Nav1.1,	  Nav1.2	  and	  Nav1.3	  with	  the	  ICA	  compound	  had	  no	  significant	  effect	  on	  the	  most	  commonly	  observed	  epileptiform	  activity,	  with	  the	  exception	  of	  a	  decrease	   in	   LFP	   duration,	   supporting	   the	   idea	   that	   perhaps	   Nav1.1	   is	   not	   a	   good	  target	  for	  the	  treatment	  of	  epilepsy	  syndromes.	  	  	   Nav1.2	  activity	  is	  inhibited	  by	  approximately	  fifty	  percent	  at	  a	  concentration	  of	  500nM	  with	  both	  the	  ICA	  and	  LY	  compounds.	  Since	  we	  observed	  starkly	  different	  effects	   of	   these	   two	   compounds	   on	   4-­‐AP	   induced	   hyper-­‐excitability	   at	   this	  concentration,	  we	  were	  compelled	   to	  conclude	   that	  Nav1.2	  does	  not	  play	  an	  overt	  role	  in	  epileptiform	  activity	  in	  this	  model.	  However,	  Nav1.2	  has	  been	  implicated	  in	  epilepsy	   as	   evidenced	   by	   genetic	   mutations	   in	   Nav1.2	   that	   result	   in	   epileptic	  syndromes	   [239].	   Interestingly,	   the	   epilepsy-­‐associated	   missense	   mutations	   in	  Nav1.2	   have	   been	   reported	   to	   cause	   both	   gain-­‐	   and	   loss-­‐	   of	   function	   effects	   on	  channel	  properties	  when	  expressed	  in	  heterologous	  expression	  systems	  [264-­‐266].	  While	   this	   may	   seem	   paradoxical,	   it	   is	   not	   entirely	   surprising	   due	   to	   the	   dense	  expression	   of	   Nav1.2	   in	   the	   proximal	   axon	   initial	   segment	   of	   both	   excitatory,	  pyramidal	  neurons	  as	  well	  as	  somatostatin	  positive	  GABAergic,	  inhibitory	  neurons.	  Alternatively,	   it	   is	   possible	   that	   the	   effects	   of	   inhibiting	   Nav1.2	   are	   masked	   by	  concurrently	  inhibiting	  either	  Nav1.1	  with	  the	  ICA	  compound	  or	  Nav1.6	  with	  the	  LY	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compound.	  In	  the	  case	  of	  the	  ICA	  compound,	  inhibiting	  Nav1.1	  and	  Nav1.2	  activity,	  would	   result	   in	   decreased	   excitability	   of	   both	   parvalbumin	   and	   somatostatin	  positive	  GABAergic	  neurons,	  which	  comprise	  the	  majority	  of	  GABAergic	  neurons	  in	  the	  cortex	  [253,	  267].	  Therefore,	  a	  decrease	  in	  excitatory	  neuron	  excitability	  due	  to	  partial	  inhibition	  of	  Nav1.2	  in	  pyramidal	  neurons	  would	  not	  be	  predicted	  to	  restore	  inhibitory-­‐excitatory	   balance.	   Indeed,	   global	   inhibition	   of	   Nav1.2	   results	   in	   a	  decreased	   threshold	   for	   recurrent	   network	   activity	   suggesting	   that	   the	   effects	   of	  Nav1.2	  inhibition	  in	  somatostatin	  positive	  GABAergic	  neurons	  outweigh	  the	  effects	  of	  Nav1.2	  inhibition	  in	  pyramidal	  neurons	  [233].	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Figure	   37.	   An	   example	   of	   4-­‐AP	   induced	   ictal-­‐like	   events	   in	   mouse	   cortical	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Overall,	   our	   findings	   suggest	   that	   selective	   inhibition	   of	   Nav1.6	   may	   be	   a	  better	  treatment	  strategy	  for	  epileptic	  syndromes.	  We	  found	  that	  partially	  inhibiting	  Nav1.6	   activity	   pharmacologically	   can	   abolish	   interictal	   LFPs	   in	   a	   4-­‐AP	   model	   of	  epilepsy,	   while	   preserving	   some	   slice	   activity.	   Selective	   targeting	   of	   this	   isoform,	  rather	   than	   broadly	   inhibiting	   all	   VGSC	   isoforms	   as	   many	   current	   AEDs	   do,	   may	  reduce	   unwanted	   side	   effects.	  While	   genetic	   studies	   support	   the	   idea	   that	   partial	  loss	   of	   Nav1.6	   reduces	   seizure	   generation,	   they	   also	   demonstrate	   the	   potential	  adverse	   consequences	   that	   have	   been	   associated	   with	   loss	   of	   Nav1.6	   activity	  including:	   absence	   seizures,	   motor	   defects	   and	   cognitive	   defects	   [268-­‐271].	  However,	   these	   genetic	   studies	   result	   in	   global	   loss	   of	   one	   allele	   of	   Nav1.6	   and	  possibly	   compensatory	   changes	   that	   could	   further	   fuel	   these	   adverse	   effects,	  whereas	  pharmacological	  inhibition	  of	  Nav1.6	  can	  supposedly	  be	  titrated	  to	  achieve	  a	  balance	  wherein	  the	  benefits	  of	  seizure	  control	  could	  outweigh	  the	  consequences	  of	  unwanted	  side	  effects.	  	  Moreover,	  the	  compounds	  used	  in	  this	  study	  demonstrate	  a	   use-­‐dependence	   property	   that	   is	   a	   greater	   degree	   of	   inhibition	   with	   repetitive	  stimulation,	   similar	   to	   current	   AEDs	   that	   broadly	   target	   voltage-­‐gated	   sodium	  channels	  [140],	  which	  allows	  for	  the	  selective	  targeting	  of	  hyper-­‐excitable	  neurons,	  further	  reducing	  unnecessary	  inhibition	  of	  activity.	  	  	  In	   the	   previous	   chapters,	   it	   was	   demonstrated	   that	   Nav1.6	   has	   a	   greater	  propensity	  to	  generate	  resurgent	  current	  (Chapter	  II)	  and	  that	  epilepsy-­‐associated	  mutations	  in	  Nav1.6	  enhance	  resurgent	  current	  generation	  (Chapter	  III),	  suggesting	  that	  the	  selective	  inhibition	  of	  Nav1.6	  may	  have	  greater	  advantages	  in	  some	  types	  of	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inherited	   and	   even	   acquired	   epileptic	   syndromes.	   Cannabidiol	   is	   one	   potential	  compound	   that	   was	   found	   to	   selectively	   inhibit	   resurgent	   and	   persistent	   current	  generated	  by	  Nav1.6,	  but	  not	  Nav1.1	  (Chapter	  III).	  Indeed,	  cannabidiol	  has	  recently	  been	   shown	   to	   be	   efficacious	   in	   the	   treatment	   of	   intractable	   pediatric	   epilepsies	  [192].	  	  We	  performed	  pilot	  experiments	  examining	  the	  effects	  of	  1μM	  CBD	  on	  4-­‐AP	  induced	  epileptiform	  activity,	  but	  did	  not	  find	  any	  major	  effect.	  However,	  Jones	  et	  al.	  found	   a	   significant	   reduction	   in	   LFP	   frequency	   induced	   by	   4-­‐AP	   with	   CBD	   at	  concentrations	   ranging	   from	   (0.01	   –	   100μM)	   using	   hippocampal	   slices	   [272].	  Overall,	   selective	   inhibition	   of	   Nav1.6,	   potentially	   underlying	   the	   efficacy	   of	  cannabidiol,	  may	  provide	  a	  more	  efficacious	   treatment	  strategy	   for	  many	  epileptic	  syndromes.	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V. CONCLUSIONS	  	  A. Summary	  of	  findings	  	  1. Human	  Nav1.6	  channels	  generate	  larger	  resurgent	  currents	  than	  human	  Nav1.1	  channels,	  but	  the	  Navβ4	  peptide	  does	  not	  protect	  either	  isoform	  from	  use-­‐dependent	  reduction	  	  Voltage-­‐gated	   sodium	   channels	   are	   responsible	   for	   the	   initiation	   and	  propagation	   of	   APs.	   Two	   brain	   isoforms,	   Nav1.1	   and	   Nav1.6,	   have	   very	   distinct	  cellular	   expression	   and	   subcellular	   localization.	   Specifically,	   Nav1.1	   is	  predominantly	   expressed	   in	   the	   soma	   and	   proximal	   axon	   initial	   segment	   of	   fast-­‐spiking	   GABAergic	   neurons	   [143-­‐145],	   while	   Nav1.6	   is	   found	   at	   the	   distal	   axon	  initial	  segment	  and	  nodes	  of	  Ranvier	  of	  both	  fast-­‐spiking	  GABAergic	  and	  excitatory	  neurons	   [116,	   144,	   145].	   Interestingly,	   an	   auxiliary	   voltage-­‐gated	   sodium	   channel	  subunit,	   Navβ4,	   is	   also	   enriched	   in	   the	   axon	   initial	   segment	   of	   fast-­‐spiking	  GABAergic	   neurons	   [138].	   The	   C-­‐terminal	   tail	   of	   Navβ4	   is	   thought	   to	   mediate	  resurgent	  sodium	  current,	  an	  atypical	  current	  that	  occurs	  immediately	  following	  the	  action	  potential	  and	  is	  predicted	  to	  enhance	  excitability	  [68,	  70,	  273,	  274].	  To	  better	  understand	  the	  contribution	  of	  Nav1.1,	  Nav1.6	  and	  Navβ4	  to	  high	  frequency	  firing,	  we	   compared	   the	   properties	   of	   these	   two	   channel	   isoforms	   in	   the	   presence	   and	  absence	  of	  a	  peptide	  corresponding	  to	  part	  of	  the	  C-­‐terminal	  tail	  of	  Navβ4.	  We	  used	  whole-­‐cell	   patch	   clamp	   recordings	   to	   examine	   the	   biophysical	   properties	   of	   these	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two	   channel	   isoforms	   in	   HEK293T	   cells	   and	   found	   several	   differences	   between	  human	  Nav1.1	  and	  Nav1.6	  currents.	  	  Nav1.1	  channels	  exhibited	  slower	  closed-­‐state	  inactivation	   but	   faster	   open-­‐state	   inactivation	   than	   Nav1.6	   channels.	   	   We	   also	  observed	  a	  greater	  propensity	  of	  Nav1.6	  to	  generate	  resurgent	  currents,	  most	  likely	  due	  to	  its	  slower	  kinetics	  of	  open-­‐state	  inactivation,	  compared	  to	  Nav1.1.	  These	  two	  isoforms	  also	  showed	  differential	  responses	  to	  slow	  and	  fast	  AP	  waveforms,	  which	  were	   altered	   by	   the	   Navβ4	   peptide.	   Although	   the	   Navβ4	   peptide	   substantially	  increased	   the	   rate	   of	   recovery	   from	   apparent	   inactivation,	   Navβ4	   peptide	   did	   not	  protect	   either	   channel	   isoform	   from	  undergoing	  use-­‐dependent	   reduction	  with	  10	  Hz	  step-­‐pulse	  stimulation	  or	  trains	  of	  slow	  or	  fast	  AP	  waveforms.	  Overall,	  these	  two	  channels	   have	   distinct	   biophysical	   properties	   that	   are	   predicted	   to	   differentially	  contribute	  to	  regulating	  neuronal	  excitability.	  	  	  	  2. Aberrant	  epilepsy-­‐associated	  mutant	  Nav1.6	  voltage-­‐gated	  sodium	  channel	  activity	  can	  be	  targeted	  with	  cannabidiol	  	   Mutations	   in	  brain	   isoforms	  of	  VGSCs	  have	  been	   identified	   in	  patients	  with	  distinct	  epileptic	  phenotypes.	  Clinically,	  these	  patients	  often	  do	  not	  respond	  well	  to	  classic	   AEDs	   and	   many	   remain	   refractory	   to	   treatment.	   Exogenous	   as	   well	   as	  endogenous	   cannabinoids	   have	   been	   shown	   to	   target	   VGSCs	   and	   cannabidiol	   has	  recently	   received	   attention	   for	   its	   potential	   efficacy	   in	   the	   treatment	   of	   childhood	  epilepsies	   [81,	   139,	   196,	   197].	   In	   this	   study,	  we	   further	   investigated	   the	   ability	   of	  cannabinoids	   to	  modulate	   sodium	  currents	   from	  wildtype	  and	  epilepsy-­‐associated	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mutant	   VGSCs.	   	   We	   first	   determined	   the	   biophysical	   consequences	   of	   epilepsy-­‐associated	  missense	  mutations	   in	  both	  Nav1.1	   (R1648H	  and	  N1788K)	   and	  Nav1.6	  (N1768D	  and	  L1331V)	  by	  obtaining	  whole-­‐cell	  patch	  clamp	  recordings	  in	  HEK293T	  cells	  with	  200μM	  Navβ4	  peptide	  in	  the	  pipette	  solution	  to	  induce	  resurgent	  sodium	  currents.	  Resurgent	  sodium	  currents	  have	  been	  implicated	  in	  multiple	  disorders	  of	  excitability	  [64,	  80,	  195,	  275].	  We	  found	  that	  three	  mutations	  in	  Nav1.6	  dramatically	  increased	  resurgent	  currents	  while	  mutations	  in	  Nav1.1	  did	  not.	  We	  then	  examined	  the	  effects	  of	  anandamide	  and	  cannabidiol	  on	  peak	  transient	  and	  resurgent	  currents	  from	  wildtype	   and	  mutant	   channels.	   Interestingly,	   we	   found	   that	   cannabidiol	   can	  preferentially	   target	   resurgent	   sodium	   currents	   over	   peak	   transient	   currents	  generated	   by	   wildtype	   Nav1.6	   as	   well	   as	   the	   aberrant	   resurgent	   and	   persistent	  current	  generated	  by	  Nav1.6	  mutant	  channels.	  To	  further	  validate	  our	  findings,	  we	  examined	   the	   effects	   of	   cannabidiol	   on	   endogenous	   sodium	   currents	   from	   striatal	  neurons,	  and	  similarly	  we	  found	  an	  inhibition	  of	  resurgent	  and	  persistent	  current	  by	  cannabidiol.	  Moreover,	   current	   clamp	   recordings	   show	   that	   cannabidiol	   increases	  the	  reduces	  overall	  action	  potential	  firing	  of	  striatal	  neurons.	  These	  findings	  suggest	  that	  cannabidiol	  could	  be	  exerting	  its	  anticonvulsant	  effects,	  at	  least	  in	  part,	  through	  its	  actions	  on	  VGSCs,	  and	  resurgent	  current	  may	  be	  a	  promising	  therapeutic	  target	  for	  the	  treatment	  of	  epilepsy	  syndromes.	  	  	  3. Preferential	  pharmacological	  inhibition	  of	  Nav1.6,	  but	  not	  Nav1.1,	  abolishes	  epileptiform	  activity	  induced	  by	  4-­‐aminopyridine	  in	  mouse	  cortical	  brain	  slices	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Brain	   isoforms	   of	   VGSCs	   have	   distinct	   cellular	   and	   subcellular	   expression	  patterns	   as	   well	   as	   functional	   roles	   that	   are	   critical	   for	   normal	   physiology	   as	  aberrations	   in	   their	   expression	   and/or	   activity	   can	   lead	   to	   pathophysiological	  conditions.	  In	  this	  study,	  we	  asked	  how	  inhibition	  of	  select	  isoforms	  of	  VGSCs	  alters	  epileptic	   activity	   to	   further	   parse	   out	   the	   roles	   of	   VGSCs	   in	   the	   brain.	   We	   first	  determined	   the	   relative	   selectivity	   of	   recently	   discovered	   small	   molecule,	   aryl	  sulfonamide,	   inhibitors	   (ICA-­‐121431	   and	   LY-­‐03049227)	   [140]	   against	   Nav1.1,	  Nav1.2,	  and	  Nav1.6	  activity	  using	  whole-­‐cell	  patch	  clamp	  recordings	  obtained	  from	  HEK293T	   cells.	   To	   test	   the	   effects	   of	   these	   inhibitors	   on	   epileptic	   activity,	   we	  obtained	  MEA	  recordings	  from	  mouse	  cortical	  brain	  slices	  in	  the	  presence	  of	  4-­‐AP	  to	  induce	   epileptiform	   activity.	   We	   found	   that	   the	   ICA-­‐121431	   and	   LY-­‐03049227	  compounds	   are	   relatively	   selective	   for	   Nav1.1	   and	  Nav1.6,	   respectively.	   From	   the	  MEA	   recordings,	   we	   found	   that	   500nM	   of	   the	   LY-­‐03049227	   compound,	   a	  concentration	   that	   partially	   inhibits	   Nav1.6	   and	   Nav1.2,	   completely	   abolishes	  interictal	   LFPs	   induced	   by	   4-­‐AP,	   whereas	   in	   contrast	   500nM	   of	   the	   ICA-­‐121431	  compound,	  a	  concentration	  that	  produces	  inhibition	  of	  Nav1.1,	  Nav1.2,	  and	  Nav1.3,	  had	   minimal	   effect	   on	   epileptic	   activity	   induced	   by	   4-­‐AP.	   Due	   to	   the	   prominent	  expression	   of	   Nav1.1	   in	   inhibitory	   neurons	   [143,	   145],	   we	   asked	   whether	  preferential	  inhibition	  of	  Nav1.1	  over	  Nav1.6	  alters	  baseline	  brain	  slice	  activity.	  We	  found	  that,	   indeed,	   inhibition	  with	  300nM	  of	   the	   ICA-­‐121431	  compound	   increased	  basal	   activity	   in	   the	   absence	   of	   4-­‐AP.	   These	   findings	   expand	   our	   current	  understanding	  of	  the	  roles	  of	  VGSC	  isoforms	  in	  the	  brain	  and	  suggest	  that	  selective	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targeting	   of	   Nav1.6	   may	   be	   a	   more	   efficacious	   treatment	   strategy	   for	   epileptic	  syndromes.	  	  	   B. Benefits	  and	  limitations	  of	  experimental	  design	  	  A. Use	  of	  HEK293T	  cell	  line	  as	  a	  model	  system	  to	  study	  VGSCs	  	  	   Many	  of	  the	  experiments	  conducted	  for	  this	  dissertation	  involved	  the	  use	  of	  HEK293T	  cells	  to	  study	  VGSC	  activity.	  While	  this	  is	  a	  common	  practice	  in	  the	  field,	  it	  is	   important	   to	   recognize	   the	   benefits	   and	   limitations	   of	   this	   model	   system	  especially	   in	   regards	   to	   data	   interpretation	   and	   extrapolation	   to	   higher	   model	  systems.	   	   For	   the	   study	   of	   ion	   channels,	   specifically	   VGSCs	   in	   this	   case,	   HEK293T	  cells	  are	  advantageous	  in	  that	  they	  provide	  a	  reduced	  system	  in	  which	  the	  current	  of	  interest	  can	  easily	  be	  isolated	  due	  to	  the	  lack	  of	  significant	  endogenous	  expression	  of	   VGSCs.	   This	   allowed	   for	   the	   study	   of	   human	   channel	   clones,	   which	   have	  differences	  in	  their	  amino	  acid	  sequences	  compared	  to	  other	  species	  and	  of	  specific	  VGSC	  isoforms.	  Moreover,	  their	  relatively	  small	  and	  simple	  cell	  morphology	  allows	  for	  excellent	  voltage	  control	  over	  the	  entire	  cell,	  reducing	  voltage-­‐clamp	  error,	  and	  allowing	  for	  the	  precise	  measurement	  of	  sodium	  currents.	  However,	  VGSCs	  function	  as	  a	  channel	  complex	  wherein	  many	  auxiliary	  proteins	  can	  associate	  and	  modulate	  channel	   activity.	   Therefore,	   the	   cellular	   background	   in	   which	   these	   channels	   are	  studied	  can	  potentially	  greatly	  influence	  their	  biophysical	  properties.	  HEK293T	  are	  derived	  from	  human	  embryonic	  kidney	  cells,	  although	  they	  express	  some	  neuronal	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specific	  proteins	  [276],	  they	  lack	  a	  complete	  neuronal	  background.	  	  A	  caveat	  that	  is	  particularly	  important	  to	  point	  out	  for	  this	  dissertation	  is	  that	  the	  full	  length	  Navβ4	  does	  not	  produce	  resurgent	  currents	  in	  HEK293T	  cells.	  It	  is	  unclear	  why	  this	  is	  but	  it	  may	  be	  due	  in	  part	  to	  cellular	  background	  as	  phosphorylation	  of	  channels	  has	  been	  demonstrated	   to	   be	   necessary	   for	   the	   generation	   of	   resurgent	   sodium	   currents	   in	  cerebellar	  Purkinje	  neurons	  [72].	  For	  this	  reason	  a	  peptide	  corresponding	  to	  part	  of	  the	  C-­‐terminal	  tail	  of	  Navβ4,	  that	  can	  induce	  resurgent	  sodium	  currents,	  was	  used.	  It	  is	  possible	  that	  the	  peptide	  does	  not	  mimic	  all	  the	  properties	  of	  the	  full	  length	  Navβ4	  –	   a	   significant	   difference	   is	   the	   diffuse	   nature	   of	   the	   peptide	   compared	   to	   close	  proximity	  of	  the	  full	   length	  Navβ4	  to	  the	  channel.	  Despite	  these	  disadvantages,	  the	  use	  of	  HEK293T	  cells	  as	  a	  model	  system	  was	  appropriate	  and	  very	  useful	  to	  address	  the	   questions	   posed	   in	   this	   dissertation.	   Reassuringly,	   findings	   in	   HEK293T	   cells	  with	  Nav1.6	  and	  Navβ4	  on	  use-­‐dependent	  reduction	  (Fig.	  14,15)	  were	  reproduced	  in	  DRG	  neurons	  with	  co-­‐transfection	  of	  Nav1.6	  and	  full-­‐length	  Navβ4.	  Moreover,	  the	  effects	   of	   cannabidiol	   on	   Nav1.6	   wildtype	   currents	   in	   HEK293T	   cells	   were	  reproduced	   in	   striatal	   neurons	   with	   endogenous	   sodium	   currents.	   Therefore,	   the	  findings	  cannot	  simply	  be	  attributed	  to	  an	  artifact	  of	  using	  the	  peptide	  rather	  than	  the	  full	  form	  of	  the	  Navβ4	  subunit	  or	  due	  to	  lack	  of	  a	  neuronal	  background,	  further	  demonstrating	   the	   appropriate	  use	  of	   this	   simplified	  model	   system	   to	   study	  VGSC	  currents.	  	  	   Another	   common	   practice	   in	   ion	   channel	   research	   that	   is	   important	   to	  recognize	   when	   extrapolating	   results	   to	   physiological	   implications	   is	   the	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temperature	   at	   which	   recordings	   are	   obtained.	   All	   recordings	   in	   HEK293T	   cells	  were	   obtained	   at	   room	   temperature	   (~23°C).	   Temperature	   can	   greatly	   influence	  physiological	   processes.	   It	   is	   well	   recognized	   that	   ion	   channels	   are	   temperature	  sensitive	  and	  gating	  properties	  of	  both	  sodium	  and	  potassium	  channels	  are	  faster	  at	  higher	   temperatures	   [277].	   Indeed,	   there	   are	   several	   temperature-­‐associated	  pathologies	   linked	   to	  mutations	   in	  VGSCs	  and	   studies	  have	   revealed	  alterations	   in	  gating	  properties	  of	  mutant	   channels	  at	   increased	   temperatures	   (~32-­‐40°C)	   [278-­‐281].	   However,	   recording	   at	   higher	   temperatures	   can	   increase	   potential	   voltage-­‐clamp	   errors	   due	   to	   the	   significantly	   increased	   speed	   of	   gating	   transitions	   and	  difficulties	   with	   fully	   compensating	   for	   series	   resistance	   errors;	   this	   can	   be	  especially	   problematic	   with	   VGSCs	   due	   to	   their	   fast	   kinetics.	   	   Therefore,	   room	  temperature	  recordings	  were	  used	   for	   the	  purposes	  of	  addressing	  the	  aims	  of	   this	  dissertation.	  	  	  B. Use	  of	  cultured	  striatal	  neurons	  as	  a	  model	  system	  to	  study	  sodium	  currents	  and	  excitability	  	  	   Cultured	   striatal	   neurons	   were	   used	   to	   further	   validate	   the	   findings	   in	  HEK293T	   cells.	   The	   use	   of	   striatal	   neurons	   as	   a	   model	   system	   was	   specifically	  advantageous	   for	   addressing	   the	   questions	   posed	   in	   this	   dissertation	   due	   to	   their	  expression	  of	  endogenous	  resurgent	  sodium	  currents	  that	  are	  presumably	  mediated	  by	  Navβ4	  [67].	  Additionally,	  striatal	  neurons	  could	  be	  used	  for	  both	  examining	  VGSC	  currents	  as	  well	  as	  neuronal	  excitability	  –	  allowing	  for	  extrapolation	  of	  findings	  on	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sodium	  currents	   to	   implications	  on	  neuronal	   excitability.	  However,	  because	  of	   the	  complex	  arborization	  of	  dendritic	  and	  axonal	  processes	  of	  cultured	  neurons,	   it	  can	  be	   difficult	   to	  maintain	   good	   voltage	   control	   over	   the	   entire	   neuron	   adding	   some	  voltage-­‐clamp	   error	   associated	   artifacts	   to	   sodium	   current	   recordings.	   Moreover,	  most	   cultured	   neurons,	   especially	   CNS	   neurons,	   are	   relatively	   immature	   and	  may	  lack	   the	   full	   compliment	   of	   ion	   channels	   and	   consequently	   activity	   compared	   to	  adult	  neurons.	  The	  striatum	  contains	  many	  different	  cell	  types	  [282],	  therefore	  the	  cultured	  striatal	  neurons	  are	  heterogeneous,	  which	  can	  additionally	  add	  variability	  to	  the	  results.	  While	  the	  cultured	  striatal	  neurons	  are	  very	  useful,	  they	  still	  may	  not	  entirely	   reflect	   the	   activity	   of	   striatal	   neurons	   in	   vivo.	   	   For	   example,	   the	   resting	  membrane	   potential	   of	   striatal	   neurons	   in	   vivo	   are	   substantially	   more	  hyperpolarized	   (~90mV)	   compared	   to	   data	   in	   cultured	   striatal	   neurons	   (~50mV)	  [67,	  230].	  Indeed,	  in	  an	  intact	  circuit,	  striatal	  neurons	  in	  vivo,	  receive	  glutamatergic	  and	   dopaminergic	   inputs	   from	   other	   brain	   structures	   that	   can	   substantially	  modulate	   activity	   both	   acutely	   and	   long-­‐term	   [230].	   Therefore,	   the	   findings	   from	  cultured	  striatal	  neurons	  and	  their	  implications	  should	  be	  cautiously	  interpreted.	  	  	  	  C. MEA	  recordings	  obtained	  from	  mouse	  cortical	  brain	  slices	  	  	   To	   pharmacologically	   study	   epileptiform	   activity,	   multielectrode	   array	  recordings	   were	   used.	   MEAs	   are	   advantageous	   in	   that	   neuronal	   activity	   can	   be	  measured	  from	  multiple	  sites	  within	  a	  brain	  slice	  simultaneously.	  Since	  epileptiform	  activity	   is	   thought	   to	   be	   the	   result	   of	   synchronized	   activity	   of	  many	  neurons,	   it	   is	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important	  to	  study	  this	  type	  of	  activity	  in	  a	  model	  in	  which	  local	  circuitry	  is	  intact.	  Therefore,	   acute	   coronal,	   cortical	  brain	   slices	  were	  used	   to	  examine	  how	  selective	  inhibition	  of	  VGSC	  isoforms	  alters	  epileptiform	  activity.	  Coronal,	  cortical	  brain	  slices	  are	  advantageous	  in	  that	  the	  columnar	  circuitry	  of	  the	  cerebral	  cortex	  (layers	  I-­‐IV)	  remains	   intact	   along	   with	   some	   long-­‐range	   projects	   from	   sub-­‐cortical	   areas.	  Seizures	  can	  occur	  anywhere	  in	  the	  brain	  but	  the	  most	  common	  types	  of	  partial	  (i.e.	  focal)	   seizures	   are	   localized	   to	   the	   temporal	   and	   frontal	   lobes	   according	   to	   the	  Epilepsy	  Foundation	  [283].	  Indeed,	  the	  cerebral	  cortex	  is	  the	  origin	  site	  of	  seizures	  associated	  with	  several	  acquired	  epilepsy	  syndromes	  [284].	  	  Therefore,	  the	  cortical	  slices	  provide	  a	  relevant	  model	  system	  in	  which	  to	  study	  epileptiform	  activity.	  	  	   The	  4-­‐AP	  model	  of	  epilepsy	  is	  well	  established	  and	  has	  been	  validated	  using	  current	   anti-­‐epileptic	   drugs	   in	   vitro	   [248,	   285,	   286].	   4-­‐AP	   is	   a	   potassium	   channel	  blocker	  that	  can	  induce	  spontaneous	  synchronized	  interictal	  and	  ictal-­‐like	  activity	  in	  brain	   slices.	   Indeed,	   4-­‐AP	   can	   cause	   seizures	   in	   vivo	   [287].	   It	   is	   important	   to	  recognize	  that	  this	  is	  a	  model	  for	  symptomatic	  epileptiform	  activity	  as	  washout	  of	  4-­‐AP	   abolishes	   epileptiform	   activity	   [288].	   Mechanistically,	   4-­‐AP	   block	   of	   voltage-­‐gated	   potassium	   channels	   presumably	   results	   in	   broadening	   of	   the	   AP,	   which	  consequently	   leads	   to	   increased	   calcium	  entry	  at	   the	  axon	   terminal	   and	   increased	  neurotransmitter	  release.	  Other	  mechanisms	  have	  also	  been	  proposed	  to	  underlie	  4-­‐AP	   induced	   interictal	  and	   ictal-­‐like	  events	   [285].	  Regardless,	   the	  model	   is	   likely	   to	  have	   limitations	   as	   still	   other	  mechanisms,	   not	   reflected	   in	   this	  model,	  may	   occur	  during	  epileptic	  activity	  in	  vivo	  in	  different	  syndromes	  and	  patients.	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   An	   important	   caveat	   of	   MEA	   recordings	   is	   that	   the	   recorded	   signals	   are	  generated	   from	   neurons	   near	   the	   surface	   of	   the	   slice	   directly	   adjacent	   to	   the	  electrodes.	  This	  region	  of	  the	  slice	  may	  be	  more	  damaged	  compared	  to	  the	  interior	  of	  the	  slice,	  although	  damage	  is	  reduced	  when	  slices	  are	  cut	  with	  a	  vibratome,	  and	  therefore	   may	   not	   function	   the	   same	   as	   healthy/undamaged	   neurons	   would.	  Another	   important	   consideration	   is	   that	   the	   signals	   being	  measured	   are	   complex.	  Although	  LFPs	  are	  thought	  to	  primarily	  reflect	  synchronized	  synaptic	  activity,	  LFPs	  are	   ultimately	   the	   superimposition	   of	   many	   other	   signals	   including:	   AP	   signals,	  calcium	   spikes	   and	   current	   movement	   through	   gap	   junctions	   [289].	   Therefore,	  interpreting	  and	  understanding	  the	  molecular	  mechanism	  underlying	  alterations	  in	  LFP	  signals	  can	  be	  difficult.	  However,	  the	  paired	  nature	  of	  our	  experiments	  and	  the	  use	  of	  selective	  inhibitors	  along	  with	  our	  current	  understanding	  of	  cortical	  circuitry	  and	  localization	  of	  VGSCs	  allowed	  us	  to	  draw	  some	  conclusions	  regarding	  the	  roles	  of	  select	  isoforms	  in	  epileptiform	  activity.	  	  	   C. Implications	  of	  findings	  towards	  disease	  and	  therapy	  	  	   	  	   Brain	   isoforms	   of	   VGSCs	   have	   distinct	   expression	   and	   cellular	   localization	  patterns	   as	   described	   in	   Chapter	   I.	   Their	   functional	   roles	  within	   these	   specialized	  regions	   are	   not	   well	   understood.	   However,	   it	   is	   clear	   that	   disruption	   of	   their	  expression	  or	  activity	  can	  have	  pathophysiological	  consequences.	  The	  localization	  of	  specific	   isoforms	  in	  particular	  regions	  within	  a	  neuron	  such	  as	  the	  dendrites,	  axon	  initial	   segment,	   axon,	   or	   nerve	   terminals	   influences	   the	   integration	   and	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amplification	   of	   synaptic	   signals,	   action	   potential	   initiation,	   backpropagation	   of	  action	  potentials	   into	   the	  dendrite,	   and	  neurotransmitter	   release.	   	   For	   example,	   it	  can	   be	   theorized	   that	   VGSC	   isoforms	   that	   generate	   large	   persistent	   current	   (i.e.	  Nav1.6)	   if	  expressed	  in	  the	  dendrites	  can	  amplify	  synaptic	  potentials	   leading	  to	  an	  increased	  dendritic	   summation	  of	   excitatory	   input,	   if	   expressed	   in	   the	   axon	   initial	  segment	  may	   lead	   to	   increased	  action	  potential	  generation	   in	   response	   to	  a	   single	  event,	   or	   if	   expressed	   in	   the	   nerve	   terminal	   may	   lead	   to	   longer	   duration	   action	  potential	  waveform	   and	   consequently	  more	   neurotransmitter	   release.	   The	   unique	  biophysical	   properties	   of	   each	   isoform	   are	   therefore	   crucial	   for	   maintaining	  physiological	  neuronal	  activity.	  Understanding	  the	  role	  of	  each	  isoform	  in	  different	  neuronal	   populations	   will	   help	   to	   identify	   potential	   mechanisms	   underlying	  pathophysiologies	  associated	  with	  disruption	  of	  VGSCs.	  	  	   Genetic	   epilepsies	   due	   to	  mutations	   in	   brain	   isoforms	   of	   VGSCs	   arise	   from	  different	  mechanisms	  as	  a	  result	  of	  both	  the	  biophysical	  consequences	  conferred	  by	  the	   mutation	   and	   the	   neuronal	   expression	   of	   the	   channel	   isoform	   in	   which	   the	  mutation	  occurs	  (i.e.	   inhibitory	  versus	  excitatory).	   	  The	  Nav1.1	  epilepsy-­‐associated	  mutations	   studied	  here	  were	   found	   to	  be	   loss-­‐of-­‐function	   (Fig.	  17,	  18;	  Table	  3,	  4),	  consistent	   with	   the	   prominent	   hypothesis	   by	   which	   mutations	   in	   Nav1.1	   cause	  epilepsy.	   That	   is,	   a	   decrease	   in	   Nav1.1	   activity	   leading	   to	   an	   overall	   decrease	   in	  inhibitory	   tone	  due	   to	   the	  primary	  expression	  of	  Nav1.1	   in	  GABAergic	  neurons.	   In	  contrast,	   Nav1.6	   epilepsy-­‐associated	  mutations	   were	   found	   to	   be	   gain-­‐of-­‐function	  (Fig.	   18,	   19,	   28;	   Table	   3,	   4)	   in	   accordance	   with	   the	   major	   hypothesis	   of	   the	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mechanism	   underlying	   epilepsy-­‐associated	   mutations	   in	   Nav1.6.	   Due	   to	   the	  ubiquitous	  expression	  of	  Nav1.6,	  an	  increase	  in	  Nav1.6	  activity	  is	  thought	  to	  lead	  to	  an	   overall	   increase	   in	   neuronal	   excitability.	   One	   novel,	   potential	   mechanism,	  identified	  in	  this	  work,	  by	  which	  Nav1.6	  mutations	  could	  induce	  epileptogenesis	   is	  through	   increased	   generation	   of	   resurgent	   current,	   atypical	   currents	   predicted	   to	  enhance	   neuronal	   excitability,	  which	  was	   not	   observed	  with	  mutations	   in	  Nav1.1.	  	  Interestingly,	   of	   the	   epilepsy-­‐associated	   mutations	   in	   Nav1.2	   that	   have	   been	  characterized	  both	  gain-­‐	  and	  loss-­‐of-­‐function	  effects	  have	  been	  observed.	  While	  not	  a	   major	   focus	   of	   this	   dissertation,	   we	   also	   observed	   mixed	   effects	   on	   resurgent	  current	   generation	   by	   epilepsy-­‐associated	   mutations	   in	   Nav1.2	   (Fig.	   38).	   While	  seemingly	  paradoxical,	   it	   is	   consistent	  with	   the	  dense	   expression	  of	  Nav1.2	   in	   the	  proximal	   axon	   initial	   segment	   of	   both	   somatostatin	   GABAergic	   neurons	   and	  excitatory	   pyramidal	   neurons	   [150,	   233].	   These	   findings	   further	   demonstrate	   the	  need	  for	  treatment	  strategies	  tailored	  to	  phenotype	  and	  genetic	  cause.	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Figure	  38.	  Epilepsy-­‐associated	  mutations	  in	  hNav1.2	  can	  increase	  or	  decrease	  
resurgent	  current	  generation.	  A,	  hNav1.2	  WT	  (black;	  n	  =	  11)	  and	  hNav1.2	  R853Q	  (red;	  n	  =	  11)	  B,	  hNav1.2	  WT	  (black;	  n	  =	  9)	  and	  hNav1.2	  R1882Q	  (blue;	  n	  =	  11).	   *,	  p<0.05,	  **,	  p<0.01;	  two-­‐way	  ANOVA.	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   Current	  AEDs	  are	  effective	  in	  controlling	  seizures	  in	  some	  patients,	  but	  30%	  of	   patients	   are	   refractory	   to	   treatment.	   In	   particular,	   patients	   with	   intractable	  pediatric	   epilepsy	   syndromes	  do	  not	   respond	  well	   to	  AEDs.	   Indeed,	   in	   the	   case	   of	  SMEI,	   AEDs	   that	   broadly	   inhibit	   VGSC	   activity	   are	   contraindicated.	   Cannabidiol,	  marketed	  as	  Epidolex	  by	  GW	  pharmaceuticals,	  has	  recently	  passed	  phase	  III	  clinical	  trials	   for	   its	  use	  for	   intractable	  pediatric	  epilepsies	  [192].	  Accordingly,	  cannabidiol	  reduced	   resurgent	   and	   persistent	   current	   produced	   by	   wildtype	   and	   mutant	  channels	  and	  decreased	  excitability	  of	  striatal	  neurons	  identifying	  a	  mechanism	  by	  which	   cannabidiol	   could	   be	   exerting	   its	   anti-­‐epileptics	   actions.	   Importantly,	  cannabidiol’s	   effects	   were	   specific	   to	   Nav1.6	   as	   no	   affect	   on	   Nav1.1	   generated	  currents	   were	   observed.	   Due	   to	   the	   ubiquitous	   expression	   of	   Nav1.6	   and	   its	  upregulated	   activity	   in	   epileptic	   models,	   cannabidiol	   may	   be	   efficacious	   for	   the	  treatment	   of	   many	   epileptic	   syndromes.	   Indeed,	   preferentially	   inhibiting	   Nav1.1	  versus	   Nav1.6	   during	   epileptiform	   activity	   induced	   by	   4-­‐AP	   results	   in	   starkly	  different	   effects.	   Partial	   pharmacological	   inhibition	   of	   Nav1.6,	   but	   not	   Nav1.1,	  completely	   abolishes	   epileptiform	   activity	   suggesting	   that	   1)	   these	   isoforms	   have	  very	   different	   functional	   roles	   in	   maintaining	   pathological	   activity,	   2)	   Nav1.1	   is	  likely	  not	  a	  good	  target	  and	  it	  may	  be	  beneficial	  to	  avoid	  inhibition	  of	  Nav1.1	  and	  3)	  selectively	   inhibiting	   Nav1.6	   generated	   currents	   may	   be	   a	   better	   strategy	   for	  treatment	  of	  epileptic	  syndromes.	  Intriguingly,	  while	  Nav1.3	  expression	  is	  negligible	  in	  the	  adult	  rodent	  brain,	  Nav1.3	  activity	  is	  also	  upregulated	  in	  many	  animal	  models	  and	   human	   epilepsies	   [108,	   145,	   290,	   291]	   suggesting	   a	   potential	   role	   of	   Nav1.3	  activity	   in	   the	   development	   and/or	   maintenance	   of	   epileptic	   activity.	   Therefore,	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Nav1.3	   may	   be	   a	   good	   target	   for	   the	   treatment	   of	   some	   epilepsy	   syndromes.	  However,	  in	  an	  animal	  model	  of	  SMEI	  (Scn1a+/-­‐)	  up-­‐regulated	  expression	  of	  Nav1.3	  specifically	  occurred	  in	  a	  subpopulation	  of	  GABAergic	  neurons	  in	  the	  hippocampus	  [145].	  This	  upregulated	  expression	  might	  compensate	  in	  part	  to	  the	  loss	  of	  Nav1.1	  channel	  activity.	   In	  this	  case,	   targeting	  Nav1.3	  activity	  may	  be	  deleterious.	  Overall,	  these	   findings	   add	   to	   our	   current	   understanding	   of	   the	   mechanisms	   underlying	  epilepsy	   syndromes	   associated	   with	   mutations	   in	   VGSC	   isoforms,	   their	   role	   in	  maintaining	  epileptiform	  activity	  and	  their	  potential	  to	  be	  targeted	  for	  treatment	  of	  epilepsy	  syndromes.	  	   D. Future	  Directions	  	  	   While	   the	   findings	   presented	   in	   this	   dissertation	   expand	   our	   current	  understanding	   of	   brain	   isoforms	   of	   VGSCs,	   they	   need	   further	   experimental	  validation	   and	   also	   raise	   additional	   questions.	   	   In	   regards	   to	   the	   mechanism	  underlying	  epilepsy-­‐associated	  mutations	  in	  Nav1.1	  and	  Nav1.6,	  a	  logical	  extension	  would	   be	   to	   confirm	   loss-­‐	   and	   gain-­‐of-­‐function	   by	   examining	   the	   effects	   of	   these	  mutant	  channels	  on	  neuronal	  excitability.	  Moreover,	  it	  would	  be	  interesting	  to	  study	  these	  mutant	   channels	   in	   different	   neuronal	   populations	   including:	   paravalbumin	  positive	   GABAergic	   neurons,	   somatostatin	   positive	   GABAergic	   neurons,	   and	  pyramidal	   neurons.	   It	   is	   possible	   that	   the	   biophysical	   consequences	   of	   epilepsy-­‐associated	   mutations	   may	   differ	   depending	   on	   cellular	   background	   as	   has	   been	  demonstrated	  with	  wildtype	  channels	  [292].	  Trafficking	  and	  expression	  level,	  which	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are	   highly	   regulated	   in	   neurons,	   of	   a	   particular	   isoform	   in	   a	   specific	   neuronal	  population	  will	  also	  influence	  the	  consequences	  of	  mutant	  channels	  on	  the	  electrical	  properties	  of	  the	  neuron	  and	  may	  help	  identify	  unknown	  mechanisms.	  	  	  	  	   To	  further	  validate	  Nav1.6	  and/or	  resurgent	  currents	  as	  an	  efficacious	  target	   for	   the	   treatment	   of	   epileptic	   syndromes,	   the	   effects	   of	   the	   compounds	  examined	   in	   this	   dissertation	   (CBD,	   ICA	   and	   LY	   compounds)	   should	   be	   tested	   in	  other	  epilepsy	  models.	  Specifically,	  MEA	  recordings	  from	  brain	  slices	  obtained	  from	  
Scn1a	   heterozygous	   mice,	   a	   model	   of	   SMEI,	   and	   recently	   generated	   Scn8a+/N168D	  knock-­‐in	  mice	  [241]	  would	  be	  useful.	  	  It	  is	  unknown	  whether	  these	  slices	  would	  be	  spontaneously	  active.	  Increasing	  slice	  temperature	  may	  induce	  epileptiform	  activity	  in	   slices	   obtained	   from	  Scn1a	   heterozygous	  mice	   as	   these	  mice	   are	   susceptible	   to	  hyperthermia-­‐induced	  seizures	  [178].	  Additionally,	   the	  theorized	  effects	  of	  the	  ICA	  and	  LY	  compounds	  on	  specific	  neuronal	  populations,	  due	  to	  the	  expression	  of	  select	  VGSC	   isoforms,	   should	   be	   confirmed	   in	   cortical	   slices	   using	   transgenic	  mice	   with	  labeled	   neuronal	   populations.	   Ultimately,	   the	   effects	   of	   viral	   mediated	   shRNA	  knockdown	   of	   Navβ4	   in	   the	   hippocampus	   [293],	   thalamus	   [294]	   or	   entorhinal	  cortex	   [194,	   195],	   regions	   strongly	   implicated	   in	   epilepsy	   and	   containing	  neurons	  known	   to	   express	   resurgent	   currents	   [90],	   on	   seizure	   thresholds	   or	   on	   seizure	  activity	   induced	  prior	   to	  knockdown	  could	  potentially	  provide	  strong	  evidence	   for	  the	  involvement	  of	  resurgent	  currents	  in	  epilepsy.	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  Invited	  Talk	  –	  Indiana	  University	  School	  of	  Medicine	  	  Enhanced	  Resurgent	  Sodium	  Current	  Generation	  by	  	   Nov	  2014	  Epilepsy-­‐Associated	  Mutant	  Voltage-­‐Gated	  Sodium	  Channels	  	   Washington,	  DC	  can	  be	  Targeted	  with	  Cannabidiol	   	  	  Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Theodore	  R.	  Cummins	  	  	  	  Society	  for	  Neuroscience	  Meeting	  	  	  	  	  	  	  	  
	  	   	  
Epilepsy-­‐Associated	  Mutant	  Voltage-­‐Gated	  Sodium	  Channels	  	   July	  2014	  alter	  Resurgent	  Current	  Generation	  that	  could	  be	  Preferentially	  	   South	  Hadley,	  MA	  Targeted	  with	  Cannabidiol	   	  Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Theodore	  R.	  Cummins	  	  	  	  	  Gordon	  Research	  Seminar:	  Ion	  Channels	  	  	  	  RESEARCH	  PRESENTATIONS	  –	  POSTER	  	  Enhanced	  Resurgent	  Sodium	  Current	  Generation	  by	  	   Dec	  2014	  Epilepsy-­‐Associated	  Mutant	  Voltage-­‐Gated	  Sodium	  Channels	  	   Seattle,	  WA	  can	  be	  Targeted	  with	  Cannabidiol	   	  Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Theodore	  R.	  Cummins	  	  	  	  	  American	  Epilepsy	  Society	  	  	  Enhanced	  Resurgent	  Sodium	  Current	  Generation	  by	  	   Oct	  2014	  Epilepsy-­‐Associated	  Mutant	  Voltage-­‐Gated	  Sodium	  Channels	  	   Bloomington,	  IN	  can	  be	  Targeted	  with	  Cannabidiol	   	  Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Theodore	  R.	  Cummins	  	  	  	  	  Gill	  Symposium	  	  Enhanced	  Resurgent	  Sodium	  Current	  Generation	  by	  	   Oct	  2014	  Epilepsy-­‐Associated	  Mutant	  Voltage-­‐Gated	  Sodium	  Channels	  	   Indianapolis,	  IN	  can	  be	  Targeted	  with	  Cannabidiol	   	  Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Theodore	  R.	  Cummins	  	  	  	  	  Indianapolis	  Chapter	  of	  the	  Society	  for	  Neuroscience	  Meeting	  	  	  Epilepsy-­‐Associated	  Mutant	  Voltage-­‐Gated	  Sodium	  Channels	  	   July	  2014	  alter	  Resurgent	  Current	  Generation	  that	  could	  be	  Preferentially	  	   South	  Hadley,	  MA	  Targeted	  with	  Cannabidiol	  	   	  Reesha	  R.	  Patel,	  Cindy	  Barbosa,	  Theodore	  R.	  Cummins	  	  	  	  	  Gordon	  Research	  Conference:	  Ion	  Channels	  	  	  	  RESEARCH	  SUPPORT	  	  Paul	  and	  Carole	  Stark	  Neuroscience	  Research	  Institute	  Fellowship	   	  	  2011	  	  SOCIETY	  AFFILIATIONS	  American	  Epilepsy	  Society	   	  	  2014	  -­‐	  2015	  Society	  for	  Neuroscience	  Member	   	  	  2011	  -­‐	  Present	  
	  	   	  
American	  Association	  for	  the	  Advancement	  of	  Science	  Member	   	  	  2010	  –	  2011	  	  PROFESSIONAL	  ACTIVITIES	  Member	  of	  Central	  Indiana	  Science	  Outreach	  (CINSO)	   2014	  -­‐	  Present	  	  	  	   	  	  
